Alset EHome International (AEI) 10-K 31 Mar 23 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-39732
Entity Registrant Name	ALSET INC.
Entity Central Index Key	0001750106
Entity Tax Identification Number	83-1079861
Entity Incorporation, State or Country Code	TX
Entity Address, Address Line One	4800 Montgomery Lane
Entity Address, Address Line Two	Suite 210
Entity Address, City or Town	Bethesda
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	20814
City Area Code	301
Local Phone Number	971-3940
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	AEI
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 20,298,644
Entity Common Stock, Shares Outstanding		9,235,119
ICFR Auditor Attestation Flag	false
Auditor Firm ID	606
Auditor Location	Jericho, New York
Auditor Name	Grassi & Co., CPAs, P.C.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)		Dec. 31, 2022	Dec. 31, 2021
Current Assets:
Cash		$ 17,827,383	$ 56,061,309
Restricted Cash		694,520	4,740,870
Account Receivables, Net		46,522	39,622
Other Receivables		446,798	334,788
Note Receivables - Related Parties		3,617,176	12,792,671
Prepaid Expense		188,070	1,202,451
Inventory		35,020	47,290
Investment in Securities at Fair Value		6,288,236	19,211,582
Investment in Securities at Fair Value - Related Party		13,193,089	17,125,441
Investment in Securities at Cost		98,129	99,216
Investment in Securities at Equity Method		52,987,224	30,801,129
Deposit			275,204
Total Current Assets		95,422,167	142,731,573
Real Estate
Rental Properties		31,169,031	24,820,253
Properties under Development		23,449,698	15,695,127
Operating Lease Right-Of-Use Asset		1,614,159	659,620
Deposit		536,947	39,653
Property and Equipment, Net		1,298,334	263,917
Total Assets		153,490,336	184,210,143
Current Liabilities:
Accounts Payable and Accrued Expenses		2,983,470	11,341,789
Deferred Revenue		21,198	728,343
Builder Deposits			31,553
Operating Lease Liability		45,556	283,989
Notes Payable		181,846	317,671
Notes Payable - Related Parties		12,668	833,658
Total Current Liabilities		3,244,738	13,537,003
Long-Term Liabilities:
Operating Lease Liability		1,582,483	383,354
Total Liabilities		4,827,221	13,920,357
Stockholders’ Equity:
Common Stock, $0.001 par value; 250,000,000 shares authorized; 7,422,846 and 4,368,422 shares issued and outstanding on December 31, 2022 and December 31, 2021, respectively	[1]	7,423	87,368
Additional Paid in Capital		322,534,891	296,181,977
Accumulated Deficit		(188,724,411)	(148,233,473)
Accumulated Other Comprehensive Income		3,836,063	341,646
Total Alset Inc. Stockholders’ Equity		137,653,966	148,377,518
Non-controlling Interests		11,009,149	21,912,268
Total Stockholders’ Equity		148,663,115	170,289,786
Total Liabilities and Stockholders’ Equity		$ 153,490,336	$ 184,210,143
[1]The common stock share amounts were adjusted retrospectively to reflect the 20-for-1 reverse stock split on December 28, 2022

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	7,422,846	4,368,422
Common stock, shares outstanding	7,422,846	4,368,422

Consolidated Statements of Oper

Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue
Total Revenue	$ 4,480,442	$ 19,798,822
Operating Expenses
Cost of Sales	3,731,990	11,301,814
General and Administrative	7,837,826	23,491,130
Total Operating Expenses	11,569,816	34,792,944
Operating Losses from Operations	(7,089,374)	(14,994,122)
Other Income (Expense)
Interest Income	67,470	183,636
Interest Expense	(1,853)	(317,281)
Foreign Exchange Transaction (Loss) Gain	(547,845)	1,363,061
Unrealized Loss on Securities Investment	(7,794,139)	(1,959,664)
Unrealized Loss on Securities Investment - Related Party	(23,556,219)	(47,231,084)
Realized Loss on Securities Investment	(7,308,580)	(4,698,078)
Loss on Investment on Security by Equity Method	(685,533)	(51,999)
Finance Costs	(450,000)	(50,871,869)
Other Income	1,153,568	93,823
Total Other Expense, Net	(39,123,131)	(103,489,455)
Net Loss Income Before Income Taxes	(46,212,505)	(118,483,577)
Income Tax Expense		(534,014)
Net Loss	(46,212,505)	(119,017,591)
Net Loss Attributable to Non-Controlling Interest	(5,721,567)	(15,694,415)
Net Loss Attributable to Common Stockholders	(40,490,938)	(103,323,176)
Other Comprehensive Loss, Net
Unrealized Gain (Loss) on Securities Investment	40,201	(57,179)
Foreign Currency Translation Adjustment	508,277	(3,974,966)
Comprehensive Loss	(45,664,027)	(123,049,736)
Comprehensive Loss Attributable to Non-controlling Interests	(5,620,606)	(16,933,170)
Comprehensive Loss Attributable to Common Stockholders	$ (40,043,421)	$ (106,116,566)
Net Loss Per Share - Basic and Diluted	$ (6.22)	$ (73.85)
Weighted Average Common Shares Outstanding - Basic and Diluted	6,513,453	1,399,144
Rental [Member]
Revenue
Total Revenue	$ 1,810,011	$ 327,296
Property [Member]
Revenue
Total Revenue	1,278,617	13,886,083
Biohealth [Member]
Revenue
Total Revenue	753,651	5,543,066
Digital Transformation Technology [Member]
Revenue
Total Revenue	69,915
Other [Member]
Revenue
Total Revenue	$ 568,248	$ 42,377

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2020			$ 8,570	$ 102,729,944	$ 2,143,338	$ (44,910,297)	$ 59,971,555	$ 38,023,260	$ 97,994,815
Balance, shares at Dec. 31, 2020			8,570,000
Transactions under Common Control				(57,190,499)			(57,190,499)		(57,190,499)
Issuance of Common Stock by Exercising Warrants			$ 67,502	104,498,157			104,565,659		104,565,659
Issuance of Common Stock, shares			67,502,481
Convert Common Stock to Series A Preferred Stock	$ 6		$ (6,380)	6,374
Convert Common stock to Series A Preferred Stock, shares	6,380		(6,380,000)
Convert Related Party Note Payable to Series B Preferred Stock		$ 2		12,999,998			13,000,000		13,000,000
Convert Related Party Note Payable to Series B Preferred Stock, shares		2,132
Convert Preferred Stock Series A and B to Common Stock	$ (6)	$ (2)	$ 8,512	(8,504)
Convert Preferred Stock Series A and B To Common Shares	(6,380)	(2,132)	8,512,000
Sale of Vivacitas to Related Party				2,279,872			2,279,872		2,279,872
Purchase Stock of True Partner from Related Party				3,274,060			3,274,060		3,274,060
Beneficial Conversion Feature Intrinsic Value, Net				50,770,192			50,770,192		50,770,192
Convert Related Party Note to Common Stock			$ 9,164	51,217,402			51,226,566		51,226,566
Convert Related Party Note Payable to Common Stock, shares			9,163,965
Subsidiary’s Issuance of Stock				2,328,707			2,328,707	920,632	3,249,339
Proceeds from Selling Subsidiary Equity				164,107			164,107	115,893	280,000
Change in Non-Controlling Interest				(5,729,539)	865,493		(4,864,046)	2,664,056	(2,199,990)
Deconsolidate American Pacific Bancorp				28,287,920			28,287,920	(383,063)	27,904,857
Exercise American Premium Water Warrant to Purchase Stock				553,786			553,786	180,614	734,400
Change in Unrealized Loss on Investment					(41,273)		(41,273)	(15,906)	(57,179)
Foreign Currency Translations					(2,625,912)		(2,625,912)	(1,349,054)	(3,974,966)
Distribution to Non-Controlling Shareholders								(2,549,750)	(2,549,750)
Net Loss						(103,323,176)	(103,323,176)	(15,694,415)	(119,017,591)
Balance at Dec. 31, 2021			$ 87,368	296,181,977	341,646	(148,233,473)	148,377,518	21,912,268	170,289,786
Balance, shares at Dec. 31, 2021			87,368,446
Issuance of Common Stock by Exercising Warrants			$ 15,820	(11,925)			3,895		3,895
Issuance of Common Stock, shares			15,819,452
Beneficial Conversion Feature Intrinsic Value, Net				450,000			450,000		450,000
Convert Related Party Note to Common Stock			$ 10,000	6,203,000			6,213,000		6,213,000
Convert Related Party Note Payable to Common Stock, shares			10,000,000
Change in Unrealized Loss on Investment					35,110		35,110	5,091	40,201
Foreign Currency Translations					489,167		489,167	19,110	508,277
Net Loss						(40,490,938)	(40,490,938)	(5,721,567)	(46,212,505)
Issuance of Common Stock to Purchase Alset International Stock			$ 35,319	(35,319)
Issuance of Common Stock to Purchase Alset International Stock, shares			35,319,290
Reverse Stock Split 1 for 20			$ (141,084)	141,084
Reverse Stock Split 1 for 20, shares			(141,084,342)
Deconsolidate Alset Capital Acquisition				14,536,215			14,536,215	2,021,367	16,557,582
Gain from Purchase of DSS Stock				737,572			737,572		737,572
Change in Non-Controlling Interests				4,256,980	2,970,140		7,227,120	(7,227,120)
Gain from Purchasing Value Exchange Stock from Related Party				75,307			75,307		75,307
Balance at Dec. 31, 2022			$ 7,423	$ 322,534,891	$ 3,836,063	$ (188,724,411)	$ 137,653,966	$ 11,009,149	$ 148,663,115
Balance, shares at Dec. 31, 2022			7,422,846

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities
Net Loss from Operations	$ (46,212,505)	$ (119,017,591)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Depreciation	963,077	166,451
Amortization of Right-Of-Use Asset	747,975	611,253
Amortization of Debt Discount	450,000	50,871,869
Share-based Compensation and Expense		134,192
Impairment of Promissory Note		421,754
Foreign Exchange Transaction Loss (Gain)	547,845	(1,403,859)
Unrealized Loss on Securities Investment	7,794,139	1,959,664
Unrealized Loss on Securities Investment – Related Party	23,556,219	47,231,084
Realized Loss on Securities Investment	7,308,580	4,698,078
Loss on Exchange of Investment Securities	417,468
PPP Loan Forgiveness	(68,502)
Director Compensation Adjustment	(1,185,251)
Loss on Equity Method Investment	685,533	51,999
Changes in Operating Assets and Liabilities
Real Estate	(8,241,487)	4,810,464
Account Receivables	(221,869)	849,413
Prepaid Expense	400,154	399,442
Deposits	(295,585)	(16,361)
Trading Securities	(7,510,442)	(14,426,785)
Inventory	13,164	34,991
Accounts Payable and Accrued Expenses	(9,535,319)	9,663,367
Other Receivables - Related Parties	(91,925)
Deferred Revenue	(707,145)	(2,199,477)
Operating Lease Liability	(638,006)	(293,525)
Builder Deposits	(31,553)	(1,230,783)
Net Cash Used in Operating Activities	(31,855,435)	(16,684,360)
Cash Flows from Investing Activities
Purchase of Fixed Assets	(599,650)	(227,821)
Purchase of Real Estate Properties	(6,057,493)	(25,362,146)
Real Estate Improvements	(767,237)
Purchase of Investment Securities	(8,429,620)	(19,390,318)
Proceeds from Investment Securities	103,809	110,718
Sales of Investment Securities to Related Party		2,480,000
Cash Loss of Deconsolidation of American Pacific Bancorp Inc.		(1,235,953)
Issuing Loan Receivable - Related Party	(377,864)	(11,878,605)
Proceeds from Loan Receivable - Related Party	1,005,014	(539,876)
Net Cash Used in Investing Activities	(15,123,041)	(56,044,001)
Cash Flows from Financing Activities
Proceeds from Common Stock Issuance	6,213,000	104,565,659
Proceeds from Exercise of Subsidiary Warrants		3,249,339
Proceeds from Sale of Subsidiary Shares		280,000
Dividend Paid on Subsidiary Preferred Stock		(73,750)
Borrowing from PPP Loan		68,502
Borrowing from a Commercial Loan	123,633
Distribution to Non-controlling Interest Shareholders		(2,549,750)
Repayment to Notes Payable	(279,152)	(610,767)
Proceeds from Note Payable - Related Parties		5,545,495
Repayment to Notes Payable - Related Parties		(7,057,324)
Net Cash Provided by Financing Activities	6,057,481	103,417,404
Net (Decrease) Increase in Cash and Restricted Cash	(40,920,995)	30,689,043
Effects of Foreign Exchange Rates on Cash	(1,359,281)	(1,622,343)
Cash and Restricted Cash - Beginning of Year	60,802,179	31,735,479
Cash and Restricted Cash- End of Year	18,521,903	60,802,179
Cash	17,827,383	56,061,309
Restricted Cash	694,520	4,740,870
Total Cash and Restricted Cash	18,521,903	60,802,179
Supplementary Cash Flow Information
Cash Paid for Interest	1,853	20,154
Cash Paid for Taxes		446,757
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Unrealized Gain (Loss) on Investment	777,773	(57,179)
Initial Recognition of ROU / Lease Liability	1,702,514	256,928
Acquiring True Partner Stock by Issuing Promissory Note		10,003,689
Sale of Investment in Vivacitas to Related Party		2,279,872
Deconsolidate Alset Capital Acquisition	16,557,582
Intrinsic Value of BCF	450,000	(50,770,192)
Issuance of Stock by Exercising Warrants	3,895
Transactions under Common Control		57,190,499
Convert Related Party Note Payable to Common Stock	6,213,000	64,226,566
Deconsolidate American Pacific Bancorp Inc.		27,904,857
Gain from Exercise of American Premium Water Warrant		734,400
Purchase of Fixed Asset by Issuing Promissory Note		$ 95,000

NATURE OF OPERATIONS AND SUMMAR

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Alset Inc. (the “Company” or “AEI”), formerly known as Alset EHome International Inc. and HF Enterprises Inc., was incorporated in the State of Delaware on March 7, 2018 and 50 On October 1, 2018, Chan Heng Fai transferred his 100 425,000 100 2,983,918,265 0 2,810,999,176 10,000,000 85.4 76.8 Also, on October 1, 2018, Chan Heng Fai transferred his 100 25,000 50,000 The contributions to AEI on October 1, 2018 of Alset Global, Impact Oncology, and Global eHealth from Chan Heng Fai represented transactions under common control with a related party. On June 24, 2020, HFE Holdings Limited surrendered 180,000 50 On November 24, 2020 the Company held its initial public offering and the Company’s common stock began trading on Nasdaq Capital Market. As a result, 108,000 13.2 On May 13, 2021, July 30, 2021 and December 8, 2021 the Company held follow up offerings of its common shares. As a result of the offerings, the Company issued a total of 3,374,624 105 On December 13, 2021 the Company entered into a Securities Purchase Agreement with Chan Heng Fai for the issuance and sale of a convertible promissory note in favor of Chan Heng Fai, in the principal amount of $ 6,250,000 3 December 31, 2024 12.50 500,000 On January 17, 2022 the Company entered into a securities purchase agreement with Chan Heng Fai, pursuant to which the Company agreed to purchase from Chan Heng Fai 293,428,200 1,473,449 293,428,200 1,765,964 293,428,200 8.4 3,492,713,362 On December 6, 2022, the Company filed a Certificate of Amendment to the Company’s Certificate of Formation with the Texas Secretary of State to effect a 1-for-20 reverse stock split. The Reverse Stock Split was effective as of December 28, 2022. The par value of the common stock following the reverse stock split remains at $0.001 per share. The reverse stock split has been retroactively applied to all financial statements presented. As of December 31, 2022 and 2021, the total outstanding common shares of the Company were 7,422,846 4,368,422 The Company has four Real Estate The Company’s real estate segment is comprised of LiquidValue Development Inc. (“LiquidValue Development”) and SeD Perth Pty Ltd. In 2014, Alset International commenced operations developing property projects and participating in third-party property development projects. LiquidValue Development Inc. (f.k.a. SeD Intelligent Home Inc.), a 99.9 Development activities are generally contracted out, including planning, design and construction, as well as other work with engineers, surveyors, architects and general contractors. The developed lots are then sold to builders for the construction of new homes. LiquidValue Development’s primary real estate projects are two subdivision development projects, one near Houston, Texas, known as Black Oak, currently projected to have approximately 550-600 units, and one in Frederick, Maryland, known as Ballenger Run, consisting of 197 In 2022 and 2021, LiquidValue Development’s subsidiaries purchased 23 and 109 homes, respectively, in Texas from other builders in different communities. The Company intends to rent these homes. LiquidValue Development pursued this new endeavor in part to improve cash flow and smooth out the inconsistencies of income in residential land development. We intend to develop our subsidiary American Home REIT Inc. as the owner of most of single-family rental homes. Digital Transformation Technology The Company’s digital transformation technology segment is comprised of Hapi Metaverse Inc. and its subsidiaries. The Company’s digital transformation technology business is involved in mobile application product development and other businesses, providing information technology services to end-users, service providers and other commercial users through multiple platforms. This technology platform consists of instant messaging systems, social media, e-commerce and payment systems, direct marketing platforms, e-real estate, brand protection and counterfeit and fraud detection. Hapi Metaverse Inc. (“Hapi Metaverse”), our 99.7 Biohealth The Company’s biohealth segment is comprised of HWH International Inc. and its subsidiaries and is committed to both funding research and developing and selling products that promote a healthy lifestyle. In October 2019, the Company expanded its biohealth segment into the Korean market through one of the subsidiaries of HWH International Inc., HWH World Inc (“HWH World”). HWH World is in the business of sourcing and distributing dietary supplements and other health products through its network of members in the Republic of Korea (“South Korea”). HWH World generates product sales via its direct sale model as products are sold to its members. Through the use of a Hapi Gig platform that combines e-commerce, social media and a customized rewards system, HWH Korea equips, trains and empowers its members. We compete with numerous direct sales companies in South Korea. HWH World recognized $ 753,651 5,543,066 21,198 728,343 Other Business Activities In addition to the segments identified above, the Company provides corporate strategy and business development services, asset management services, corporate restructuring and leveraged buy-out expertise. These service offerings build relationships with promising companies for potential future collaboration and expansion. We believe that our other business activities complement our three principal businesses. The Company’s other business activities segment is primarily comprised of Alset International, SeD Capital Pte. Ltd., BMI Capital Partners International Limited, Singapore Construction & Development Pte. Ltd. and food and beverage part of HWH International Inc. The Company, through Alset F&B One Pte. Ltd. (“Alset F&B One”) and Alset F&B (PLQ) Pte. Ltd. (“Alset F&B PLQ”) each acquired a restaurant franchise licenses at the end of 2021 and 2022 respectively, both of which have since commenced operations. These licenses will allow Alset F&B One and Alset F&B PLQ each to operate a Killiney Kopitiam restaurant in Singapore. Killiney Kopitiam, founded in 1919, is a Singapore-based chain of mass-market, traditional kopitiam style service cafes selling traditional coffee and tea, along with a range of local delicacies such as Curry Chicken, Laksa, Mee Siam, and Mee Rebus. The Company, through Hapi Café Inc. (“HCI-T”), commenced operation of two cafés during 2022 and 2021, which are located in Singapore and South Korea. The cafes are operated by subsidiaries of HCI-T, namely Hapi Café SG Pte. Limited (“HCSG”) in Singapore and Hapi Café Korea Inc. (“HCKI”) in Seoul, South Korea. Hapi Cafes are distinctive lifestyle café outlets that strive to revolutionize the way individuals dine, work, and live, by providing a conducive environment for everyone to relish the four facets – health and wellness, fitness, productivity, and recreation all under one roof. During the years ended on December 31, 2022 and 2021, the revenue from the other business activities described above was approximately $ 568,248 42,377

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include all accounts of the Company and its majority owned and controlled subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting common stock The Company’s consolidated financial statements include the financial positions, results of operations and cash flows of the following entities as of December 31, 2022 and 2021 as follows: SCHEDULE OF SUBSIDIARIES Attributable interest State or other jurisdiction of as of, Name of subsidiary consolidated under AEI incorporation or organization December 31, 2022 December 31, 2021 % % Alset Global Pte. Ltd. Singapore 100 100 Alset Business Development Pte. Ltd. Singapore 100 100 Global eHealth Limited Hong Kong 100 100 Alset International Limited Singapore 85.4 76.8 Singapore Construction & Development Pte. Ltd. Singapore 85.4 76.8 Art eStudio Pte. Ltd. Singapore 43.6 * 39.2 * Singapore Construction Pte. Ltd. Singapore 85.4 76.8 Global BioMedical Pte. Ltd. Singapore 85.4 76.8 Alset Innovation Pte. Ltd. Singapore 85.4 76.8 Health Wealth Happiness Pte. Ltd. Singapore 85.4 76.8 SeD Capital Pte. Ltd. Singapore 85.4 76.8 LiquidValue Asset Management Pte. Ltd. Singapore 85.4 76.8 * Alset Solar Limited Hong Kong 85.4 76.8 Alset F&B One Pte. Ltd. Singapore 76.9 69.2 Global TechFund of Fund Pte. Ltd. Singapore 100 76.8 Singapore eChainLogistic Pte. Ltd. Singapore 100 76.8 BMI Capital Partners International Limited Hong Kong 85.4 76.8 SeD Perth Pty Ltd Australia 85.4 76.8 SeD Intelligent Home Inc. United States of America 85.4 76.8 LiquidValue Development Inc. United States of America 85.4 76.8 Alset EHome Inc. United States of America 85.4 76.8 SeD USA, LLC United States of America 85.4 76.8 150 Black Oak GP, Inc. United States of America 85.4 76.8 SeD Development USA Inc. United States of America 85.4 76.8 150 CCM Black Oak, Ltd. United States of America 85.4 76.8 SeD Texas Home, LLC United States of America 85.4 76.8 SeD Ballenger, LLC United States of America 85.4 76.8 SeD Maryland Development, LLC United States of America 71.4 64.2 SeD Development Management, LLC United States of America 72.6 65.3 SeD Builder, LLC United States of America 85.4 76.8 Hapi Metaverse Inc. (f.k.a. GigWorld Inc.) United States of America 99.7 76.8 HotApp BlockChain Pte. Ltd. Singapore 99.7 76.6 HotApp International Limited Hong Kong 99.7 76.6 HWH International, Inc. United States of America 85.4 76.8 Health Wealth & Happiness Inc. United States of America 85.4 76.8 HWH Multi-Strategy Investment, Inc. United States of America 85.4 76.8 SeD REIT Inc. United States of America 85.4 76.8 Gig Stablecoin Inc. United States of America 99.7 76.6 HWH World Inc. United States of America 99.7 76.6 HWH World Pte. Ltd. Singapore 85.4 76.6 UBeauty Limited Hong Kong 85.4 76.8 WeBeauty Korea Inc South Korea 85.4 76.8 HWH World Limited Hong Kong 85.4 76.8 HWH World Inc. South Korea 85.4 76.8 Alset BioHealth Pte. Ltd. Singapore - 76.8 Alset Energy Pte. Ltd. Singapore - 76.8 GDC REIT Inc. (f.k.a. Alset Payment Inc.) United States of America 85.4 76.8 Alset World Pte. Ltd. Singapore - 76.8 BioHealth Water Inc. United States of America 85.4 76.8 Impact BioHealth Pte. Ltd. Singapore 85.4 76.8 American Home REIT Inc. United States of America 85.4 76.8 Alset Solar Inc. United States of America 68.3 61.5 HWH KOR Inc. United States of America 85.4 76.8 Open House Inc. United States of America 100 76.8 Open Rental Inc. United States of America 100 76.8 Hapi Cafe Inc. (Nevada) United States of America 100 76.8 Global Solar REIT Inc. United States of America 100 76.8 OpenBiz Inc. United States of America 100 76.8 Hapi Cafe Inc. (Texas) United States of America 85.4 100 HWH (S) Pte. Ltd. Singapore 85.4 76.8 True Partner International Limited Hong Kong - 100 LiquidValue Development Pte. Ltd. Singapore 100 100 LiquidValue Development Limited Hong Kong 100 100 Alset EPower Inc. United States of America 100 100 EPowerTech Inc. United States of America 100 100 AHR Asset Management Inc. United States of America 85.4 76.8 HWH World Inc. (Nevada) United States of America 85.4 76.8 Alset F&B Holdings Pte. Ltd. Singapore 85.4 76.8 Credas Capital Pte. Ltd. Singapore 42.7 * 38.4 * Smart Reward Express Limited Hong Kong 49.8 * 38.3 * Partners HWH Pte. Ltd. Singapore - 76.8 AHR Texas Two, LLC United States of America 85.4 76.8 AHR Black Oak One, LLC United States of America 85.4 76.8 Hapi Air Inc. United States of America 92.7 88.4 AHR Texas Three, LLC United States of America 85.4 76.8 Alset Capital Pte. Ltd. Singapore 100 100 Hapi Cafe Korea Inc. South Korea 85.4 100 Green Energy Inc. United States of America 100 100 Green Energy Management Inc. United States of America 100 100 Alset Metaverse Inc. United States of America 97.2 95.6 Alset Management Group Inc. United States of America 83.4 88.2 Alset Acquisition Sponsor, LLC United States of America 93.4 79.6 Alset Capital Acquisition Corp. United States of America 23.4 79.6 Alset Spac Group Inc. United States of America 93.4 - Hapi Travel Pte. Ltd. Singapore 85.4 - Hapi WealthBuilder Pte. Ltd. Singapore 85.4 - Alset Mining Pte. Ltd. Singapore 85.4 - HWH Marketplace Pte. Ltd. Singapore 85.4 - HWH International Inc. (Nevada) United States of America 85.4 - Hapi Cafe SG Pte. Ltd. Singapore 85.4 - Alset Reits Inc. United States of America 100 - Alset Home REIT Inc. United States of America 100 - Hapi Metaverse Inc. United States of America 99.7 - Hapi Cafe Limited Hong Kong 99.7 - MOC HK Limited Hong Kong 99.7 - AHR Texas Four, LLC United States of America 100 - Alset F&B (PLQ) Pte. Ltd. Singapore 85.4 - * Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, valuation of real estate assets, allocation of development costs and capitalized interest to sold lots, fair value of the investments, the valuation allowance of deferred taxes, and contingencies. Actual results could differ from those estimates. In our property development business, land acquisition costs are allocated to each lot based on the area method, the size of the lot compared to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot compared to the total size of all lots in the project. When the Company purchases properties but does not receive the assessment information from the county, the Company allocates the values between land and building based on the data of similar properties. The Company makes appropriate adjustments once the assessment from the county is received. At the same time, any necessary adjustments to depreciation expense are made in the income statement. On December 31, 2022 and 2021 the Company adjusted $ 4,791,997 821,417 197,609 0 Transactions between Entities under Common Control On March 12, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company, for four proposed transactions, consisting of (i) purchase of certain warrants (the “Warrants”) to purchase 1,500,000,000 28,363,966 173,395 62,122,908 6,729,629 4,775,523 28,653,138 63,920,129 0.001 111.80 On October 15, 2020, American Pacific Bancorp (which subsequently became a majority-owned subsidiary of the Company) entered into an acquisition agreement to acquire 3,500,001 100 1,500,000 250,000 The common control transactions resulted in the following basis of accounting for the financial reporting periods: ● The acquisition of the Warrants and True Partner stock were accounted for prospectively as of March 12, 2021 and they did not represent a change in reporting entity. ● The acquisition of LVD, APB and HFL was under common control and was consolidated in accordance with ASC 850-50. The consolidated financial statements were retrospectively adjusted for the acquisition of LVD, APB and HFL, and the operating results of LVD, APB and HFL as of January 1, 2020 for comparative purposes. AEI’s stock price was $ 10.03 50,770,192 63,920,128 306,438 2,123 458,198 Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents. Cash and cash equivalents include cash on hand and at the bank and short-term deposits with financial institutions that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in values. There were no Restricted Cash As a condition to the loan agreement with the Manufacturers and Traders Trust Company (“M&T Bank”), the Company is required to maintain a minimum of $ 2,600,000 309,219 4,399,984 As a condition to the loan agreement with National Australian Bank Limited in conjunction with the Perth project, an Australian real estate development project, the Company is required to maintain Australian Dollar 50,000 36,316 The Company puts funds into a brokerage account specifically for equity investment. As of December 31, 2022 and 2021, the cash balance in that brokerage account was $ 385,304 304,570 Account Receivables and Allowance for Doubtful Accounts Account receivables is stated at amounts due from buyers, contractors, and all third parties, net of an allowance for doubtful accounts. As of December 31, 2022 and 2021, the balance of account receivables was $ 46,522 39,622 0 2,500 The Company monitors its account receivables balances on a monthly basis to ensure that they are collectible. On a quarterly basis, the Company uses its historical experience to estimate its allowance for doubtful account receivables. The Company’s allowance for doubtful accounts represents an estimate of the losses expected to be incurred based on specifically identified accounts as well as nonspecific amount, when determined appropriate. Generally, the amount of the allowance is primarily decided by division management’s historical experience, the delinquency trends, the resolution rates, the aging of receivables, the credit quality indicators and financial health of specific customers. As of December 31, 2022 and 2021, the allowance was $ 0 Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method and includes all costs in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs necessary to make the sale. As of December 31, 2022 and 2021, inventory consisted of finished goods from subsidiaries of HWH International Inc. The Company continuously evaluates the need for reserve for obsolescence and possible price concessions required to write-down inventories to net realizable value. Investment Securities Investment Securities at Fair Value The Company records all equity investments with readily determinable fair values at fair value calculated by the publicly traded stock price at the close of the reporting period. Amarantus BioScience Holdings (“AMBS”) and True Partner Capital Holding Limited (“True Partner”) are publicly traded companies. The Company does not have significant influence over AMBS and True Partner, as the Company is the beneficial owner of approximately 5.3 15.5 On April 12, 2021 the Company acquired 6,500,000 650,000 7,276,163 1,743,734 38.3 During the year ended December 31, 2021, the Company’s subsidiaries established a portfolio of trading securities. The objective is to generate profits on short-term differences in market prices. The Company does not have significant influence over any trading securities in our portfolio and fair value of these trading securities are determined by quoted stock prices. The Company has elected the fair value option for the equity securities noted below that would otherwise be accounted for under the equity method of accounting. Holista CollTech Limited (“Holista”), DSS, Inc. (“DSS”) and New Electric CV Corporation ● The Company has significant influence over DSS. As of December, 2022 and 2021, the Company owned approximately 45.2 24.9 ● The Company has significant influence over Holista as the Company and its CEO are the beneficial owner of approximately 15.5 ● The Company has significant influence over NECV as the Company is the beneficial owner of approximately 0.8 On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of American Medical REIT Inc. (“AMRE”), a related party private startup company, in conjunction with the Company lending two $ 200,000 Note Receivable from a Related Party Company 0 15.8 The Company held a stock option to purchase 250,000 1 0 Sale of Investment in Vivacitas to DSS The Company accounts for certain of its investments in funds without readily determinable fair values in accordance with ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) 100,000 74,827 Investment Securities at Cost Investments in equity securities without readily determinable fair values are measured at cost minus impairment adjusted by observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These investments are measured at fair value on a nonrecurring basis when there are events or changes in circumstances that may have a significant adverse effect. An impairment loss is recognized in the consolidated statements of comprehensive income equal to the amount by which the carrying value exceeds the fair value of the investment. The Company had an equity holding in Vivacitas Oncology Inc. (“Vivacitas”), a private company that is currently not listed on an exchange. We measure Vivacitas at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Our ownership in Vivacitas was sold on March 18, 2021 to DSS for $ 2,480,000 2,279,872 Sale of Investment in Vivacitas to DSS On September 8, 2020, the Company acquired 1,666 1.45 37,826 On September 30, 2020, the Company acquired 3,800 19 42,562 During 2021, the Company invested $ 19,609 18 There has been no indication of impairment or changes in observable prices via transactions of similar securities and investments are still carried at cost. Investment Securities under Equity Method Accounting The Company accounts for equity investment in entities with significant influence under equity-method accounting. Under this method, the Group’s pro rata share of income (loss) from investment is recognized in the consolidated statements of comprehensive income. Dividends received reduce the carrying amount of the investment. When the Company’s share of loss in an equity-method investee equals or exceeds its carrying value of the investment in that entity, the equity method investment can be reduced below zero based on losses if the Company either be liable for the obligations of the investee or provide for losses in excess of the investment when imminent return to profitable operations by the investee appears to be assured. Otherwise, the Company does not recognize its share of equity method losses exceeding its carrying amount of the investment, but discloses the losses in the footnotes. Equity-method investment is reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other-than-temporary. In making this determination, factors are evaluated in determining whether a loss in value should be recognized. These include consideration of the intent and ability of the Group to hold investment and the ability of the investee to sustain an earnings capacity, justifying the carrying amount of the investment. Impairment losses are recognized in other expense when a decline in value is deemed to be other-than-temporary. American Medical REIT Inc. LiquidValue Asset Management Pte. Ltd. (“LiquidValue”), a subsidiary of the Company owns 15.8 American Pacific Bancorp, Inc. Pursuant to Securities Purchase Agreement from March 12, 2021 the Company purchased 4,775,523 6,666,700 40,000,200 As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $ 28.2 30.8 2.9 51,999 867,117 31,668,246 30,801,129 The following table presents summarized unaudited financial information for APB. SCHEDULE OF UNAUDITED FINANCIAL INFORMATION Summarized Financial Information Assets Liabilities Net Income (Loss) December 31, 2022 54,835,272 316,826 2,245,532 December 31, 2021 29,448,425 371,564 (536,481 ) Alset Capital Acquisition Corp. On February 3, 2022, Alset Capital Acquisition Corp. (“Alset Capital”), a special purpose acquisition company (SPAC) sponsored by the Company and certain affiliates, closed its initial public offering of 7,500,000 10.00 1,125,000 473,750 4,737,500 2,156,250 23.4 2,830,961 237,578 237,578 203,713 10 476,250 100 21,111,575 Ketomei Pte Ltd On June 10, 2021 the Company’s indirect subsidiary Hapi Cafe Inc. (“Hapi Cafe”) lent $ 76,723 179,595 28 48,916 207,402 Investment in Debt Securities Debt securities are reported at fair value, with unrealized gains and losses (other than impairment losses) recognized in accumulated other comprehensive income or loss. Realized gains and losses on debt securities are recognized in the net income in the consolidated statements of comprehensive income. The Company monitors its investments for other-than-temporary impairment by considering factors including, but not limited to, current economic and market conditions, the operating performance of the companies including current earnings trends and other company-specific information. The Company invested $ 50,000 9,799 50,000 28,636 On February 26, 2021, the Company invested approximately $ 88,599 2 two years 21.26 88,599 Variable Interest Entity Under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 810, Consolidation The Company evaluates its interests in VIE’s on an ongoing basis and consolidates any VIE in which it has a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE. HWH World Company Limited HWH World Co. is a direct sales company in Thailand. The Company has a 19 187,500 51 236,699 236,699 American Medical REIT Inc. In 2021 the Company owned 3.4 8,350,000 200,000 8 200,000 8,350,000 80.8 200,000 15.8 8,350,000 21,366,177 1,089,675 0 8,901,285 Real Estate Assets Real estate assets are recorded at cost, except when real estate assets are acquired that meet the definition of a business combination in accordance with Financial Accounting Standards Board (“FASB”) ASC 805 - “Business Combinations”, The Company capitalized construction costs of approximately $ 3.2 6.0 million for the years ended December 31, 2022 and 2021, respectively. The Company’s policy is to obtain an independent third-party valuation for each major project in the United States as part of our assessment of identifying potential triggering events for impairment. Management may use the market comparison method to value other relatively small projects, such as the project in Perth, Australia. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – Property Plant and Equipment The Company did not record impairment on any of its projects during the years ended on December 31, 2022 and 2021. Properties under development Properties under development are properties being constructed for sale in the ordinary course of business, rather than to be held for the Company’s own use, rental or capital appreciation. Rental Properties Rental properties are acquired with the intent to be rented to tenants. During the years ended December 31, 2022 and 2021, the Company signed multiple purchase agreements to acquire 23 and 109 homes, respectively. By December 31, 2022, all of the 132 homes were closed with an aggregate purchase cost of $ 30,998,258 Investments in Single-Family Residential Properties The Company accounts for its investments in single-family residential properties as asset acquisitions and records these acquisitions at their purchase price. The purchase price is allocated between land, building, improvements and existing leases based upon their relative fair values at the date of acquisition. The purchase price for purposes of this allocation is inclusive of acquisition costs which typically include legal fees, title fees, property inspection and valuation fees, as well as other closing costs. Building improvements and buildings are depreciated over estimated useful lives of approximately 10 27.5 The Company assesses its investments in single-family residential properties for impairment whenever events or changes in business circumstances indicate that carrying amounts of the assets may not be fully recoverable. When such events occur, management determines whether there has been impairment by comparing the asset’s carrying value with its fair value. Should impairment exist, the asset is written down to its estimated fair value. The Company did not recognize any impairment losses during the years ended on December 31, 2022 and 2021. Revenue Recognition and Cost of Sales ASC 606 - Revenue from Contracts with Customers In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which the determination of revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which the Company expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, performance obligations are satisfied. The following represents the Company’s revenue recognition policies by Segments: Real Estate Property Sales Part of the Company’s real estate business is land development. The Company purchases land and develops it for building into residential communities. The developed lots are sold to builders (customers) for the construction of new homes. The builders enter a sales contract with the Company before they take the lots. The prices and timeline are determined and agreed upon in the contract. The builders do the inspections to make sure all conditions and requirements in contracts are met before purchasing the lots. A detailed breakdown of the five-step process for the revenue recognition of the Ballenger and Black Oak projects, which represented approximately 29 70 ● Identify the contract with a customer. The Company has signed agreements with the builders for developing the raw land to ready to build lots. The agreements have agreed upon prices, timelines, and specifications for what is to be provided. ● Identify the performance obligations in the contract. Performance obligations of the Company include delivering developed lots to the customer, which are required to meet certain specifications that are outlined in the contract. The customer inspects all lots prior to accepting title to ensure all specifications are met. ● Determine the transaction price. The transaction price per lot is fixed and specified in the contract. Any subsequent change orders or price changes are required to be approved by both parties. ● Allocate the transaction price to performance obligations in the contract. Each lot or a group of lots is considered to be a separate performance obligation, for which the specified price in the contract is allocated to. ● Recognize revenue when (or as) the entity satisfies a performance obligation. The builders do the inspections to make sure all conditions/requirements are met before taking title of lots. The Company recognizes revenue at a point in time when title is transferred. The Company does not have further performance obligations or continuing involvement once title is transferred. Rental Revenue The Company leases real estate properties to its tenants under leases that are predominately classified as operating leases, in accordance with ASC 842, Leases (“ASC 842”). Real estate rental revenue is comprised of minimum base rent and revenue from the collection of lease termination fees. Rent from tenants is recorded in accordance with the terms of each lease agreement on a straight-line basis over the initial term of the lease. Rental revenue recognition begins when the tenant controls the space and continues through the term of the related lease. Generally, at the end of the lease term, the Company provides the tenant with a one-year renewal option, including mostly the same terms and conditions provided under the initial lease term, subject to rent increases. The Company defers rental revenue related to lease payments received from tenants in advance of their due dates. These amounts are presented within deferred revenues and other payables on the Company’s consolidated balance sheets. Rental revenue is subject to an evaluation for collectability on several factors, including payment history, the financial strength of the tenant and any guarantors, historical operations and operating trends of the property, and current economic conditions. If our evaluation of these factors indicates that it is not probable that we will recover substantially all of the receivable, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis (as applicable) or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. In the year ended December 31, 2022 and 2021, the Company did not recognize any deferred revenue and collected all rents due. Sale of the Front Foot Benefit Assessments We have established a front foot benefit (“FFB”) assessment on all of the NVR lots. This is a 30-year annual assessment allowed in Frederick County which requires homeowners to reimburse the developer for the costs of installing public water and sewer to the lots. These assessments become effective as homes are settled, at which time we can sell the collection rights to investors who will pay an upfront lump sum, enabling us to more quickly realize the revenue. The selling prices range from $ 3,000 4,500 126,737 289,375 Cost of Revenue ● Cost of Real Estate Sale All of the costs of real estate sales are from our land development business. Land acquisition costs are allocated to each lot based on the area method, the size of the lot comparing to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot comparing to the total size of all lots in the project. ● Cost of Rental Revenue Cost of rental revenue consists primarily of the costs associated with management and leasing fees to our management company, repairs and maintenance, depreciation and other related administrative costs. Utility expenses are paid directly by tenants. Biohealth Product Direct Sales. If any member returns a product to the Company on a timely basis, they may obtain a replacement product from the Company for such returned products. We do not have buyback program. However, when the customer requests a return and management decides that the refund is necessary, we initiate the refund after deducting all the benefits that a member has earned. The returns are deducted from our sales revenue on our financial statements. Allowances for product and membership returns are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale. Product and membership returns for the years ended December 31, 2022 and 2021 were approximately $ 41,755 39,203 Annual Membership. 21,198 728,343 Other Businesses Food and Beverage The Company, through Hapi Café Inc. (“HCI-T”), commenced operation of two cafés during 2022 and 2021, which are located in Singapore and South Korea. The cafes are operated by subsidiaries of HCI-T, namely Hapi Café SG Pte. Limited (“HCSG”) in Singapore and Hapi Café Korea Inc. (“HCKI”) in Seoul, South Korea. Hapi Cafes are distinctive lifestyle café outlets that strive to revolutionize the way individuals dine, work, and live, by providing a conducive environment for everyone to relish the four facets – health and wellness, fitness, productivity, and recreation all under one roof. Remaining performance obligations. Stock-Based Compensation The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective January 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services. During the years ended on December 31, 2022 and 2021, the Company recorded $ 0 73,292 Foreign Currency Functional and reporting currency Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (“functional currency”). The financ

CONCENTRATIONS

CONCENTRATIONS	12 Months Ended
	Dec. 31, 2022
Risks and Uncertainties [Abstract]
CONCENTRATIONS	3. CONCENTRATIONS The Company maintains cash balances at various financial institutions in different countries. These balances are usually secured by the central banks’ insurance companies. At times, these balances may exceed the insurance limits. As of December 31, 2022 and 2021, uninsured cash and restricted cash balances were $ 15,723,599 57,905,303 For the year ended December 31, 2022, two customers accounted for approximately 81 19 97 3

SEGMENTS

SEGMENTS	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
SEGMENTS	4. SEGMENTS Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments. The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2022 and 2021: SCHEDULE OF SEGMENT INFORMATION Real Estate Digital Transformation Technology Biohealth Business Other Total Year Ended on December 31, 2022 Revenue $ 3,088,628 $ 69,915 $ 753,651 $ 568,248 $ 4,480,442 Cost of Sales (3,016,200 ) (23,423 ) (523,534 ) (168,833 ) (3,731,990 ) Gross Margin 72,428 46,492 230,117 399,415 748,452 Operating Expenses (1,479,674 ) (414,167 ) (850,044 ) (5,093,941 ) (7,837,826 ) Operating Income (Loss) (1,407,246 ) (367,675 ) (619,927 ) (4,694,526 ) (7,089,374 ) Other Income (Expense) 5,885 (1,359,977 ) (4,669,309 ) (33,099,730 ) (39,123,131 ) Net Income (Loss) Before Income Tax (1,401,361 ) (1,727,652 ) (5,289,236 ) (37,794,256 ) (46,212,505 ) Real Estate Digital Transformation Technology Biohealth Business Other Total Year Ended on December 31, 2021 Revenue $ 14,213,379 $ - $ 5,543,066 $ 42,377 $ 19,798,822 Cost of Sales (11,073,756 ) - (214,019 ) (14,039 ) (11,301,814 ) Gross Margin 3,139,623 - 5,329,047 28,338 8,497,008 Operating Expenses (1,136,031 ) (183,429 ) (3,624,200 ) (18,547,470 ) (23,491,130 ) Operating Income (Loss) 2,003,592 (183,429 ) 1,704,847 (18,519,132 ) (14,994,122 ) Other Income (Expense) (8,955 ) 1,286,962 (39,265,445 ) (65,502,017 ) (103,489,455 ) Net Income (Loss) Before Income Tax 1,994,637 1,103,533 (37,560,598 ) (84,021,149 ) (118,483,577 ) December 31, 2022 Cash and Restricted Cash $ 2,592,577 $ 514,260 $ 1,338,404 $ 14,076,662 $ 18,521,903 Total Assets 57,951,324 3,184,416 4,861,615 87,492,981 153,490,336 December 31, 2021 Cash and Restricted Cash $ 7,493,921 $ 245,780 $ 2,629,464 $ 50,433,014 $ 60,802,179 Total Assets 55,465,600 2,199,466 11,056,779 115,488,298 184,210,143

REAL ESTATE ASSETS

REAL ESTATE ASSETS	12 Months Ended
	Dec. 31, 2022
Real Estate [Abstract]
REAL ESTATE ASSETS	5. REAL ESTATE ASSETS As of December 31, 2022 and 2021, real estate assets consisted of the following: SCHEDULE OF REAL ESTATE ASSETS December 31, 2022 December 31, 2021 Construction in Progress $ 15,506,572 $ 8,597,023 Land Held for Development 7,943,126 7,098,104 Rental Properties 31,169,031 24,820,253 Total Real Estate Assets $ 54,618,729 $ 40,515,380 Single family residential properties As of December 31, 2022 and 2021, the Company owns 132 109 31 882,814 120,511 The following table presents the summary of our SRFs as of December 31, 2022: SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES Number of Homes Aggregate Average SFRs 132 $ 30,998,258 $ 234,835

BUILDER DEPOSITS

BUILDER DEPOSITS	12 Months Ended
	Dec. 31, 2022
Disclosure Builder Deposits Abstract
BUILDER DEPOSITS	6. BUILDER DEPOSITS In November 2015, SeD Maryland Development, LLC (“SeD Maryland”) entered into lot purchase agreements with NVR, Inc. (“NVR”) relating to the sale of single-family home and townhome lots to NVR in the Ballenger Run Project. The purchase agreements were amended three times thereafter. Based on the agreements, NVR is entitled to purchase 479 lots for a price of approximately $ 64,000,000 As part of the agreements, NVR was required to give a deposit in the amount of $ 5,600,000 9.9 100,000 220,000 0 31,553

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE	7. NOTES PAYABLE As of December 31, 2022 and 2021, notes payable consisted of the following: SCHEDULE OF NOTES PAYABLE December 31, December 31, ($) ($) PPP Loan - 68,502 Australia Loan - 162,696 Motor Vehicle Loans 181,846 86,473 Total notes payable $ 181,846 $ 317,671 M&T Bank Loan On April 17, 2019, SeD Maryland Development LLC entered into a Development Loan Agreement with Manufacturers and Traders Trust Company (“M&T Bank”) in the principal amount not to exceed at any one time outstanding the sum of $ 8,000,000 18,500,000 900,000 1.5 2,600,000 outstanding balance of the revolving loan was $0 381,823 2,300,000 300,000 On June 18, 2020, Alset EHome Inc. (“Alset EHome”), a wholly owned subsidiary of LiquidValue Development Inc., entered into a Loan Agreement with Manufacturers and Traders Trust Company (the “Lender”). Pursuant to the Loan Agreement, the Lender provided a non-revolving loan to Alset EHome in an aggregate amount of up to $ 2,990,000 July 1, 2022 20,000,000 During the year ended December 31, 2020, Alset EHome borrowed $ 664,810 61,679 42,906 664,810 25,225 42,907 Paycheck Protection Program Loan On February 11, 2021, the Company entered into a five year 68,502 1.00 The PPP Term Note is unsecured and guaranteed by the United States Small Business Administration. The Company may apply to M&T Bank for forgiveness of the PPP Term Note, with the amount which may be forgiven equal to at least 60 68,502 Australia Loan On January 7, 2017, SeD Perth Pty Ltd (“SeD Perth”) entered into a loan agreement with National Australian Bank Limited (the “Australia Loan”) for the purpose of funding land development. The loan facility provides SeD Perth with access to funding of up to approximately $ 460,000 December 31, 2018 35,276 500,000 4.48 4.49 179,000 April 30, 2022 Motor Vehicle Loans On May 17, 2021, Alset International Limited entered into a Hire Purchase Agreement with Hong Leong Finance Limited to purchase a car for business. The total purchase price of the car, including associated charges, was approximately $ 184,596 78,640 1,300 1.88 84 On September 22, 2022 Alset International entered into an agreement with United Overseas Bank Limited to purchase additional car for business. The total purchase price of the car, including associated charges, was approximately $ 182,430 66,020 1,472 1.88 84

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS Personal Guarantees by Director As of December 31, 2022 and 2021, a director of the Company had provided personal guarantees amounting to approximately $ 0 500,000 Purchase Shares and Warrants from NECV On July 17, 2020, the Company purchased 122,039,000 9.99 1,220,390,000 0.0001 122,039 860,342 327,565 1,009,854 945,769 1,067,808 122,039 Sale of Investment in Vivacitas to DSS On March 18, 2021, the Company sold equity investment in Vivacitas, a U.S.-based biopharmaceutical company, equaling to 2,480,000 250,000 2,480,000 200,128 2,279,872 Purchase and Sale of Stock in True Partner Capital Holding Limited On March 12, 2021, the Company purchased 62,122,908 6,729,629 10,003,689 3,274,060 62,122,908 17,570,948 446,104 Notes Payable Chan Heng Fai provided an interest-free, due on demand advance to LiquidValue Development Pte. Ltd. and its subsidiary LiquidValue Development Limited for general operations. As of December 31, 2022 and 2021, the outstanding balance was approximately $ 0 820,113 Chan Heng Fai provided an interest-free, due on demand advance to SeD Perth Pty. Ltd. for its general operations. On December 31, 2022 and 2021, the outstanding balance was $ 12,668 13,546 On March 12, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company, for four proposed transactions, consisting of (i) purchase of certain warrants (the “Warrants”) to purchase 1,500,000,000 28,363,966 173,395 62,122,908 6,729,629 4,775,523 28,653,138 63,920,129 0.001 111.80 10.03 50,770,192 63,920,128 306,438 2,123 458,198 On May 14, 2021, the Company borrowed S$ 7,395,472 5,545,495 0 Management Fees MacKenzie Equity Partners, LLC, an entity owned by Charles MacKenzie, the Chief Development Officer of the Company, has had a consulting agreement with a majority-owned subsidiary of the Company since 2015. Pursuant to the terms of the agreement, as amended on January 1, 2018, the Company’s subsidiary paid a monthly fee of $ 20,000 25,000 In addition, MacKenzie Equity Partners will be paid certain bonuses, including (i) a sum of $50,000 on June 30, 2022; (ii) a sum of $50,000 upon the successful financing of 100 homes owned by American Housing REIT Inc. with an entity not affiliated with SeD Development Management LLC (a subsidiary of the Company); and (iii) a sum of $50,000 upon the successful leasing of 30 homes in the Alset of Black Oak development. The Company incurred expenses of $ 350,000 360,000 120,000 50,000 25,000 80,000 Note Receivable from a Related Party Company On March 2, 2020 and on October 29, 2021, LiquidValue Asset Management Pte. Ltd. (“LiquidValue”) received two $ 200,000 8,350,000 15.8 8 5.00 The amount of the warrants equals to the note principal divided by the exercise price. If AMRE goes to IPO in the future and IPO price is less than $10.00 per share, the exercise price shall be adjusted downward to fifty percent (50%) of the IPO price. 200,000 3.4 15.8 8,350,000 21,366,177 1,089,675 0 0 130,000 On January 24, 2017, SeD Capital Pte Ltd, a 100 350,000 The term of the loan was two years, with an interest rate of 3% per annum for the first year and 5% per annum for the second year. The expiration term was renewed as due on demand after two years with 5% per annum interest rate. 350,000 61,555 412,754 As of December 31, 2022 and 2021, the Company provided advances for operation of $ 236,699 19 In the first quarter of 2022, a subsidiary of the Company made a non-interest bearing advance in the amount of $ 476,250 100 476,250 In June 2022, Alset International Limited, a subsidiary of the Company, entered into a stock purchase agreement with one of our directors and paid $ 1,746,279 7,276,163 7,276,163 1,743,734 2,545 The Company paid some operating expenses for Alset Capital Acquisition Corp., a special purpose acquisition company of which the Company holds 23.4 0 On July 28, 2022 Hapi Café Inc. entered into binding term sheet (the “First Term Sheet”) with Ketomei Pte Ltd and Tong Leok Siong Constant, pursuant to which Hapi Café lent Ketomei $ 41,750 0 8 360,000 250,500 8 29,922 197,596 On October 13, 2021 BMI Capital Partners International Limited (“BMI”) entered into loan agreement with Liquid Value Asset Management Limited (“LVAML”), a subsidiary of DSS, pursuant to which BMI agreed to lend $ 3,000,000 3,042,811 2,987,039 Loan to Employees On November 24, 2020, American Pacific Bancorp. Inc. lent $ 560,000 6 November 23, 2023 This loan was secured by an irrevocable letter of instruction on 4,000 shares of Alset Inc 280,000 November 23, 2023 This loan was secured by an irrevocable letter of instruction on 2,000 shares of Alset Inc. 840,000 28,031

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
EQUITY	9. EQUITY On June 14, 2021, the Company filed an amendment (the “Amendment”) to its Third Amended and Restated Certificate of Incorporation, as amended, to increase the Company’s authorized share capital. The Amendment increased the Company’s authorized share capital to 250,000,000 25,000,000 20,000,000 5,000,000 The Company has designated 6,380 2,132 On December 6, 2022 the Company filed a certificate of Amendment to the Company’s Certificate of Formation with the Texas Secretary of State to effect a 1-for-20 reverse stock split. The reverse stock split was effective as of December 28, 2022. Holders of the Series A Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock, par value $ 0.001 Holders of the Series B Preferred Stock shall be entitled to receive dividends equal, on an as-if-converted basis, to and in the same form as dividends actually paid on shares of the Company’s common stock par value $ 0.001 The Company analyzed the Preferred stock and the embedded conversion option for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option should be classified as equity. On January 19, 2021, the Company issued 500 60,900 On May 3, 2021, the Company entered into a Loan and Exchange Agreement with its Chief Executive Officer, Chan Heng Fai pursuant to which he loaned the Company his shares of Common Stock of the Company by exchanging 319,000 6,380 319,000 6,380 On May 12, 2021, the Company entered into an Exchange Agreement with Chan Heng Fai, pursuant to which he converted $ 13,000,000 2,132 106,600 2,132 On May 10, 2021, the Company entered into an underwriting agreement with Aegis Capital Corp., as the sole book-running manager and representative of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “May Offering”) of (i) 235,032 101.40 0.001 101.40 65.90 80,550 101.20 80,550 The Company also granted the Underwriters a 45-day over-allotment option to purchase up to 40,418 40,418 40,418 40,418 20,209 40,418 40,418 40,418 101.40 68,201 330 424,366 39,765,440 The Company incurred approximately $88,848 in expenses related to the May Offering and subsequent warrants exercises, including SEC fees, FINRA fees, auditor fees and filing fees. The following table presents net funds received from the May Offering and warrants exercised as of December 31, 2022. SCHEDULE OF NET FUNDS RECEIVED ON OFFERING AND WARRANTS EXERCISED Shares Par value Amount received Offering 235,032 $ 235 $ 29,145,056 Exercise of Pre-Funded Units 80,550 $ 81 $ 16,110 Exercise of Underwriter’s Series A Warrants 40,418 $ 40 $ 3,755,774 Exercise of Series A and Series B Warrants 68,366 $ 68 $ 6,937,347 Offering Expenses - $ - $ (88,848 ) Total 424,366 $ 424 $ 39,765,439 On July 27, 2021, the Company entered into another underwriting agreement with Aegis Capital Corp., as the sole book-running manager and representative of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “July Offering”) of (i) 266,207 0.001 42.40 488,510 488,510 42.20 33,392,444 The Company granted the Underwriters a 45-day over-allotment option to purchase up to 113,207 7.0 1.5 26,038 125 53 24 113,207 4,386,998 The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering in lieu of Common Stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of the Company’s outstanding Common Stock (or, at the election of the purchaser, 9.99%). Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.20 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full The Company incurred approximately $ 49,553 The following table presents net funds received from the July Offering and warrants exercised as of December 31, 2022. Shares Par value Amount received Offering 266,207 $ 266 $ 28,957,297 Exercise of Pre-Funded Units 488,510 $ 489 $ 97,702 Exercise of Underwriter’s Over-Allotment Option 113,207 $ 113 $ 4,386,998 Offering Expenses - $ - $ (49,553 ) Total 867,924 $ 868 $ 33,392,444 On December 5, 2021, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp., as the sole book-running manager and representative of the underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “December Offering”) of (i) 903,833 0.001 12.00 1,553,833 1,553,833 11.98 The December Offering closed on December 8, 2021. As a result of the December Offering and subsequent exercise notice received for the pre-funded warrants, the net proceeds to the Company were $ 27,231,875 The Company granted the Underwriters a 45-day over-allotment option to purchase up to 375,000 7 1 375,000 15 12.00 4,115,000 The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering. Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.001 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full. At December 31, 2021 761,664 warrants were exercised, some in cashless exercise transactions The Company incurred approximately $ 40,621 The following table presents net funds received from the December Offering and warrants exercised as of December 31, 2022. Shares Par value Amount received Offering 946,166 $ 946 $ 27,263,673 Exercise of Pre-Funded Units 761,167 $ 761 $ 8,823 Exercise of Underwriter’s Over-Allotment Option 375,000 $ 375 $ 4,115,000 Offering Expenses - $ - $ (40,621 ) Total 2,082,333 $ 2,082 $ 31,346,875 On December 31, 2022, there were 7,422,846 The following table summarizes the warrant activity for the year ended December 31, 2022. SCHEDULE OF WARRANT ACTIVITY Warrant for Common Shares Weighted Average Exercise Price Remaining Contractual Term (Years) Aggregate Intrinsic Value Warrants Outstanding as of December 31, 2021 1,426,657 $ 35.80 1.88 $ - Warrants Vested and exercisable at December 31, 2021 1,426,657 $ 35.80 1.88 $ - Granted - - Exercised (792,169 ) 0.02 Forfeited, cancelled, expired - - Warrants Outstanding as of December 31, 2022 634,488 $ 80.40 3.23 $ - Warrants Vested and exercisable at December 31, 2022 634,488 $ 80.40 3.23 $ - Hapi Metaverse Inc. Sale of Shares In year ended December 31, 2021 , the Company sold 280,000 to international investors for the amount of $ 280,000 505,381,376 506,898,576 99 ’s total outstanding shares. During the year ended December 31, 2021, the sale of Hapi Metaverse ’s shares was de minimis compared to its outstanding shares and did not change the minority interest. Distribution to Minority Shareholder In 2021, SeD Maryland Development LLC Board approved the payment distribution plan to members and paid $ 2,549,750 411,250 Changes of Ownership of Alset International In the year ended December 31, 2021, Alset International issued 1,721,303,416 0.04 60,300,464 58 73,292 1,500,000 In the year ended December 31, 2022 the Company purchased 6,670,200 On January 17, 2022 the Company entered into a securities purchase agreement with Chan Heng Fai, pursuant to which the Company agreed to purchase from Chan Heng Fai 293,428,200 29,468,977 293,428,200 35,319,290 293,428,200 8.4 3,492,713,362 Due to these transactions the Company’s ownership of Alset International changed from 76.8 85.4 Promissory Note Converted into Shares On December 13, 2021 the Company entered into a Securities Purchase Agreement with Chan Heng Fai for the issuance and sale of a convertible promissory note in favor of Chan Heng Fai, in the principal amount of $ 6,250,000 3 12.50 500,000 Registration Statement on Form S-3 On April 11, 2022 the Company filed a Registration Statement on Form S-3 using a “shelf” registration or continuous offering process. Under this shelf registration process, the Company may, from time to time, sell any combination of the securities (common stock, preferred stock, warrants, rights, units) described in the filed prospectus in one or more offerings up to a total aggregate offering price of $ 75,000,000

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME	10. ACCUMULATED OTHER COMPREHENSIVE INCOME The following is a summary of the changes in the balances of accumulated other comprehensive income, net of tax: SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX Unrealized Gains and Losses on Security Investment Foreign Currency Translations Change in Minority Interest Total Balance at January 1, 2022 $ (90,031 ) $ (367,895 ) $ 799,572 $ 341,646 Other Comprehensive Income 35,110 489,167 2,970,140 3,494,417 Balance at December 31, 2022 $ (54,921 ) $ 121,272 $ 3,769,712 $ 3,836,063 Unrealized Gains and Losses on Security Investment Foreign Currency Translations Change in Minority Interest Total Balance at January 1, 2021 $ (48,758 ) $ 2,258,017 $ (65,921 ) $ 2,143,338 Balance at beginning $ (48,758 ) $ 2,258,017 $ (65,921 ) $ 2,143,338 Other Comprehensive Income (41,273 ) (2,625,912 ) 865,493 (1,801,692 ) Balance at December 31, 2021 $ (90,031 ) $ (367,895 ) $ 799,572 $ 341,646 Balance at end $ (90,031 ) $ (367,895 ) $ 799,572 $ 341,646

LEASE INCOME

LEASE INCOME	12 Months Ended
	Dec. 31, 2022
Lease Income
LEASE INCOME	11. LEASE INCOME The Company generally rents its SFRs under lease agreements with a term of one year SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS 2023 1,148,308 2024 11,145 Total Future Receipts $ 1,159,453 Property Management Agreements The Company has entered into property management agreement with the property managers under which the property managers generally oversee and direct the leasing, management and advertising of the properties in our portfolio, including collecting rents and acting as liaison with the tenants. The Company pays its property managers a monthly property management fee for each property unit and a leasing fee. For the years ended December 31, 2022 and 2021, property management fees incurred by the property managers were $ 90,630 15,390 174,850 63,880

INVESTMENTS MEASURED AT FAIR VA

INVESTMENTS MEASURED AT FAIR VALUE	12 Months Ended
	Dec. 31, 2022
Investments, All Other Investments [Abstract]
INVESTMENTS MEASURED AT FAIR VALUE	12. INVESTMENTS MEASURED AT FAIR VALUE Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the consolidated balance sheets as of December 31, 2022 and 2021: SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Fair Value Measurement Using Amount at Cost Level 1 Level 2 Level 3 Amount at Fair Value December 31, 2022 Assets Investment Securities- Fair Value Option $ 76,264,051 $ 13,749,957 $ - $ - $ 13,749,957 Investment Securities- Trading 11,268,362 5,315,204 - - 5,315,204 Convertible Note Receivable 138,599 - - 88,599 88,599 Warrants - American Premium Water 696,791 - - 327,565 327,565 Warrants - AMRE - - - - - Total Investment in Securities at Fair Value $ 88,367,803 $ 19,065,161 $ - $ 416,164 $ 19,481,325 Fair Value Measurement Using Amount at Cost Level 1 Level 2 Level 3 Amount at Fair Value December 31, 2021 Assets Investment Securities- Fair Value Option $ 72,000,301 $ 25,320,694 $ - $ - $ 25,320,694 Investment Securities- Trading 9,809,778 9,908,077 - - 9,908,077 Convertible Note Receivable 138,599 - - 98,398 98,398 Warrants - American Premium Water 696,791 - - 1,009,854 1,009,854 Warrants - AMRE - - - - - Total Investment in Securities at Fair Value $ 82,645,469 $ 35,228,771 $ - $ 1,108,252 $ 36,337,023 Realized loss on investment securities for the year ended December 31, 2022 and 2021 was $ 7,308,580 4,698,078 31,350,358 49,190,748 40,201 57,179 For U.S. trading stocks, we use Bloomberg Market stock prices as the share prices to calculate fair value. For overseas stock, we use the stock price from local stock exchange to calculate fair value. The following chart shows details of the fair value of equity security investments at December 31, 2022 and 2021, respectively. SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT Share price Market Value 12/31/2022 Shares 12/31/2022 Valuation DSS (Related Party) $ 0.164 62,812,264 $ 10,301,211 Investment in Securities at Fair Value AMBS (Related Party) $ 0.002 20,000,000 $ 34,000 Investment in Securities at Fair Value Holista (Related Party) $ 0.20 42,999,621 $ 850,432 Investment in Securities at Fair Value American Premium Water (Related Party) $ 0.001 354,039,000 $ 212,423 Investment in Securities at Fair Value Value Exchange $ 0.170 13,834,643 $ 2,351,889 Investment in Securities at Fair Value Trading Stock $ 5,315,204 Investment in Securities at Fair Value Total Level 1 Equity Securities $ 19,065,161 Nervotech N/A 1,666 $ 35,958 Investment in Securities at Cost HWH World Co. N/A 3,800 $ 42,562 Investment in Securities at Cost K Beauty N/A 3,600 $ 19,609 Investment in Securities at Cost Total Equity Securities $ 19,163,290 Share price Market Value 12/31/2021 Shares 12/31/2021 Valuation DSS (Related Party) $ 0.672 19,888,262 $ 13,364,912 Investment in Securities at Fair Value AMBS (Related Party) $ 0.016 20,000,000 $ 328,000 Investment in Securities at Fair Value Holista (Related Party) $ 0.034 43,626,621 $ 1,489,179 Investment in Securities at Fair Value American Premium Water (Related Party) $ 0.002 354,039,000 $ 778,886 Investment in Securities at Fair Value True Partner $ 0.119 62,122,908 $ 7,409,717 Investment in Securities at Fair Value Value Exchange $ 0.300 6,500,000 $ 1,950,000 Investment in Securities at Fair Value Trading Stock $ 9,908,077 Investment in Securities at Fair Value Total Level 1 Equity Securities $ 35,228,771 Nervotech N/A 1,666 $ 37,045 Investment in Securities at Cost HWH World Co. N/A 3,800 $ 42,562 Investment in Securities at Cost K Beauty N/A 3,600 $ 19,609 Investment in Securities at Cost Total Equity Securities $ 35,327,987 DSS convertible preferred stock During the year ended December 31, 2021, Global BioMedical Pte Ltd., converted 42,575 6,570,170 Sharing Services Convertible Note The fair value of the Sharing Services Convertible Note under level 3 category as of December 31, 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions: SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS December 31, December 31, Dividend yield - % 0.00 % Expected volatility - % 138.85 % Risk free interest rate - % 3.25 % Contractual term (in years) - 0.76 Exercise price $ - $ 0.15 We assumed dividend yield rate is 0.00% Changes in the observable input values would likely cause material changes in the fair value of the Company’s Level 3 financial instruments. A significant increase (decrease) in this likelihood would result in a higher (lower) fair value measurement. The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2022 and 2021: SCHEDULE OF CHANGE IN FAIR VALUE Total Balance at January 1, 2021 $ 38,604,701 Net loss (57,179 ) Conversion of DSS Preferred Stock (37,439,270 ) Balance at December 31, 2021 $ 1,108,252 Net gain 40,201 Balance at December 31, 2022 $ 1,148,453 The Note was redeemed in July 2022. Vector Com Convertible Bond On February 26, 2021, the Company invested approximately $ 88,599 2% two years 21.26 Warrants On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of AMRE, a related party private company, in conjunction with the Company lending two $ 200,000 Note Receivable from a Related Party Company 0 On July 17, 2020, the Company purchased 122,039,000 9.99% 1,220,390,000 0.0001 122,039 232,000,000 232,000,000 232,000 988,390,000 327,565 1,009,854 The fair value of the NECV warrants under level 3 category as of December 31, 2022 and 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions: SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS December 31, 2022 December 31, 2021 As of As of December 31, 2022 December 31, 2021 Stock Price $ 0.0006 $ 0.0022 Exercise Price $ 0.001 $ 0.001 Risk-free Interest Rate 3.95 % 1.48 % Annualized volatility 186.1 % 186.5 % Dividend Yield 0.00 0.00 Year to Maturity 7.56 8.58 The following table presents summarized unaudited financial information for our investments that we elected the fair value option that would otherwise be accounted for under the equity method of accounting. SCHEDULE OF FAIRVALUE OF FINANCIAL INVESTMENTS Summarized Financial Information Assets Liabilities Net Income (Loss) December 31, 2022 NECV* $ 1,038,946 $ 2,507,797 $ 128,968 Holista $ 3,717,593 $ 2,660,281 $ (1,053,668 ) DSS* $ 264,880,000 $ 82,231,000 $ (52,214,667 ) VEII* $ 5,047,729 $ 2,676,237 $ 185,321 December 31, 2021 NECV $ 348,688 $ 4,049,594 $ (873,550 ) Holista $ 5,031,866 $ 2,870,177 $ (1,018,871 ) DSS $ 284,826,000 $ 84,522,000 $ (31,921,000 ) * Data derived from Financial Statement as of September 30, 2022 which was the latest available date source we could reach. 12-month Net Income (Loss) was estimated by adding one-third of 9-month Net Loss.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	13. INCOME TAXES US Income Taxes The components of income tax expense and the effective tax rates for the years ended December 31, 2022 and 2021 are as follows: SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2022 2021 Year Ended December 31, 2022 2021 Current: Federal $ - $ 45,736 State - 46,179 Total Current - 91,916 Deferred: Federal (3,905,452 ) (2,725,007 ) State 1,163,407 (1,266,545 ) Total Deferred (2,742,045 ) (3,991,553 ) Valuation Allowance 2,742,045 3,991,553 Total Income Tax Expense $ - $ 91,916 Pre-tax Loss $ (46,212,505 ) $ (118,483,577 ) Effective Income Tax Rate 0.0 % -0.1 % A reconciliation of our income tax expense at federal statutory income tax rate of 21% to our income tax expense at the effective tax rate is as follows: SCHEDULE OF RECONCILIATION OF INCOME TAX 2022 2021 Year Ended December 31, 2022 2021 Federal Statutory Tax Rate 21.0 % 21.0 % State Income Tax, Net of Federal Income Taxes 0.0 % 0.0 % Intercompany Management & Oversight Fees 0.0 % -0.1 % Capitalized Construction Costs 0.0 % 0.2 % Minority interest in Partnerships 0.0 % 0.1 % Deferred Finance Costs -0.4 % -0.2 % Amort of BCF Debt Discount 0.0 % -9.0 % Miscellaneous Permanent Items 0.2 % 0.0 % Non includible foreign entities loss/(income) -13.8 % -9.6 % Valuation Allowance -7.1 % -2.5 % Effective Income Tax Rate 0.0 % -0.1 % Deferred tax assets consist of the following at December 31, 2022 and 2021: SCHEDULE OF DEFERRED TAX ASSETS 2022 2021 Interest Income (6,304,175 ) (5,660,333 ) Interest Expense 5,802,873 5,100,076 Depreciation and Amortization (140,886 ) (10,434 ) Impairment 2,253,228 2,253,228 Accrued Expense 1,102,779 60,662 Unrealized Loss on Investment 4,324,883 2,512,554 Partnership Loss 13,175 13,175 Other Amortization 1,160,710 - Others 377,180 (224,637 ) Net Operating Loss 1,297,770 2,047,388 Total deferred tax asset 9,887,537 6,091,679 Valuation Allowance (9,887,537 ) (6,091,679 ) Net Deferred Tax Asset - - As of December 31, 2022, the Company has Federal and State net operating loss carry-forwards of approximately $ 7,573,000 2,020,000 3,795,858 As of December 31, 2022, total tax receivable is $ 143,574 111,351 32,223 151,211 77,390 73,821 We are subject to U.S. federal income tax as well as income tax of certain state jurisdictions. We have substantially concluded all U.S. federal income tax and state tax matters through 2018. However, our federal tax returns for the years 2019 through 2021 remain open to examination. State tax jurisdiction tax years remain open to examination as well, though we believe that any additional assessment would be immaterial to the Consolidated Financial Statements. Income taxes – Other Countries On December 31, 2022 and 2021, foreign subsidiaries have tax losses of approximately $ 4.27 1.99 As of December 31, 2022: SCHEDULE OF OTHER COUNTRY INCOME TAXES SG Companies HK Companies KR Companies AU Companies Total Calculation: Cumulative loss & other deferred tax assets before tax $ (25,140,421 ) $ - $ - $ - $ (25,140,421 ) Effective tax rates 17.00 % 16.50 % 25.00 % 30.00 % Tax at the domestic tax rates applicable to profits in the countries where the Company operates $ (4,273,872 ) $ - $ - $ - $ (4,273,872 ) Adjustments: Deferred tax assets not recognized $ 4,273,872 $ - $ - $ - $ 4,273,872 Income tax expenses recognized in profit or loss $ - $ - $ - $ - $ - As of December 31, 2021: SG Companies HK Companies KR Companies AU Companies Total Calculation: Cumulative loss & other deferred tax assets before tax $ (11,692,089 ) $ - $ - $ - $ (11,692,089 ) Effective tax rates 17.00 % 16.50 % 19.24 % 30.00 % Tax at the domestic tax rates applicable to profits in the countries where the Company operates $ (1,987,655 ) $ - $ - $ - $ (1,987,655 ) Adjustments: Deferred tax assets not recognized $ 1,987,655 $ - $ - $ - $ 1,987,655 Income tax expenses recognized in profit or loss $ - $ - $ 442,098 $ - $ 442,098

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	14. COMMITMENTS AND CONTINGENCIES Leases The Company leases offices in Maryland, Singapore, Magnolia, Texas, Hong Kong and South Korea through leased spaces aggregating approximately 15,811 2,335 23,020 685,724 587,685 SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL Office Location Lease Term as of December 31, 2022 Singapore - AI June 2022 to May 2023 Singapore – F&B October 2021 to September 2024 Singapore – Four Seasons Park July 2022 to July 2024 Singapore – Hapi Cafe July 2022 to June 2024 Singapore - PLQ December 2022 to July 2024 Hong Kong October 2022 to October 2024 Hong Kong - Warehouse November 2022 to October 2024 Hong Kong - Shop October 2022 to September 2024 South Korea - Hapi Café August 2022 to August 2025 South Korea - HWH World August 2022 to July 2025 Magnolia, Texas, USA May 2022 to January 2023 Bethesda, Maryland, USA January 2021 to March 2024 The Company adopted ASU No. 2016-02, Leases (Topic 842) (“ASU 2016-02”) to recognize a right-of-use asset and a lease liability for all the leases with terms greater than twelve months. We elected the practical expedient to not recognize operating lease right-of-use assets and operating lease liabilities for lease agreements with terms less than 12 months. Operating lease right-of-use assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are at a range from 0.5% to 4.5% per annum in 2022 and from 0.5% to 5.4% per annum in 2021 1,614,159 1,628,039 659,620 667,343 The table below summarizes future payments due under these leases as of December 31, 2022. For the Years Ended December 31: SCHEDULE OF LEASE PAYMENTS 2023 $ 944,807 2024 656,668 2025 195,811 Total Minimum Lease Payments 1,797,287 Less: Effect of Discounting (169,248 ) Present Value of Future Minimum Lease Payments 1,628,039 Less: Current Obligations under Leases (45,556 ) Long-term Lease Obligations $ 1,582,483 Lots Sales Agreement On November 23, 2015, SeD Maryland Development LLC completed the $ 15,700,000 197 15,000,000 197 On December 31, 2018, SeD Maryland entered into the Third Amendment to the Lot Purchase Agreement for Ballenger Run with NVR. Pursuant to the Third Amendment, SeD Maryland converted the 5.9 acre CCRC parcel to 36 lots (the 28 feet wide villa lot) and sell to NVR. SeD Maryland pursued the required zoning approval to change the number of such lots from 85 to 121, which was approved in July 2019. Subsequently, SeD Maryland Development signed the Fourth Amendment to the Lot Purchase Agreement, pursuant to which NVR agreed to purchase all of the new 121 lots During the years ended on December 31, 2022 and 2021, NVR purchased 3 88 479 476 Certain arrangements for the sale of buildable lots to NVR require the Company to credit NVR with an amount equal to one year of the FFB assessment. Under ASC 606, the credits to NVR are not in exchange for a distinct good or service and accordingly, the amount of the credit was recognized as the reduction of revenue. As of December 31, 2022 and 2021, the accrued balance due to NVR was $ 189,475 188,125 Promissory Note from Azure Pursuant to a Secured Promissory Note dated as of August 13, 2018, on October 13, 2019 Azure Holdings, LLC, was obligated to pay our subsidiary, 150 CCM Black Oak Ltd, $ 140,000 2.5% 19.5

DIRECTORS AND EMPLOYEES_ BENEFI

DIRECTORS AND EMPLOYEES’ BENEFITS	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
DIRECTORS AND EMPLOYEES’ BENEFITS	15. DIRECTORS AND EMPLOYEES’ BENEFITS Stock Option plans AEI The Company previously reserved 25,000 Alset International Stock Option plans On November 20, 2013, Alset International approved a Stock Option Plan (the “2013 Plan”). Employees, executive directors, and non-executive directors (including the independent directors) are eligible to participate in the 2013 Plan. The following tables summarize stock option activity under the 2013 Plan for the year ended December 31, 2022: SCHEDULE OF OPTION ACTIVITY Options for Common Shares Exercise Price Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding as of January 1, 2021 1,061,333 $ 0.09 3.00 $ - Vested and exercisable at January 1, 2021 1,061,333 $ 0.09 3.00 $ - Granted - - Exercised - - Forfeited, cancelled, expired - - Outstanding as of December 31, 2021 1,061,333 $ 0.09 2.00 $ - Vested and exercisable at December 31, 2021 1,061,333 $ 0.09 2.00 $ - Granted - - Exercised - - Forfeited, cancelled, expired - - Outstanding as of December 31, 2022 1,061,333 $ 0.09 1.00 $ - Vested and exercisable at December 31, 2022 1,061,333 $ 0.09 1.00 $ -

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	16. SUBSEQUENT EVENTS Public Offering On February 6, 2023, Alset Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) in connection with an offering (the “Offering”) of its common stock, par value $ 0.001 1,727,273 2.20 45 212,863 The net proceeds to the Company from the Offering were approximately $ 3.3 The Offering closed on February 8, 2023. The Common Stock was being offered pursuant to an effective registration statement on Form S-3 (File No. 333-264234), as well as a prospectus supplement in connection with the Offering filed with the Securities and Exchange Commission. Recent Agreements to Sell Additional Lots Agreement to Sell 110 Lots On March 16, 2023, 150 CCM Black Oak Ltd. (the “Seller”) entered into a Purchase and Sale Agreement (the “Purchase and Sale Agreement”) with Rausch Coleman Homes Houston, LLC, a Texas limited liability company (“Rausch Coleman”). Pursuant to the terms of the Purchase and Sale Agreement, the Seller has agreed to sell approximately 110 single-family detached residential lots which comprise a section of the Lakes at Black Oak. The price of the lots and certain community enhancement fees the Seller will be entitled to receive are anticipated to equal an aggregate of $ 6,586,250 The closing of the sale of these 110 lots depends on the satisfaction of certain conditions set forth in the Purchase and Sale Agreement. There can be no assurance that such closings will be completed on the terms outlined herein or at all. Commencing on March 16, 2023, Rausch Coleman has a thirty (30) day inspection period in which to inspect the properties and determine their suitability; during such inspection period, Rausch Coleman may decline to proceed with the closing of these transactions. The Seller shall be required to complete certain improvements at the property at the Seller’s cost prior to the closing. Agreement to Sell 189 Lots On March 17, 2023, the Seller entered into a Contract of Sale (the “Contract of Sale”) with Davidson Homes, LLC, an Alabama limited liability company (“Davidson Homes”). Pursuant to the terms of the Contract of Sale, the Seller has agreed to sell approximately 189 single-family detached residential lots comprising an additional section of the Lakes at Black Oak. The price of the lots and certain community enhancement fees the Seller will be entitled to receive are anticipated to equal an aggregate of $ 10,022,500 The closing of the transactions described in the Contract of Sale depends on the satisfaction of certain conditions set forth therein. There can be no assurance that such closings will be completed on the terms outlined herein or at all. Davidson Homes has agreed to purchase the lots in stages, comprising an initial closing of 94 lots, the remaining lots to be purchase on or before December 29, 2023. Commencing on March 17, 2023, Davidson Homes shall have a thirty (30) day inspection period in which to inspect the properties and determine their suitability; during such inspection period, Davidson Homes may decline to proceed with the closing of these transactions. The Seller shall be required to complete certain improvements at the property at the Seller’s cost prior to the closing.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and following the requirements of the Securities and Exchange Commission (“SEC”). The consolidated financial statements include all accounts of the Company and its majority owned and controlled subsidiaries. The Company consolidates entities in which it owns more than 50% of the voting common stock The Company’s consolidated financial statements include the financial positions, results of operations and cash flows of the following entities as of December 31, 2022 and 2021 as follows: SCHEDULE OF SUBSIDIARIES Attributable interest State or other jurisdiction of as of, Name of subsidiary consolidated under AEI incorporation or organization December 31, 2022 December 31, 2021 % % Alset Global Pte. Ltd. Singapore 100 100 Alset Business Development Pte. Ltd. Singapore 100 100 Global eHealth Limited Hong Kong 100 100 Alset International Limited Singapore 85.4 76.8 Singapore Construction & Development Pte. Ltd. Singapore 85.4 76.8 Art eStudio Pte. Ltd. Singapore 43.6 * 39.2 * Singapore Construction Pte. Ltd. Singapore 85.4 76.8 Global BioMedical Pte. Ltd. Singapore 85.4 76.8 Alset Innovation Pte. Ltd. Singapore 85.4 76.8 Health Wealth Happiness Pte. Ltd. Singapore 85.4 76.8 SeD Capital Pte. Ltd. Singapore 85.4 76.8 LiquidValue Asset Management Pte. Ltd. Singapore 85.4 76.8 * Alset Solar Limited Hong Kong 85.4 76.8 Alset F&B One Pte. Ltd. Singapore 76.9 69.2 Global TechFund of Fund Pte. Ltd. Singapore 100 76.8 Singapore eChainLogistic Pte. Ltd. Singapore 100 76.8 BMI Capital Partners International Limited Hong Kong 85.4 76.8 SeD Perth Pty Ltd Australia 85.4 76.8 SeD Intelligent Home Inc. United States of America 85.4 76.8 LiquidValue Development Inc. United States of America 85.4 76.8 Alset EHome Inc. United States of America 85.4 76.8 SeD USA, LLC United States of America 85.4 76.8 150 Black Oak GP, Inc. United States of America 85.4 76.8 SeD Development USA Inc. United States of America 85.4 76.8 150 CCM Black Oak, Ltd. United States of America 85.4 76.8 SeD Texas Home, LLC United States of America 85.4 76.8 SeD Ballenger, LLC United States of America 85.4 76.8 SeD Maryland Development, LLC United States of America 71.4 64.2 SeD Development Management, LLC United States of America 72.6 65.3 SeD Builder, LLC United States of America 85.4 76.8 Hapi Metaverse Inc. (f.k.a. GigWorld Inc.) United States of America 99.7 76.8 HotApp BlockChain Pte. Ltd. Singapore 99.7 76.6 HotApp International Limited Hong Kong 99.7 76.6 HWH International, Inc. United States of America 85.4 76.8 Health Wealth & Happiness Inc. United States of America 85.4 76.8 HWH Multi-Strategy Investment, Inc. United States of America 85.4 76.8 SeD REIT Inc. United States of America 85.4 76.8 Gig Stablecoin Inc. United States of America 99.7 76.6 HWH World Inc. United States of America 99.7 76.6 HWH World Pte. Ltd. Singapore 85.4 76.6 UBeauty Limited Hong Kong 85.4 76.8 WeBeauty Korea Inc South Korea 85.4 76.8 HWH World Limited Hong Kong 85.4 76.8 HWH World Inc. South Korea 85.4 76.8 Alset BioHealth Pte. Ltd. Singapore - 76.8 Alset Energy Pte. Ltd. Singapore - 76.8 GDC REIT Inc. (f.k.a. Alset Payment Inc.) United States of America 85.4 76.8 Alset World Pte. Ltd. Singapore - 76.8 BioHealth Water Inc. United States of America 85.4 76.8 Impact BioHealth Pte. Ltd. Singapore 85.4 76.8 American Home REIT Inc. United States of America 85.4 76.8 Alset Solar Inc. United States of America 68.3 61.5 HWH KOR Inc. United States of America 85.4 76.8 Open House Inc. United States of America 100 76.8 Open Rental Inc. United States of America 100 76.8 Hapi Cafe Inc. (Nevada) United States of America 100 76.8 Global Solar REIT Inc. United States of America 100 76.8 OpenBiz Inc. United States of America 100 76.8 Hapi Cafe Inc. (Texas) United States of America 85.4 100 HWH (S) Pte. Ltd. Singapore 85.4 76.8 True Partner International Limited Hong Kong - 100 LiquidValue Development Pte. Ltd. Singapore 100 100 LiquidValue Development Limited Hong Kong 100 100 Alset EPower Inc. United States of America 100 100 EPowerTech Inc. United States of America 100 100 AHR Asset Management Inc. United States of America 85.4 76.8 HWH World Inc. (Nevada) United States of America 85.4 76.8 Alset F&B Holdings Pte. Ltd. Singapore 85.4 76.8 Credas Capital Pte. Ltd. Singapore 42.7 * 38.4 * Smart Reward Express Limited Hong Kong 49.8 * 38.3 * Partners HWH Pte. Ltd. Singapore - 76.8 AHR Texas Two, LLC United States of America 85.4 76.8 AHR Black Oak One, LLC United States of America 85.4 76.8 Hapi Air Inc. United States of America 92.7 88.4 AHR Texas Three, LLC United States of America 85.4 76.8 Alset Capital Pte. Ltd. Singapore 100 100 Hapi Cafe Korea Inc. South Korea 85.4 100 Green Energy Inc. United States of America 100 100 Green Energy Management Inc. United States of America 100 100 Alset Metaverse Inc. United States of America 97.2 95.6 Alset Management Group Inc. United States of America 83.4 88.2 Alset Acquisition Sponsor, LLC United States of America 93.4 79.6 Alset Capital Acquisition Corp. United States of America 23.4 79.6 Alset Spac Group Inc. United States of America 93.4 - Hapi Travel Pte. Ltd. Singapore 85.4 - Hapi WealthBuilder Pte. Ltd. Singapore 85.4 - Alset Mining Pte. Ltd. Singapore 85.4 - HWH Marketplace Pte. Ltd. Singapore 85.4 - HWH International Inc. (Nevada) United States of America 85.4 - Hapi Cafe SG Pte. Ltd. Singapore 85.4 - Alset Reits Inc. United States of America 100 - Alset Home REIT Inc. United States of America 100 - Hapi Metaverse Inc. United States of America 99.7 - Hapi Cafe Limited Hong Kong 99.7 - MOC HK Limited Hong Kong 99.7 - AHR Texas Four, LLC United States of America 100 - Alset F&B (PLQ) Pte. Ltd. Singapore 85.4 - * Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, but are not limited to, allowance for doubtful accounts, valuation of real estate assets, allocation of development costs and capitalized interest to sold lots, fair value of the investments, the valuation allowance of deferred taxes, and contingencies. Actual results could differ from those estimates. In our property development business, land acquisition costs are allocated to each lot based on the area method, the size of the lot compared to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot compared to the total size of all lots in the project. When the Company purchases properties but does not receive the assessment information from the county, the Company allocates the values between land and building based on the data of similar properties. The Company makes appropriate adjustments once the assessment from the county is received. At the same time, any necessary adjustments to depreciation expense are made in the income statement. On December 31, 2022 and 2021 the Company adjusted $ 4,791,997 821,417 197,609 0
Transactions between Entities under Common Control	Transactions between Entities under Common Control On March 12, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Chan Heng Fai, the founder, Chairman and Chief Executive Officer of the Company, for four proposed transactions, consisting of (i) purchase of certain warrants (the “Warrants”) to purchase 1,500,000,000 28,363,966 173,395 62,122,908 6,729,629 4,775,523 28,653,138 63,920,129 0.001 111.80 On October 15, 2020, American Pacific Bancorp (which subsequently became a majority-owned subsidiary of the Company) entered into an acquisition agreement to acquire 3,500,001 100 1,500,000 250,000 The common control transactions resulted in the following basis of accounting for the financial reporting periods: ● The acquisition of the Warrants and True Partner stock were accounted for prospectively as of March 12, 2021 and they did not represent a change in reporting entity. ● The acquisition of LVD, APB and HFL was under common control and was consolidated in accordance with ASC 850-50. The consolidated financial statements were retrospectively adjusted for the acquisition of LVD, APB and HFL, and the operating results of LVD, APB and HFL as of January 1, 2020 for comparative purposes. AEI’s stock price was $ 10.03 50,770,192 63,920,128 306,438 2,123 458,198
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less at the date of acquisition to be cash equivalents. Cash and cash equivalents include cash on hand and at the bank and short-term deposits with financial institutions that are readily convertible to a known amount of cash and are subject to an insignificant risk of changes in values. There were no
Restricted Cash	Restricted Cash As a condition to the loan agreement with the Manufacturers and Traders Trust Company (“M&T Bank”), the Company is required to maintain a minimum of $ 2,600,000 309,219 4,399,984 As a condition to the loan agreement with National Australian Bank Limited in conjunction with the Perth project, an Australian real estate development project, the Company is required to maintain Australian Dollar 50,000 36,316 The Company puts funds into a brokerage account specifically for equity investment. As of December 31, 2022 and 2021, the cash balance in that brokerage account was $ 385,304 304,570
Account Receivables and Allowance for Doubtful Accounts	Account Receivables and Allowance for Doubtful Accounts Account receivables is stated at amounts due from buyers, contractors, and all third parties, net of an allowance for doubtful accounts. As of December 31, 2022 and 2021, the balance of account receivables was $ 46,522 39,622 0 2,500 The Company monitors its account receivables balances on a monthly basis to ensure that they are collectible. On a quarterly basis, the Company uses its historical experience to estimate its allowance for doubtful account receivables. The Company’s allowance for doubtful accounts represents an estimate of the losses expected to be incurred based on specifically identified accounts as well as nonspecific amount, when determined appropriate. Generally, the amount of the allowance is primarily decided by division management’s historical experience, the delinquency trends, the resolution rates, the aging of receivables, the credit quality indicators and financial health of specific customers. As of December 31, 2022 and 2021, the allowance was $ 0
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method and includes all costs in bringing the inventories to their present location and condition. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs necessary to make the sale. As of December 31, 2022 and 2021, inventory consisted of finished goods from subsidiaries of HWH International Inc. The Company continuously evaluates the need for reserve for obsolescence and possible price concessions required to write-down inventories to net realizable value.
Investment Securities	Investment Securities Investment Securities at Fair Value The Company records all equity investments with readily determinable fair values at fair value calculated by the publicly traded stock price at the close of the reporting period. Amarantus BioScience Holdings (“AMBS”) and True Partner Capital Holding Limited (“True Partner”) are publicly traded companies. The Company does not have significant influence over AMBS and True Partner, as the Company is the beneficial owner of approximately 5.3 15.5 On April 12, 2021 the Company acquired 6,500,000 650,000 7,276,163 1,743,734 38.3 During the year ended December 31, 2021, the Company’s subsidiaries established a portfolio of trading securities. The objective is to generate profits on short-term differences in market prices. The Company does not have significant influence over any trading securities in our portfolio and fair value of these trading securities are determined by quoted stock prices. The Company has elected the fair value option for the equity securities noted below that would otherwise be accounted for under the equity method of accounting. Holista CollTech Limited (“Holista”), DSS, Inc. (“DSS”) and New Electric CV Corporation ● The Company has significant influence over DSS. As of December, 2022 and 2021, the Company owned approximately 45.2 24.9 ● The Company has significant influence over Holista as the Company and its CEO are the beneficial owner of approximately 15.5 ● The Company has significant influence over NECV as the Company is the beneficial owner of approximately 0.8 On March 2, 2020 and October 29, 2021, the Company received warrants to purchase shares of American Medical REIT Inc. (“AMRE”), a related party private startup company, in conjunction with the Company lending two $ 200,000 Note Receivable from a Related Party Company 0 15.8 The Company held a stock option to purchase 250,000 1 0 Sale of Investment in Vivacitas to DSS The Company accounts for certain of its investments in funds without readily determinable fair values in accordance with ASU No. 2015-07, Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent) 100,000 74,827 Investment Securities at Cost Investments in equity securities without readily determinable fair values are measured at cost minus impairment adjusted by observable price changes in orderly transactions for the identical or a similar investment of the same issuer. These investments are measured at fair value on a nonrecurring basis when there are events or changes in circumstances that may have a significant adverse effect. An impairment loss is recognized in the consolidated statements of comprehensive income equal to the amount by which the carrying value exceeds the fair value of the investment. The Company had an equity holding in Vivacitas Oncology Inc. (“Vivacitas”), a private company that is currently not listed on an exchange. We measure Vivacitas at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Our ownership in Vivacitas was sold on March 18, 2021 to DSS for $ 2,480,000 2,279,872 Sale of Investment in Vivacitas to DSS On September 8, 2020, the Company acquired 1,666 1.45 37,826 On September 30, 2020, the Company acquired 3,800 19 42,562 During 2021, the Company invested $ 19,609 18 There has been no indication of impairment or changes in observable prices via transactions of similar securities and investments are still carried at cost. Investment Securities under Equity Method Accounting The Company accounts for equity investment in entities with significant influence under equity-method accounting. Under this method, the Group’s pro rata share of income (loss) from investment is recognized in the consolidated statements of comprehensive income. Dividends received reduce the carrying amount of the investment. When the Company’s share of loss in an equity-method investee equals or exceeds its carrying value of the investment in that entity, the equity method investment can be reduced below zero based on losses if the Company either be liable for the obligations of the investee or provide for losses in excess of the investment when imminent return to profitable operations by the investee appears to be assured. Otherwise, the Company does not recognize its share of equity method losses exceeding its carrying amount of the investment, but discloses the losses in the footnotes. Equity-method investment is reviewed for impairment by assessing if the decline in market value of the investment below the carrying value is other-than-temporary. In making this determination, factors are evaluated in determining whether a loss in value should be recognized. These include consideration of the intent and ability of the Group to hold investment and the ability of the investee to sustain an earnings capacity, justifying the carrying amount of the investment. Impairment losses are recognized in other expense when a decline in value is deemed to be other-than-temporary. American Medical REIT Inc. LiquidValue Asset Management Pte. Ltd. (“LiquidValue”), a subsidiary of the Company owns 15.8 American Pacific Bancorp, Inc. Pursuant to Securities Purchase Agreement from March 12, 2021 the Company purchased 4,775,523 6,666,700 40,000,200 As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $ 28.2 30.8 2.9 51,999 867,117 31,668,246 30,801,129 The following table presents summarized unaudited financial information for APB. SCHEDULE OF UNAUDITED FINANCIAL INFORMATION Summarized Financial Information Assets Liabilities Net Income (Loss) December 31, 2022 54,835,272 316,826 2,245,532 December 31, 2021 29,448,425 371,564 (536,481 ) Alset Capital Acquisition Corp. On February 3, 2022, Alset Capital Acquisition Corp. (“Alset Capital”), a special purpose acquisition company (SPAC) sponsored by the Company and certain affiliates, closed its initial public offering of 7,500,000 10.00 1,125,000 473,750 4,737,500 2,156,250 23.4 2,830,961 237,578 237,578 203,713 10 476,250 100 21,111,575 Ketomei Pte Ltd On June 10, 2021 the Company’s indirect subsidiary Hapi Cafe Inc. (“Hapi Cafe”) lent $ 76,723 179,595 28 48,916 207,402 Investment in Debt Securities Debt securities are reported at fair value, with unrealized gains and losses (other than impairment losses) recognized in accumulated other comprehensive income or loss. Realized gains and losses on debt securities are recognized in the net income in the consolidated statements of comprehensive income. The Company monitors its investments for other-than-temporary impairment by considering factors including, but not limited to, current economic and market conditions, the operating performance of the companies including current earnings trends and other company-specific information. The Company invested $ 50,000 9,799 50,000 28,636 On February 26, 2021, the Company invested approximately $ 88,599 2 two years 21.26 88,599
Variable Interest Entity	Variable Interest Entity Under Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 810, Consolidation The Company evaluates its interests in VIE’s on an ongoing basis and consolidates any VIE in which it has a controlling financial interest and is deemed to be the primary beneficiary. A controlling financial interest has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact its economic performance; and (ii) the obligation to absorb losses of the VIE that could potentially be significant to it or the right to receive benefits from the VIE that could be significant to the VIE. HWH World Company Limited HWH World Co. is a direct sales company in Thailand. The Company has a 19 187,500 51 236,699 236,699 American Medical REIT Inc. In 2021 the Company owned 3.4 8,350,000 200,000 8 200,000 8,350,000 80.8 200,000 15.8 8,350,000 21,366,177 1,089,675 0 8,901,285
Real Estate Assets	Real Estate Assets Real estate assets are recorded at cost, except when real estate assets are acquired that meet the definition of a business combination in accordance with Financial Accounting Standards Board (“FASB”) ASC 805 - “Business Combinations”, The Company capitalized construction costs of approximately $ 3.2 6.0 million for the years ended December 31, 2022 and 2021, respectively. The Company’s policy is to obtain an independent third-party valuation for each major project in the United States as part of our assessment of identifying potential triggering events for impairment. Management may use the market comparison method to value other relatively small projects, such as the project in Perth, Australia. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – Property Plant and Equipment The Company did not record impairment on any of its projects during the years ended on December 31, 2022 and 2021. Properties under development Properties under development are properties being constructed for sale in the ordinary course of business, rather than to be held for the Company’s own use, rental or capital appreciation. Rental Properties Rental properties are acquired with the intent to be rented to tenants. During the years ended December 31, 2022 and 2021, the Company signed multiple purchase agreements to acquire 23 and 109 homes, respectively. By December 31, 2022, all of the 132 homes were closed with an aggregate purchase cost of $ 30,998,258 Investments in Single-Family Residential Properties The Company accounts for its investments in single-family residential properties as asset acquisitions and records these acquisitions at their purchase price. The purchase price is allocated between land, building, improvements and existing leases based upon their relative fair values at the date of acquisition. The purchase price for purposes of this allocation is inclusive of acquisition costs which typically include legal fees, title fees, property inspection and valuation fees, as well as other closing costs. Building improvements and buildings are depreciated over estimated useful lives of approximately 10 27.5 The Company assesses its investments in single-family residential properties for impairment whenever events or changes in business circumstances indicate that carrying amounts of the assets may not be fully recoverable. When such events occur, management determines whether there has been impairment by comparing the asset’s carrying value with its fair value. Should impairment exist, the asset is written down to its estimated fair value. The Company did not recognize any impairment losses during the years ended on December 31, 2022 and 2021. Revenue Recognition and Cost of Sales ASC 606 - Revenue from Contracts with Customers In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which the determination of revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which the Company expects to be entitled in exchange for those goods or services. ASC 606 requires the Company to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, performance obligations are satisfied. The following represents the Company’s revenue recognition policies by Segments: Real Estate Property Sales Part of the Company’s real estate business is land development. The Company purchases land and develops it for building into residential communities. The developed lots are sold to builders (customers) for the construction of new homes. The builders enter a sales contract with the Company before they take the lots. The prices and timeline are determined and agreed upon in the contract. The builders do the inspections to make sure all conditions and requirements in contracts are met before purchasing the lots. A detailed breakdown of the five-step process for the revenue recognition of the Ballenger and Black Oak projects, which represented approximately 29 70 ● Identify the contract with a customer. The Company has signed agreements with the builders for developing the raw land to ready to build lots. The agreements have agreed upon prices, timelines, and specifications for what is to be provided. ● Identify the performance obligations in the contract. Performance obligations of the Company include delivering developed lots to the customer, which are required to meet certain specifications that are outlined in the contract. The customer inspects all lots prior to accepting title to ensure all specifications are met. ● Determine the transaction price. The transaction price per lot is fixed and specified in the contract. Any subsequent change orders or price changes are required to be approved by both parties. ● Allocate the transaction price to performance obligations in the contract. Each lot or a group of lots is considered to be a separate performance obligation, for which the specified price in the contract is allocated to. ● Recognize revenue when (or as) the entity satisfies a performance obligation. The builders do the inspections to make sure all conditions/requirements are met before taking title of lots. The Company recognizes revenue at a point in time when title is transferred. The Company does not have further performance obligations or continuing involvement once title is transferred. Rental Revenue The Company leases real estate properties to its tenants under leases that are predominately classified as operating leases, in accordance with ASC 842, Leases (“ASC 842”). Real estate rental revenue is comprised of minimum base rent and revenue from the collection of lease termination fees. Rent from tenants is recorded in accordance with the terms of each lease agreement on a straight-line basis over the initial term of the lease. Rental revenue recognition begins when the tenant controls the space and continues through the term of the related lease. Generally, at the end of the lease term, the Company provides the tenant with a one-year renewal option, including mostly the same terms and conditions provided under the initial lease term, subject to rent increases. The Company defers rental revenue related to lease payments received from tenants in advance of their due dates. These amounts are presented within deferred revenues and other payables on the Company’s consolidated balance sheets. Rental revenue is subject to an evaluation for collectability on several factors, including payment history, the financial strength of the tenant and any guarantors, historical operations and operating trends of the property, and current economic conditions. If our evaluation of these factors indicates that it is not probable that we will recover substantially all of the receivable, rental revenue is limited to the lesser of the rental revenue that would be recognized on a straight-line basis (as applicable) or the lease payments that have been collected from the lessee. Differences between rental revenue recognized and amounts contractually due under the lease agreements are credited or charged to straight-line rent receivable or straight-line rent liability, as applicable. In the year ended December 31, 2022 and 2021, the Company did not recognize any deferred revenue and collected all rents due. Sale of the Front Foot Benefit Assessments We have established a front foot benefit (“FFB”) assessment on all of the NVR lots. This is a 30-year annual assessment allowed in Frederick County which requires homeowners to reimburse the developer for the costs of installing public water and sewer to the lots. These assessments become effective as homes are settled, at which time we can sell the collection rights to investors who will pay an upfront lump sum, enabling us to more quickly realize the revenue. The selling prices range from $ 3,000 4,500 126,737 289,375 Cost of Revenue ● Cost of Real Estate Sale All of the costs of real estate sales are from our land development business. Land acquisition costs are allocated to each lot based on the area method, the size of the lot comparing to the total size of all lots in the project. Development costs and capitalized interest are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If allocation of development costs and capitalized interest based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on area method, the size of the lot comparing to the total size of all lots in the project. ● Cost of Rental Revenue Cost of rental revenue consists primarily of the costs associated with management and leasing fees to our management company, repairs and maintenance, depreciation and other related administrative costs. Utility expenses are paid directly by tenants. Biohealth Product Direct Sales. If any member returns a product to the Company on a timely basis, they may obtain a replacement product from the Company for such returned products. We do not have buyback program. However, when the customer requests a return and management decides that the refund is necessary, we initiate the refund after deducting all the benefits that a member has earned. The returns are deducted from our sales revenue on our financial statements. Allowances for product and membership returns are provided at the time the sale is recorded. This accrual is based upon historical return rates for each country and the relevant return pattern, which reflects anticipated returns to be received over a period of up to 12 months following the original sale. Product and membership returns for the years ended December 31, 2022 and 2021 were approximately $ 41,755 39,203 Annual Membership. 21,198 728,343 Other Businesses Food and Beverage The Company, through Hapi Café Inc. (“HCI-T”), commenced operation of two cafés during 2022 and 2021, which are located in Singapore and South Korea. The cafes are operated by subsidiaries of HCI-T, namely Hapi Café SG Pte. Limited (“HCSG”) in Singapore and Hapi Café Korea Inc. (“HCKI”) in Seoul, South Korea. Hapi Cafes are distinctive lifestyle café outlets that strive to revolutionize the way individuals dine, work, and live, by providing a conducive environment for everyone to relish the four facets – health and wellness, fitness, productivity, and recreation all under one roof. Remaining performance obligations.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation to employees in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination. Effective January 1, 2019, the Company adopted ASU 2018-07 for the accounting of share-based payments granted to non-employees for goods and services. During the years ended on December 31, 2022 and 2021, the Company recorded $ 0 73,292
Foreign Currency	Foreign Currency Functional and reporting currency Items included in the financial statements of each entity in the Company are measured using the currency of the primary economic environment in which the entity operates (“functional currency”). The financial statements of the Company are presented in U.S. dollars (the “reporting currency”). The functional and reporting currency of the Company is the United States dollar (“U.S. dollar”). The financial records of the Company’s subsidiaries located in Singapore, Hong Kong, Australia and South Korea are maintained in their local currencies, the Singapore Dollar (S$), Hong Kong Dollar (HK$), Australian Dollar (“AUD”) and South Korean Won (“KRW”), which are also the functional currencies of these entities. Transactions in foreign currencies Transactions in currencies other than the functional currency during the year are converted into functional currency at the applicable rates of exchange prevailing when the transactions occurred. Transaction gains and losses are recognized in the statement of operations. The majority of the Company’s foreign currency transaction gains or losses come from the effects of foreign exchange rate changes on the intercompany loans between Singapore entities and U.S. entities. The Company recorded $ 547,845 1,363,061 Translation of consolidated entities’ financial statements Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at the rates of exchange ruling at the balance sheet date. The Company’s entities with functional currency of Singapore Dollar, Hong Kong Dollar, AUD and KRW, translate their operating results and financial positions into the U.S. dollar, the Company’s reporting currency. Assets and liabilities are translated using the exchange rates in effect on the balance sheet date. Revenue, expense, gains and losses are translated using the average rate for the year. Translation adjustments are reported as cumulative translation adjustments and are shown as a separate component of comprehensive income (loss). The Company recorded other comprehensive gain of $ 508,277 3,974,966
Income Taxes	Income Taxes US Income Taxes Income tax expense represents the sum of the current tax expense and deferred tax expense. Income tax for current and prior periods is recognized at the amount expected to be paid to or recovered from the tax authorities, using the tax rates and tax laws that have been enacted or substantially enacted by the balance sheet date. Deferred income tax is provided in full, using the liability method, on temporary differences at the balance sheet date between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax assets and liabilities are recognized for all temporary differences, except: ● Where the deferred tax arises from the initial recognition of an asset or liability in a transaction that is not a business combination and at the time of the transaction affects neither the accounting profit nor taxable profit or loss. ● In respect of temporary differences associated with investments in subsidiaries, where the timing of the reversal of the temporary differences can be determined and it is probable that the temporary differences will not reverse in the foreseeable future; and ● In respect of deductible temporary differences and carry-forward of unutilized tax losses, if it is not probable that taxable profits will be available against which those deductible temporary differences and carry-forward of unutilized tax losses can be utilized. The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at each balance sheet date and are recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be utilized. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or the liability is settled, based on tax rates and tax laws that have been enacted or substantively enacted at the balance sheet date. Current and deferred income tax are recognized as income or expense in the profit or loss, except to the extent that the tax arises from a business combination or a transaction which is recognized either in other comprehensive income or directly in equity. Deferred tax arising from a business combination is adjusted against goodwill on acquisition. Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets and they relate to income taxes levied by the same tax authorities on the same taxable entity, or on different tax entities, provided they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously. Deferred income tax assets and liabilities are determined based on the estimated future tax effects of net operating loss and credit carry-forwards and temporary differences between the tax basis of assets and liabilities and their respective financial reporting amounts measured at the current enacted tax rates. The differences relate primarily to net operating loss carryforward from date of acquisition and to the use of the cash basis of accounting for income tax purposes. The Company records an estimated valuation allowance on its deferred income tax assets if it is more likely than not that these deferred income tax assets will not be realized. The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The Company has not recorded any unrecognized tax benefits. The Company’s 2021, 2020 and 2019 tax returns remain open to examination. Income Taxes in other countries Significant judgement is involved in determining the income taxes mainly in Singapore. There are certain transactions and computations for which the ultimate tax determination is uncertain during the ordinary course of business. The Company recognizes liabilities for expected tax liabilities based on estimates of whether additional taxes will be due. Where the final tax outcome of these matters is different from the amounts that were initially recognized, such differences will impact the income tax and deferred tax provisions in the period in which such determination is made.
Earnings (loss) per Share	Earnings (loss) per Share The Company presents basic and diluted earnings (loss) per share data for its common shares. Basic earnings (loss) per share is calculated by dividing the profit or loss attributable to common stock shareholders of the Company by the weighted-average number of common shares outstanding during the year, adjusted for treasury shares held by the Company. Diluted earnings (loss) per share is determined by adjusting the profit or loss attributable to common stock shareholders and the weighted-average number of common shares outstanding, adjusted for treasury shares held, for the effects of all dilutive potential ordinary shares, which comprise convertible securities, such as stock options, convertible bonds and warrants. At December 31, 2022 there were 456,653 1,248,822
Fair Value Measurements	Fair Value Measurements ASC 820, Fair Value Measurement and Disclosures Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques. The carrying value of the Company’s financial instruments, including cash and restricted cash, accounts receivable and accounts payable and accrued expenses approximate fair value because of the short-term maturity of these financial instruments. The liabilities in connection with the conversion and make-whole features included within certain of the Company’s convertible notes payable and warrants are each classified as a level 3 liability.
Non-controlling Interests	Non-controlling Interests Non-controlling interests represent the equity in subsidiary not attributable, directly or indirectly, to shareholders of the Company, and are presented separately in the Consolidated Statements of Operation and Other Comprehensive Loss, and within equity in the Consolidated Balance Sheets, separately from equity attributable to shareholders of the Company. On December 31, 2022 and 2021, the aggregate non-controlling interests in the Company were $ 11,009,149 21,912,268
Impairment of Long-lived Assets	Impairment of Long-lived Assets Our policy is to obtain an independent third-party valuation for each major project in the United States to identify triggering events for impairment. Our management may use a market comparison method to value other relatively small projects, such as the project in Perth, Australia. In addition to the annual assessment of potential triggering events in accordance with ASC 360 – Property Plant and Equipment (“ASC 360”), we apply a fair value-based impairment test to the net book value assets on an annual basis and on an interim basis if certain events or circumstances indicate that an impairment loss may have occurred. The company did not record any impairment for the year ended on December 31, 2022 and 2021.
Capitalized Financing Costs	Capitalized Financing Costs Financing costs, such as loan origination fee, administration fee, interests and other related financing costs, should be capitalized and recorded on the balance sheet if these financing activities are directly associated with the development of real estates. Capitalized Financing Costs are allocated to lots sold based on the total expected development and interest costs of the completed project and allocating a percentage of those costs based on the selling price of the sold lot compared to the expected sales values of all lots in the project. If the allocation of capitalized financing costs based on the projection and relative expected sales value is impracticable, those costs could also be allocated based on an area method, which uses the size of the lots compared to the total project area and allocates costs based on their size. As of December 31, 2022 and 2021, the capitalized financing costs were $ 3,247,739
Related Party Transactions	Related Party Transactions The Company accounts for related party transactions in accordance with ASC 850 (“Related Party Disclosures”). A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.
Beneficial Conversion Features	Beneficial Conversion Features The Company evaluates the conversion feature for whether it was beneficial as described in ASC 470-30. The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the shares of common stock at the commitment date to be received upon conversion.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting pronouncement not yet adopted In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.” ASU 2021-08 requires the company acquiring contract assets and contract liabilities obtained in a business combination to recognize and measure them in accordance with ASC 606, “Revenue from Contracts with Customers”. At the acquisition date, the company acquiring the business should record related revenue, as if it had originated the contract. Before the update such amounts were recognized by the acquiring company at fair value. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Early adoption is permitted, including in interim periods, for any financial statements that have not yet been issued. The Company adopted these requirements prospectively, effective on the first day of the year 2023. In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amounts. An entity must use judgment in determining the relevant information and estimation methods that are appropriate in its circumstances. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those fiscal years, and a modified retrospective approach is required, with a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. In November of 2019, the FASB issued ASU 2019-10, which delayed the implementation of ASU 2016-13 to fiscal years beginning after December 15, 2022 for smaller reporting companies. The Company is currently evaluating the impact of ASU 2016-13 on its future consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of Reference Rate Reform on Financial Reporting In August 2020, the FASB issued ASU 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SCHEDULE OF SUBSIDIARIES	The Company’s consolidated financial statements include the financial positions, results of operations and cash flows of the following entities as of December 31, 2022 and 2021 as follows: SCHEDULE OF SUBSIDIARIES Attributable interest State or other jurisdiction of as of, Name of subsidiary consolidated under AEI incorporation or organization December 31, 2022 December 31, 2021 % % Alset Global Pte. Ltd. Singapore 100 100 Alset Business Development Pte. Ltd. Singapore 100 100 Global eHealth Limited Hong Kong 100 100 Alset International Limited Singapore 85.4 76.8 Singapore Construction & Development Pte. Ltd. Singapore 85.4 76.8 Art eStudio Pte. Ltd. Singapore 43.6 * 39.2 * Singapore Construction Pte. Ltd. Singapore 85.4 76.8 Global BioMedical Pte. Ltd. Singapore 85.4 76.8 Alset Innovation Pte. Ltd. Singapore 85.4 76.8 Health Wealth Happiness Pte. Ltd. Singapore 85.4 76.8 SeD Capital Pte. Ltd. Singapore 85.4 76.8 LiquidValue Asset Management Pte. Ltd. Singapore 85.4 76.8 * Alset Solar Limited Hong Kong 85.4 76.8 Alset F&B One Pte. Ltd. Singapore 76.9 69.2 Global TechFund of Fund Pte. Ltd. Singapore 100 76.8 Singapore eChainLogistic Pte. Ltd. Singapore 100 76.8 BMI Capital Partners International Limited Hong Kong 85.4 76.8 SeD Perth Pty Ltd Australia 85.4 76.8 SeD Intelligent Home Inc. United States of America 85.4 76.8 LiquidValue Development Inc. United States of America 85.4 76.8 Alset EHome Inc. United States of America 85.4 76.8 SeD USA, LLC United States of America 85.4 76.8 150 Black Oak GP, Inc. United States of America 85.4 76.8 SeD Development USA Inc. United States of America 85.4 76.8 150 CCM Black Oak, Ltd. United States of America 85.4 76.8 SeD Texas Home, LLC United States of America 85.4 76.8 SeD Ballenger, LLC United States of America 85.4 76.8 SeD Maryland Development, LLC United States of America 71.4 64.2 SeD Development Management, LLC United States of America 72.6 65.3 SeD Builder, LLC United States of America 85.4 76.8 Hapi Metaverse Inc. (f.k.a. GigWorld Inc.) United States of America 99.7 76.8 HotApp BlockChain Pte. Ltd. Singapore 99.7 76.6 HotApp International Limited Hong Kong 99.7 76.6 HWH International, Inc. United States of America 85.4 76.8 Health Wealth & Happiness Inc. United States of America 85.4 76.8 HWH Multi-Strategy Investment, Inc. United States of America 85.4 76.8 SeD REIT Inc. United States of America 85.4 76.8 Gig Stablecoin Inc. United States of America 99.7 76.6 HWH World Inc. United States of America 99.7 76.6 HWH World Pte. Ltd. Singapore 85.4 76.6 UBeauty Limited Hong Kong 85.4 76.8 WeBeauty Korea Inc South Korea 85.4 76.8 HWH World Limited Hong Kong 85.4 76.8 HWH World Inc. South Korea 85.4 76.8 Alset BioHealth Pte. Ltd. Singapore - 76.8 Alset Energy Pte. Ltd. Singapore - 76.8 GDC REIT Inc. (f.k.a. Alset Payment Inc.) United States of America 85.4 76.8 Alset World Pte. Ltd. Singapore - 76.8 BioHealth Water Inc. United States of America 85.4 76.8 Impact BioHealth Pte. Ltd. Singapore 85.4 76.8 American Home REIT Inc. United States of America 85.4 76.8 Alset Solar Inc. United States of America 68.3 61.5 HWH KOR Inc. United States of America 85.4 76.8 Open House Inc. United States of America 100 76.8 Open Rental Inc. United States of America 100 76.8 Hapi Cafe Inc. (Nevada) United States of America 100 76.8 Global Solar REIT Inc. United States of America 100 76.8 OpenBiz Inc. United States of America 100 76.8 Hapi Cafe Inc. (Texas) United States of America 85.4 100 HWH (S) Pte. Ltd. Singapore 85.4 76.8 True Partner International Limited Hong Kong - 100 LiquidValue Development Pte. Ltd. Singapore 100 100 LiquidValue Development Limited Hong Kong 100 100 Alset EPower Inc. United States of America 100 100 EPowerTech Inc. United States of America 100 100 AHR Asset Management Inc. United States of America 85.4 76.8 HWH World Inc. (Nevada) United States of America 85.4 76.8 Alset F&B Holdings Pte. Ltd. Singapore 85.4 76.8 Credas Capital Pte. Ltd. Singapore 42.7 * 38.4 * Smart Reward Express Limited Hong Kong 49.8 * 38.3 * Partners HWH Pte. Ltd. Singapore - 76.8 AHR Texas Two, LLC United States of America 85.4 76.8 AHR Black Oak One, LLC United States of America 85.4 76.8 Hapi Air Inc. United States of America 92.7 88.4 AHR Texas Three, LLC United States of America 85.4 76.8 Alset Capital Pte. Ltd. Singapore 100 100 Hapi Cafe Korea Inc. South Korea 85.4 100 Green Energy Inc. United States of America 100 100 Green Energy Management Inc. United States of America 100 100 Alset Metaverse Inc. United States of America 97.2 95.6 Alset Management Group Inc. United States of America 83.4 88.2 Alset Acquisition Sponsor, LLC United States of America 93.4 79.6 Alset Capital Acquisition Corp. United States of America 23.4 79.6 Alset Spac Group Inc. United States of America 93.4 - Hapi Travel Pte. Ltd. Singapore 85.4 - Hapi WealthBuilder Pte. Ltd. Singapore 85.4 - Alset Mining Pte. Ltd. Singapore 85.4 - HWH Marketplace Pte. Ltd. Singapore 85.4 - HWH International Inc. (Nevada) United States of America 85.4 - Hapi Cafe SG Pte. Ltd. Singapore 85.4 - Alset Reits Inc. United States of America 100 - Alset Home REIT Inc. United States of America 100 - Hapi Metaverse Inc. United States of America 99.7 - Hapi Cafe Limited Hong Kong 99.7 - MOC HK Limited Hong Kong 99.7 - AHR Texas Four, LLC United States of America 100 - Alset F&B (PLQ) Pte. Ltd. Singapore 85.4 - * Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.
SCHEDULE OF UNAUDITED FINANCIAL INFORMATION	The following table presents summarized unaudited financial information for APB. SCHEDULE OF UNAUDITED FINANCIAL INFORMATION Summarized Financial Information Assets Liabilities Net Income (Loss) December 31, 2022 54,835,272 316,826 2,245,532 December 31, 2021 29,448,425 371,564 (536,481 )

SEGMENTS (Tables)

SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
SCHEDULE OF SEGMENT INFORMATION	The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2022 and 2021: SCHEDULE OF SEGMENT INFORMATION Real Estate Digital Transformation Technology Biohealth Business Other Total Year Ended on December 31, 2022 Revenue $ 3,088,628 $ 69,915 $ 753,651 $ 568,248 $ 4,480,442 Cost of Sales (3,016,200 ) (23,423 ) (523,534 ) (168,833 ) (3,731,990 ) Gross Margin 72,428 46,492 230,117 399,415 748,452 Operating Expenses (1,479,674 ) (414,167 ) (850,044 ) (5,093,941 ) (7,837,826 ) Operating Income (Loss) (1,407,246 ) (367,675 ) (619,927 ) (4,694,526 ) (7,089,374 ) Other Income (Expense) 5,885 (1,359,977 ) (4,669,309 ) (33,099,730 ) (39,123,131 ) Net Income (Loss) Before Income Tax (1,401,361 ) (1,727,652 ) (5,289,236 ) (37,794,256 ) (46,212,505 ) Real Estate Digital Transformation Technology Biohealth Business Other Total Year Ended on December 31, 2021 Revenue $ 14,213,379 $ - $ 5,543,066 $ 42,377 $ 19,798,822 Cost of Sales (11,073,756 ) - (214,019 ) (14,039 ) (11,301,814 ) Gross Margin 3,139,623 - 5,329,047 28,338 8,497,008 Operating Expenses (1,136,031 ) (183,429 ) (3,624,200 ) (18,547,470 ) (23,491,130 ) Operating Income (Loss) 2,003,592 (183,429 ) 1,704,847 (18,519,132 ) (14,994,122 ) Other Income (Expense) (8,955 ) 1,286,962 (39,265,445 ) (65,502,017 ) (103,489,455 ) Net Income (Loss) Before Income Tax 1,994,637 1,103,533 (37,560,598 ) (84,021,149 ) (118,483,577 ) December 31, 2022 Cash and Restricted Cash $ 2,592,577 $ 514,260 $ 1,338,404 $ 14,076,662 $ 18,521,903 Total Assets 57,951,324 3,184,416 4,861,615 87,492,981 153,490,336 December 31, 2021 Cash and Restricted Cash $ 7,493,921 $ 245,780 $ 2,629,464 $ 50,433,014 $ 60,802,179 Total Assets 55,465,600 2,199,466 11,056,779 115,488,298 184,210,143

REAL ESTATE ASSETS (Tables)

REAL ESTATE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2022
Real Estate [Abstract]
SCHEDULE OF REAL ESTATE ASSETS	As of December 31, 2022 and 2021, real estate assets consisted of the following: SCHEDULE OF REAL ESTATE ASSETS December 31, 2022 December 31, 2021 Construction in Progress $ 15,506,572 $ 8,597,023 Land Held for Development 7,943,126 7,098,104 Rental Properties 31,169,031 24,820,253 Total Real Estate Assets $ 54,618,729 $ 40,515,380
SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES	The following table presents the summary of our SRFs as of December 31, 2022: SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES Number of Homes Aggregate Average SFRs 132 $ 30,998,258 $ 234,835

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	As of December 31, 2022 and 2021, notes payable consisted of the following: SCHEDULE OF NOTES PAYABLE December 31, December 31, ($) ($) PPP Loan - 68,502 Australia Loan - 162,696 Motor Vehicle Loans 181,846 86,473 Total notes payable $ 181,846 $ 317,671

EQUITY (Tables)

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
SCHEDULE OF NET FUNDS RECEIVED ON OFFERING AND WARRANTS EXERCISED	The following table presents net funds received from the May Offering and warrants exercised as of December 31, 2022. SCHEDULE OF NET FUNDS RECEIVED ON OFFERING AND WARRANTS EXERCISED Shares Par value Amount received Offering 235,032 $ 235 $ 29,145,056 Exercise of Pre-Funded Units 80,550 $ 81 $ 16,110 Exercise of Underwriter’s Series A Warrants 40,418 $ 40 $ 3,755,774 Exercise of Series A and Series B Warrants 68,366 $ 68 $ 6,937,347 Offering Expenses - $ - $ (88,848 ) Total 424,366 $ 424 $ 39,765,439 The following table presents net funds received from the July Offering and warrants exercised as of December 31, 2022. Shares Par value Amount received Offering 266,207 $ 266 $ 28,957,297 Exercise of Pre-Funded Units 488,510 $ 489 $ 97,702 Exercise of Underwriter’s Over-Allotment Option 113,207 $ 113 $ 4,386,998 Offering Expenses - $ - $ (49,553 ) Total 867,924 $ 868 $ 33,392,444 The following table presents net funds received from the December Offering and warrants exercised as of December 31, 2022. Shares Par value Amount received Offering 946,166 $ 946 $ 27,263,673 Exercise of Pre-Funded Units 761,167 $ 761 $ 8,823 Exercise of Underwriter’s Over-Allotment Option 375,000 $ 375 $ 4,115,000 Offering Expenses - $ - $ (40,621 ) Total 2,082,333 $ 2,082 $ 31,346,875
SCHEDULE OF WARRANT ACTIVITY	SCHEDULE OF WARRANT ACTIVITY Warrant for Common Shares Weighted Average Exercise Price Remaining Contractual Term (Years) Aggregate Intrinsic Value Warrants Outstanding as of December 31, 2021 1,426,657 $ 35.80 1.88 $ - Warrants Vested and exercisable at December 31, 2021 1,426,657 $ 35.80 1.88 $ - Granted - - Exercised (792,169 ) 0.02 Forfeited, cancelled, expired - - Warrants Outstanding as of December 31, 2022 634,488 $ 80.40 3.23 $ - Warrants Vested and exercisable at December 31, 2022 634,488 $ 80.40 3.23 $ -

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX	The following is a summary of the changes in the balances of accumulated other comprehensive income, net of tax: SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX Unrealized Gains and Losses on Security Investment Foreign Currency Translations Change in Minority Interest Total Balance at January 1, 2022 $ (90,031 ) $ (367,895 ) $ 799,572 $ 341,646 Other Comprehensive Income 35,110 489,167 2,970,140 3,494,417 Balance at December 31, 2022 $ (54,921 ) $ 121,272 $ 3,769,712 $ 3,836,063 Unrealized Gains and Losses on Security Investment Foreign Currency Translations Change in Minority Interest Total Balance at January 1, 2021 $ (48,758 ) $ 2,258,017 $ (65,921 ) $ 2,143,338 Balance at beginning $ (48,758 ) $ 2,258,017 $ (65,921 ) $ 2,143,338 Other Comprehensive Income (41,273 ) (2,625,912 ) 865,493 (1,801,692 ) Balance at December 31, 2021 $ (90,031 ) $ (367,895 ) $ 799,572 $ 341,646 Balance at end $ (90,031 ) $ (367,895 ) $ 799,572 $ 341,646

LEASE INCOME (Tables)

LEASE INCOME (Tables)	12 Months Ended
	Dec. 31, 2022
Lease Income
SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS	SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS 2023 1,148,308 2024 11,145 Total Future Receipts $ 1,159,453

INVESTMENTS MEASURED AT FAIR _2

INVESTMENTS MEASURED AT FAIR VALUE (Tables)	12 Months Ended
	Dec. 31, 2022
Net Investment Income [Line Items]
SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS	Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the consolidated balance sheets as of December 31, 2022 and 2021: SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS Fair Value Measurement Using Amount at Cost Level 1 Level 2 Level 3 Amount at Fair Value December 31, 2022 Assets Investment Securities- Fair Value Option $ 76,264,051 $ 13,749,957 $ - $ - $ 13,749,957 Investment Securities- Trading 11,268,362 5,315,204 - - 5,315,204 Convertible Note Receivable 138,599 - - 88,599 88,599 Warrants - American Premium Water 696,791 - - 327,565 327,565 Warrants - AMRE - - - - - Total Investment in Securities at Fair Value $ 88,367,803 $ 19,065,161 $ - $ 416,164 $ 19,481,325 Fair Value Measurement Using Amount at Cost Level 1 Level 2 Level 3 Amount at Fair Value December 31, 2021 Assets Investment Securities- Fair Value Option $ 72,000,301 $ 25,320,694 $ - $ - $ 25,320,694 Investment Securities- Trading 9,809,778 9,908,077 - - 9,908,077 Convertible Note Receivable 138,599 - - 98,398 98,398 Warrants - American Premium Water 696,791 - - 1,009,854 1,009,854 Warrants - AMRE - - - - - Total Investment in Securities at Fair Value $ 82,645,469 $ 35,228,771 $ - $ 1,108,252 $ 36,337,023
SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT	SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT Share price Market Value 12/31/2022 Shares 12/31/2022 Valuation DSS (Related Party) $ 0.164 62,812,264 $ 10,301,211 Investment in Securities at Fair Value AMBS (Related Party) $ 0.002 20,000,000 $ 34,000 Investment in Securities at Fair Value Holista (Related Party) $ 0.20 42,999,621 $ 850,432 Investment in Securities at Fair Value American Premium Water (Related Party) $ 0.001 354,039,000 $ 212,423 Investment in Securities at Fair Value Value Exchange $ 0.170 13,834,643 $ 2,351,889 Investment in Securities at Fair Value Trading Stock $ 5,315,204 Investment in Securities at Fair Value Total Level 1 Equity Securities $ 19,065,161 Nervotech N/A 1,666 $ 35,958 Investment in Securities at Cost HWH World Co. N/A 3,800 $ 42,562 Investment in Securities at Cost K Beauty N/A 3,600 $ 19,609 Investment in Securities at Cost Total Equity Securities $ 19,163,290 Share price Market Value 12/31/2021 Shares 12/31/2021 Valuation DSS (Related Party) $ 0.672 19,888,262 $ 13,364,912 Investment in Securities at Fair Value AMBS (Related Party) $ 0.016 20,000,000 $ 328,000 Investment in Securities at Fair Value Holista (Related Party) $ 0.034 43,626,621 $ 1,489,179 Investment in Securities at Fair Value American Premium Water (Related Party) $ 0.002 354,039,000 $ 778,886 Investment in Securities at Fair Value True Partner $ 0.119 62,122,908 $ 7,409,717 Investment in Securities at Fair Value Value Exchange $ 0.300 6,500,000 $ 1,950,000 Investment in Securities at Fair Value Trading Stock $ 9,908,077 Investment in Securities at Fair Value Total Level 1 Equity Securities $ 35,228,771 Nervotech N/A 1,666 $ 37,045 Investment in Securities at Cost HWH World Co. N/A 3,800 $ 42,562 Investment in Securities at Cost K Beauty N/A 3,600 $ 19,609 Investment in Securities at Cost Total Equity Securities $ 35,327,987
SCHEDULE OF FAIRVALUE OF FINANCIAL INVESTMENTS	The following table presents summarized unaudited financial information for our investments that we elected the fair value option that would otherwise be accounted for under the equity method of accounting. SCHEDULE OF FAIRVALUE OF FINANCIAL INVESTMENTS Summarized Financial Information Assets Liabilities Net Income (Loss) December 31, 2022 NECV* $ 1,038,946 $ 2,507,797 $ 128,968 Holista $ 3,717,593 $ 2,660,281 $ (1,053,668 ) DSS* $ 264,880,000 $ 82,231,000 $ (52,214,667 ) VEII* $ 5,047,729 $ 2,676,237 $ 185,321 December 31, 2021 NECV $ 348,688 $ 4,049,594 $ (873,550 ) Holista $ 5,031,866 $ 2,870,177 $ (1,018,871 ) DSS $ 284,826,000 $ 84,522,000 $ (31,921,000 ) * Data derived from Financial Statement as of September 30, 2022 which was the latest available date source we could reach. 12-month Net Income (Loss) was estimated by adding one-third of 9-month Net Loss.
Sharing Services Convertible Note [Member]
Net Investment Income [Line Items]
SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS	The fair value of the Sharing Services Convertible Note under level 3 category as of December 31, 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions: SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS December 31, December 31, Dividend yield - % 0.00 % Expected volatility - % 138.85 % Risk free interest rate - % 3.25 % Contractual term (in years) - 0.76 Exercise price $ - $ 0.15
SCHEDULE OF CHANGE IN FAIR VALUE	The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2022 and 2021: SCHEDULE OF CHANGE IN FAIR VALUE Total Balance at January 1, 2021 $ 38,604,701 Net loss (57,179 ) Conversion of DSS Preferred Stock (37,439,270 ) Balance at December 31, 2021 $ 1,108,252 Net gain 40,201 Balance at December 31, 2022 $ 1,148,453
NECV Warrants [Member]
Net Investment Income [Line Items]
SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS	The fair value of the NECV warrants under level 3 category as of December 31, 2022 and 2021 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions: SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS December 31, 2022 December 31, 2021 As of As of December 31, 2022 December 31, 2021 Stock Price $ 0.0006 $ 0.0022 Exercise Price $ 0.001 $ 0.001 Risk-free Interest Rate 3.95 % 1.48 % Annualized volatility 186.1 % 186.5 % Dividend Yield 0.00 0.00 Year to Maturity 7.56 8.58

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)	The components of income tax expense and the effective tax rates for the years ended December 31, 2022 and 2021 are as follows: SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2022 2021 Year Ended December 31, 2022 2021 Current: Federal $ - $ 45,736 State - 46,179 Total Current - 91,916 Deferred: Federal (3,905,452 ) (2,725,007 ) State 1,163,407 (1,266,545 ) Total Deferred (2,742,045 ) (3,991,553 ) Valuation Allowance 2,742,045 3,991,553 Total Income Tax Expense $ - $ 91,916 Pre-tax Loss $ (46,212,505 ) $ (118,483,577 ) Effective Income Tax Rate 0.0 % -0.1 %
SCHEDULE OF RECONCILIATION OF INCOME TAX	A reconciliation of our income tax expense at federal statutory income tax rate of 21% to our income tax expense at the effective tax rate is as follows: SCHEDULE OF RECONCILIATION OF INCOME TAX 2022 2021 Year Ended December 31, 2022 2021 Federal Statutory Tax Rate 21.0 % 21.0 % State Income Tax, Net of Federal Income Taxes 0.0 % 0.0 % Intercompany Management & Oversight Fees 0.0 % -0.1 % Capitalized Construction Costs 0.0 % 0.2 % Minority interest in Partnerships 0.0 % 0.1 % Deferred Finance Costs -0.4 % -0.2 % Amort of BCF Debt Discount 0.0 % -9.0 % Miscellaneous Permanent Items 0.2 % 0.0 % Non includible foreign entities loss/(income) -13.8 % -9.6 % Valuation Allowance -7.1 % -2.5 % Effective Income Tax Rate 0.0 % -0.1 %
SCHEDULE OF DEFERRED TAX ASSETS	Deferred tax assets consist of the following at December 31, 2022 and 2021: SCHEDULE OF DEFERRED TAX ASSETS 2022 2021 Interest Income (6,304,175 ) (5,660,333 ) Interest Expense 5,802,873 5,100,076 Depreciation and Amortization (140,886 ) (10,434 ) Impairment 2,253,228 2,253,228 Accrued Expense 1,102,779 60,662 Unrealized Loss on Investment 4,324,883 2,512,554 Partnership Loss 13,175 13,175 Other Amortization 1,160,710 - Others 377,180 (224,637 ) Net Operating Loss 1,297,770 2,047,388 Total deferred tax asset 9,887,537 6,091,679 Valuation Allowance (9,887,537 ) (6,091,679 ) Net Deferred Tax Asset - -
SCHEDULE OF OTHER COUNTRY INCOME TAXES	As of December 31, 2022: SCHEDULE OF OTHER COUNTRY INCOME TAXES SG Companies HK Companies KR Companies AU Companies Total Calculation: Cumulative loss & other deferred tax assets before tax $ (25,140,421 ) $ - $ - $ - $ (25,140,421 ) Effective tax rates 17.00 % 16.50 % 25.00 % 30.00 % Tax at the domestic tax rates applicable to profits in the countries where the Company operates $ (4,273,872 ) $ - $ - $ - $ (4,273,872 ) Adjustments: Deferred tax assets not recognized $ 4,273,872 $ - $ - $ - $ 4,273,872 Income tax expenses recognized in profit or loss $ - $ - $ - $ - $ - As of December 31, 2021: SG Companies HK Companies KR Companies AU Companies Total Calculation: Cumulative loss & other deferred tax assets before tax $ (11,692,089 ) $ - $ - $ - $ (11,692,089 ) Effective tax rates 17.00 % 16.50 % 19.24 % 30.00 % Tax at the domestic tax rates applicable to profits in the countries where the Company operates $ (1,987,655 ) $ - $ - $ - $ (1,987,655 ) Adjustments: Deferred tax assets not recognized $ 1,987,655 $ - $ - $ - $ 1,987,655 Income tax expenses recognized in profit or loss $ - $ - $ 442,098 $ - $ 442,098

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL	SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL Office Location Lease Term as of December 31, 2022 Singapore - AI June 2022 to May 2023 Singapore – F&B October 2021 to September 2024 Singapore – Four Seasons Park July 2022 to July 2024 Singapore – Hapi Cafe July 2022 to June 2024 Singapore - PLQ December 2022 to July 2024 Hong Kong October 2022 to October 2024 Hong Kong - Warehouse November 2022 to October 2024 Hong Kong - Shop October 2022 to September 2024 South Korea - Hapi Café August 2022 to August 2025 South Korea - HWH World August 2022 to July 2025 Magnolia, Texas, USA May 2022 to January 2023 Bethesda, Maryland, USA January 2021 to March 2024
SCHEDULE OF LEASE PAYMENTS	The table below summarizes future payments due under these leases as of December 31, 2022. For the Years Ended December 31: SCHEDULE OF LEASE PAYMENTS 2023 $ 944,807 2024 656,668 2025 195,811 Total Minimum Lease Payments 1,797,287 Less: Effect of Discounting (169,248 ) Present Value of Future Minimum Lease Payments 1,628,039 Less: Current Obligations under Leases (45,556 ) Long-term Lease Obligations $ 1,582,483

DIRECTORS AND EMPLOYEES_ BENE_2

DIRECTORS AND EMPLOYEES’ BENEFITS (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
SCHEDULE OF OPTION ACTIVITY	The following tables summarize stock option activity under the 2013 Plan for the year ended December 31, 2022: SCHEDULE OF OPTION ACTIVITY Options for Common Shares Exercise Price Remaining Contractual Term (Years) Aggregate Intrinsic Value Outstanding as of January 1, 2021 1,061,333 $ 0.09 3.00 $ - Vested and exercisable at January 1, 2021 1,061,333 $ 0.09 3.00 $ - Granted - - Exercised - - Forfeited, cancelled, expired - - Outstanding as of December 31, 2021 1,061,333 $ 0.09 2.00 $ - Vested and exercisable at December 31, 2021 1,061,333 $ 0.09 2.00 $ - Granted - - Exercised - - Forfeited, cancelled, expired - - Outstanding as of December 31, 2022 1,061,333 $ 0.09 1.00 $ - Vested and exercisable at December 31, 2022 1,061,333 $ 0.09 1.00 $ -

NATURE OF OPERATIONS AND SUMM_2

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)											12 Months Ended
	Feb. 28, 2022 shares	Jan. 27, 2022 shares	Jan. 17, 2022 shares	Dec. 13, 2021 USD ($) $ / shares shares	Dec. 08, 2021 USD ($) shares	Jul. 30, 2021 USD ($) shares	May 13, 2021 USD ($) shares	Nov. 24, 2020 USD ($) shares	Jun. 24, 2020 shares	Oct. 01, 2018 shares	Dec. 31, 2022 USD ($) a Integer shares	Dec. 31, 2021 USD ($) ft² shares	Aug. 16, 2021 a	Oct. 13, 2019 USD ($)
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of shares issued					3,374,624	3,374,624	3,374,624	108,000
Number of shares held in entity											2,983,918,265	2,810,999,176
Number of warrants held in entity											0	10,000,000
Stock issued value | $					$ 105,000,000	$ 105,000,000	$ 105,000,000	$ 13,200,000			$ 3,895	$ 104,565,659
Principal amount | $														$ 140,000
Interest rate														2.50%
Debt conversion of shares		500,000
CommonStockSharesIssued											7,422,846	4,368,422
Common stock, shares, outstanding			3,492,713,362								7,422,846	4,368,422
Number of operating segments | Integer											4
Area of land											197	15,811	19.5
Revenues | $											$ 4,480,442	$ 19,798,822
Deferred revenue | $											21,198	728,343
Revenue From Other Busines [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Revenues | $											$ 568,248	$ 42,377
Alset Global Pte. Ltd. [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership										100%	100%	100%
Number of exchanged shares										425,000
Alset International Inc [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership											85.40%	76.80%
Heng Fai Enterprises Pte. Ltd. [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership										100%
Number of exchanged shares										25,000
Globale Health Limited [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership											100%	100%
Number of exchanged shares										50,000
HFE Holdings Limited [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of shares surrendered									180,000
Alset International [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of ordinary shares issued	293,428,200
Shares issued and outstanding percentage	8.40%
CommonStockSharesIssued	3,492,713,362
Common stock, shares, outstanding	3,492,713,362
FKA Sed Intelligent Home Inc [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership											99.90%
Hapi Metaverse Inc. [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership											99.70%
HWH World [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Ownership											19%
Revenues | $											$ 753,651	$ 5,543,066
Deferred revenue | $											$ 21,198	$ 728,343
Chan Heng Fai [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of shares issued	1,765,964		1,473,449								50
Number of shares surrendered									50
Principal amount | $				$ 6,250,000
Interest rate				3%
Due date				Dec. 31, 2024
Debt conversion price | $ / shares				$ 12.50
Debt conversion of shares				500,000
Number of ordinary shares issued	293,428,200		293,428,200

SCHEDULE OF SUBSIDIARIES (Detai

SCHEDULE OF SUBSIDIARIES (Details)		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021		Oct. 01, 2018
Alset Global Pte. Ltd. [Member]
Name of subsidiary		Alset Global Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		100%	100%		100%
Alset Business Development Pte Ltd [Member]
Name of subsidiary		Alset Business Development Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		100%	100%
Globale Health Limited [Member]
Name of subsidiary		Global eHealth Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		100%	100%
Alset International Inc [Member]
Name of subsidiary		Alset International Limited
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Singapore Construction & Development Pte. Ltd. [Member]
Name of subsidiary		Singapore Construction & Development Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Art eStudio Pte. Ltd. [Member]
Name of subsidiary		Art eStudio Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage	[1]	43.60%	39.20%
Singapore Construction Pte. Ltd. [Member]
Name of subsidiary		Singapore Construction Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Global Bio Medical Pte Ltd [Member]
Name of subsidiary		Global BioMedical Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Alset Innovation Pte Ltd [Member]
Name of subsidiary		Alset Innovation Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Health Wealth Happiness Pte Ltd [Member]
Name of subsidiary		Health Wealth Happiness Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
SeD Capital Pte Ltd [Member]
Name of subsidiary		SeD Capital Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Liquid Value Asset Management Pte Ltd [Member]
Name of subsidiary		LiquidValue Asset Management Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%	[1]
Alset Solar Limited [Member]
Name of subsidiary		Alset Solar Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		85.40%	76.80%
Alset F&B one Pte Ltd [Member]
Name of subsidiary		Alset F&B One Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		76.90%	69.20%
Global TechFund of Fund Pte Ltd [Member]
Name of subsidiary		Global TechFund of Fund Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		100%	76.80%
Singapore eChain Logistic Pte Ltd [Member]
Name of subsidiary		Singapore eChainLogistic Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		100%	76.80%
BMI Capital Partners International Limited [Member]
Name of subsidiary		BMI Capital Partners International Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		85.40%	76.80%
SeD Perth Pty Ltd [Member]
Name of subsidiary		SeD Perth Pty Ltd
State or other jurisdiction of incorporation or organization		Australia
Subsidiary percentage		85.40%	76.80%
SeD Intelligent Home Inc [Member]
Name of subsidiary		SeD Intelligent Home Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
LiquidValue Development Inc [Member]
Name of subsidiary		LiquidValue Development Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Alset EHome Inc [Member]
Name of subsidiary		Alset EHome Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
SeD USA, LLC [Member]
Name of subsidiary		SeD USA, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
150 Black Oak GP Inc [Member]
Name of subsidiary		150 Black Oak GP, Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
SeD Development USA Inc [Member]
Name of subsidiary		SeD Development USA Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
150 CCM Black Oak Ltd [Member]
Name of subsidiary		150 CCM Black Oak, Ltd.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
SeD Texas Home LLC [Member]
Name of subsidiary		SeD Texas Home, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
SeD Ballenger LLC [Member]
Name of subsidiary		SeD Ballenger, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
SeD Maryland Development LLC [Member]
Name of subsidiary		SeD Maryland Development, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		71.40%	64.20%
SeD Development Management LLC [Member]
Name of subsidiary		SeD Development Management, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		72.60%	65.30%
SeD Builder LLC [Member]
Name of subsidiary		SeD Builder, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Gig World Inc [Member]
Name of subsidiary		Hapi Metaverse Inc. (f.k.a. GigWorld Inc.)
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		99.70%	76.80%
Hot App Block Chain Pte .Ltd [Member]
Name of subsidiary		HotApp BlockChain Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		99.70%	76.60%
HotApp International Limited [Member]
Name of subsidiary		HotApp International Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		99.70%	76.60%
HWH International Inc [Member]
Name of subsidiary		HWH International, Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Health Wealth & Happiness Inc [Member]
Name of subsidiary		Health Wealth & Happiness Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
HWH Multi-Strategy Investment Inc [Member]
Name of subsidiary		HWH Multi-Strategy Investment, Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
SeD REIT Inc [Member]
Name of subsidiary		SeD REIT Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Gig Stablecoin Inc [Member]
Name of subsidiary		Gig Stablecoin Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		99.70%	76.60%
HWH World Inc. [Member]
Name of subsidiary		HWH World Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		99.70%	76.60%
HWH World Pte. Ltd. [Member]
Name of subsidiary		HWH World Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.60%
UBeauty Limited [Member]
Name of subsidiary		UBeauty Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		85.40%	76.80%
WeBeauty Korea Inc [Member]
Name of subsidiary		WeBeauty Korea Inc
State or other jurisdiction of incorporation or organization		South Korea
Subsidiary percentage		85.40%	76.80%
HWH World Limited [Member]
Name of subsidiary		HWH World Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		85.40%	76.80%
HWH World Inc One [Member]
Name of subsidiary		HWH World Inc.
State or other jurisdiction of incorporation or organization		South Korea
Subsidiary percentage		85.40%	76.80%
Alset Bio Health Pte Ltd [Member]
Name of subsidiary		Alset BioHealth Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage			76.80%
Alset Energy Pte Ltd [Member]
Name of subsidiary		Alset Energy Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage			76.80%
GDCREIT Inc [Member]
Name of subsidiary		GDC REIT Inc. (f.k.a. Alset Payment Inc.)
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Alset World Pte. Ltd. [Member]
Name of subsidiary		Alset World Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage			76.80%
Bio Health Water Inc [Member]
Name of subsidiary		BioHealth Water Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Impact Bio Health Pte.Ltd [Member]
Name of subsidiary		Impact BioHealth Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
American Home REIT Inc [Member]
Name of subsidiary		American Home REIT Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Alset Solar Inc [Member]
Name of subsidiary		Alset Solar Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		68.30%	61.50%
HWHKOR Inc [Member]
Name of subsidiary		HWH KOR Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Open House Inc [Member]
Name of subsidiary		Open House Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	76.80%
Open Rental Inc [Member]
Name of subsidiary		Open Rental Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	76.80%
Hapi Cafe Inc. (Nevada) [Member]
Name of subsidiary		Hapi Cafe Inc. (Nevada)
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	76.80%
Global Solar REIT Inc [Member]
Name of subsidiary		Global Solar REIT Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	76.80%
OpenBiz Inc [Member]
Name of subsidiary		OpenBiz Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	76.80%
Hapi Cafe Inc (Texas) [Member]
Name of subsidiary		Hapi Cafe Inc. (Texas)
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	100%
HWH (S) Pte Ltd [Member]
Name of subsidiary		HWH (S) Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
True Partner International Limited [Member]
Name of subsidiary		True Partner International Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage			100%
Liquid Value Development Pte Ltd [Member]
Name of subsidiary		LiquidValue Development Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		100%	100%
LiquidValue Development Limited [Member]
Name of subsidiary		LiquidValue Development Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		100%	100%
Alset EPower Inc [Member]
Name of subsidiary		Alset EPower Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	100%
EPowerTech Inc [Member]
Name of subsidiary		EPowerTech Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	100%
AHR Asset Management Inc [Member]
Name of subsidiary		AHR Asset Management Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
HWH World Inc (Nevada) [Member]
Name of subsidiary		HWH World Inc. (Nevada)
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Alset F&B Holdings Pte Inc [Member]
Name of subsidiary		Alset F&B Holdings Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%	76.80%
Credas Capital Pte Ltd [Member]
Name of subsidiary		Credas Capital Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage	[1]	42.70%	38.40%
Smart Reward Express Limited [Member]
Name of subsidiary		Smart Reward Express Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage	[1]	49.80%	38.30%
Partners HWH Pte Ltd [Member]
Name of subsidiary		Partners HWH Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage			76.80%
AHR Texas Two LLC [Member]
Name of subsidiary		AHR Texas Two, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
AHR Black Oak One LLC [Member]
Name of subsidiary		AHR Black Oak One, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Hapi Air Inc [Member]
Name of subsidiary		Hapi Air Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		92.70%	88.40%
AHR Texas Three, LLC [Member]
Name of subsidiary		AHR Texas Three, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%	76.80%
Alset Capital Pte Ltd [Member]
Name of subsidiary		Alset Capital Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		100%	100%
Hapi Cafe Korea Inc [Member]
Name of subsidiary		Hapi Cafe Korea Inc.
State or other jurisdiction of incorporation or organization		South Korea
Subsidiary percentage		85.40%	100%
Green Energy Inc [Member]
Name of subsidiary		Green Energy Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	100%
Green Energy Management Inc [Member]
Name of subsidiary		Green Energy Management Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%	100%
Alset Metaverse Inc [Member]
Name of subsidiary		Alset Metaverse Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		97.20%	95.60%
Alset Management Group Inc [Member]
Name of subsidiary		Alset Management Group Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		83.40%	88.20%
Alset Acquisition Sponsor LLC [Member]
Name of subsidiary		Alset Acquisition Sponsor, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		93.40%	79.60%
Alset Capital Acquisitions Corp [Member]
Name of subsidiary		Alset Capital Acquisition Corp.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		23.40%	79.60%
Alset Spac Group Inc [Member]
Name of subsidiary		Alset Spac Group Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		93.40%
Hapi Travel Pte. Ltd. [Member]
Name of subsidiary		Hapi Travel Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%
Hapi Wealth Builder Pte. Ltd. [Member]
Name of subsidiary		Hapi WealthBuilder Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%
Alset Mining Pte Ltd [Member]
Name of subsidiary		Alset Mining Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%
HWH Marketing Place Pte Ltd [Member]
Name of subsidiary		HWH Marketplace Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%
HWH International Inc Nevada [Member]
Name of subsidiary		HWH International Inc. (Nevada)
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		85.40%
Hapi Cafe SG Pte [Member]
Name of subsidiary		Hapi Cafe SG Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%
Alset Reits Inc [Member]
Name of subsidiary		Alset Reits Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%
Alset Home REIT Inc [Member]
Name of subsidiary		Alset Home REIT Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%
Hapi Metaverse Inc. [Member]
Name of subsidiary		Hapi Metaverse Inc.
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		99.70%
Hapi Cafe Limited [Member]
Name of subsidiary		Hapi Cafe Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		99.70%
MOC HK Limited [Member]
Name of subsidiary		MOC HK Limited
State or other jurisdiction of incorporation or organization		Hong Kong
Subsidiary percentage		99.70%
AHR Texas Four, LLC [Member]
Name of subsidiary		AHR Texas Four, LLC
State or other jurisdiction of incorporation or organization		United States of America
Subsidiary percentage		100%
Alset F&B (PLQ) Pte. Ltd. [Member]
Name of subsidiary		Alset F&B (PLQ) Pte. Ltd.
State or other jurisdiction of incorporation or organization		Singapore
Subsidiary percentage		85.40%
[1]Although the Company indirectly holds percentage of shares of these entities less than 50%, the subsidiaries of the Company directly hold more than 50% of shares of these entities, and therefore, they are still consolidated into the Company.

SCHEDULE OF UNAUDITED FINANCIAL

SCHEDULE OF UNAUDITED FINANCIAL INFORMATION (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Assets	$ 153,490,336	$ 184,210,143
Liabilities	4,827,221	13,920,357
American Pacific Bancorp Inc. [Member]
Assets	54,835,272	29,448,425
Liabilities	316,826	371,564
Net income loss	$ 2,245,532	$ (536,481)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)																		1 Months Ended				4 Months Ended	12 Months Ended
	Oct. 17, 2022 USD ($) shares	Jul. 12, 2022 USD ($) shares	Feb. 03, 2022 USD ($) $ / shares shares	Jan. 27, 2022 shares	Dec. 08, 2021 USD ($) shares	Sep. 08, 2021 USD ($) shares	Jul. 30, 2021 USD ($) shares	Jun. 14, 2021 USD ($) shares	May 13, 2021 USD ($) shares	Apr. 12, 2021 USD ($) shares	Mar. 18, 2021 USD ($)	Mar. 12, 2021 USD ($) $ / shares shares	Feb. 26, 2021 USD ($) $ / shares	Nov. 24, 2020 USD ($) shares	Oct. 15, 2020 USD ($) shares	Sep. 30, 2020 USD ($) shares	Sep. 08, 2020 USD ($) shares	Sep. 30, 2022 USD ($)	Jul. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Nov. 29, 2023 USD ($)	Dec. 31, 2022 AUD ($)	Jul. 14, 2022 USD ($)	Oct. 29, 2021 USD ($)	Jun. 10, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 02, 2020 USD ($)	Oct. 13, 2019 USD ($)
Common stock, voting rights																							more than 50% of the voting common stock
Depreciation expenses																							$ 963,077	$ 166,451
Warrants and rights outstanding																						$ 1,248,822	$ 456,653	$ 1,248,822
Common stock, par value | $ / shares																						$ 0.001	$ 0.001	$ 0.001
Shares issued per share | $ / shares												$ 10.03
Shares issued for acquisition | shares	7,276,163
Beneficial conversion feature value												$ 50,770,192
Debt conversion instrument, shares issued | shares				500,000
Issuance of shares of common stock | shares					3,374,624		3,374,624		3,374,624					108,000
Cash equivalents																						$ 0	$ 0	$ 0
Restricted cash																						4,740,870	694,520	4,740,870
Account receivables																						39,622	46,522	39,622
Accounts receivable, net																						2,500	0	2,500
Accounts receivable, allowance of doubtful accounts																						0	0	0
Payments to acquire equity securities, FV-NI	$ 1,743,734																						8,429,620	19,390,318
Fair value of stock option
Invested amount																						82,645,469	88,367,803	82,645,469
Gain on loss on investment																			$ 74,827
Cost method investments, original cost																						99,216	98,129	$ 99,216
Gain on deconsolidation																							$ 16,557,582
Exercise of options | shares
Additional paid in capital																						296,181,977	$ 322,534,891	$ 296,181,977
Investment securities																							31,350,358	49,190,748
Number of shares issued, value					$ 105,000,000		$ 105,000,000		$ 105,000,000					$ 13,200,000									3,895	104,565,659
Investment in capital																							21,111,575
Convertible debt, fair value disclosures																						9,799		9,799
Debt instrument, face amount																																$ 140,000
Debt instrument, interest percentage																																2.50%
Payment of related parties																							1,005,014	(539,876)
Loans receivable	$ 2,545
Transaction loss																							(417,468)
Capitalized construction costs																							3,200,000	6,000,000
Payments for rent																							30,998,258
Product and returns																							41,755	39,203
Stock-based compensation																							0	73,292
Loss on foreign exchange																							547,845
Gain on foreign exchange																								1,363,061
Other comprehensive loss																							508,277	3,974,966
Non controlling interest																						21,912,268	11,009,149	21,912,268
Capitalized financing costs																						$ 3,247,739	$ 3,247,739	$ 3,247,739
Ballenger Projects [Member]
Revenue percentage																						70%	29%	70%		29%
Private Placement [Member] | Sponsor [Member]
Issuance of shares of common stock | shares			473,750
Purchase price of private placement amount			$ 4,737,500
Alset Capital Acquisition Corp [Member]
Shares issued per share | $ / shares			$ 10
Shares issued for acquisition | shares			7,500,000
Gain on loss on investment																							$ 203,713
Exercise of options | shares			1,125,000
Additional paid in capital																				$ 2,830,961
Investment securities																				237,578	$ 237,578
Number of shares issued, value																		$ 476,250
Ownership percentage																		100%
HWH World [Member]
Ownership percentage																							19%			19%
Payment of related parties																							$ 187,500
HWH World Co [Member]
Ownership percentage																							51%			51%
AMRE and AMRE Management [Member]
Ownership percentage																							80.80%			80.80%
American Pacific Bancorp Inc. [Member]
Invested amount																						$ 30,801,129	$ 31,668,246	$ 30,801,129
Gain on loss on investment																						51,999	867,117
Deconsolidation description						As a result of the new share issuances, the Company’s ownership percentage of APB fell below 50% to 41.3% and the entity was deconsolidated in accordance with ASC 810-10. Upon deconsolidation the Company elected to apply the equity method accounting as the Company still retained significant influence. As a result of the deconsolidation, the Company recognized gain of approximately $28.2 million.
Gain on deconsolidation						$ 28,200,000
Equity method investement						30,800,000
Net assets						$ 2,900,000
American Medical REIT Inc [Member]
Loans receivable																						200,000	200,000	200,000
Common Stock [Member]
Purchase of stock | shares												4,775,523
Series A Common Stock [Member]
Purchase of stock | shares						6,666,700
Stock cost						$ 40,000,200
Common Class B [Member] | Private Placement [Member] | Sponsor [Member]
Issuance of shares of common stock | shares			2,156,250
Brokerage [Member]
Restricted cash																						304,570	385,304	304,570
Novum Alpha Fund [Member]
Invested amount																				$ 100,000
Sharing Services Convertible Note [Member]
Invested amount																							50,000
Debt instrument, face amount																											$ 50,000
Iinterests receivable																											$ 28,636
AUSTRALIA
Non interest bearing deposit																										$ 50,000
Minimum [Member]
Payments for rent																							$ 2,335
Property, plant and equipment, useful life years																							10 years
Maximum [Member]
Payments for rent																							$ 23,020
Property, plant and equipment, useful life years																							27 years 6 months
Manufacturers and Traders Trust Company [Member]
Escrow Deposit																						4,399,984	$ 309,219	4,399,984
Manufacturers and Traders Trust Company [Member] | Minimum [Member]
Interest bearing deposit, amount																							2,600,000
Alset CPN [Member]
Debt conversion instrument, amount								$ 63,920,128	63,920,128
Accrued interest								$ 306,438	$ 306,438
Debt conversion instrument, shares issued | shares								2,123	2,123
Issuance of shares of common stock | shares								458,198	458,198
Value Exchange International [Member]
Shares issued for acquisition | shares										6,500,000
Cost of investment in securities at fair value, amount										$ 650,000
American Medical REIT Inc [Member]
Warrants and rights outstanding																						0		0
Accrued interest																						130,000	$ 0	130,000
Notes receivable, related parties																												$ 200,000			$ 200,000
Fair value of warrants																								0
Debt instrument, face amount																												$ 8,350,000			$ 200,000
Debt instrument, interest percentage																															8%
Notes payable related parties																					$ 200,000
Transaction loss		$ 1,089,675
Vivacitas [Member]
Common stock, par value | $ / shares																							$ 1
Number of shares purchased | shares																							250,000
Fair value of stock option																														$ 0
Document Securities Systems Inc [Member]
Gain on sale of investments											$ 2,480,000
Cost method investments, original cost											$ 2,279,872
Document Securities Systems Inc [Member] | Convertible Debt [Member]
Debt conversion instrument, shares issued | shares		21,366,177
Vector Com co. Ltd [Member]
Invested amount													$ 88,599
Debt instrument, face amount																						$ 88,599	$ 88,599	$ 88,599
Debt instrument, interest percentage													2%
Debt instrument, term													2 years
Debt instrument, convertible, conversion price | $ / shares													$ 21.26
Amarantus Bio Science Holdings [Member]
Ownership in fair value investment rate																							5.30%			5.30%
Trust Partner [Member]
Ownership in fair value investment rate																						15.50%		15.50%
Value Exchange International [Member]
Ownership in fair value investment rate	38.30%
Document Securities Systems Inc [Member]
Onwership percentage																						24.90%	45.20%	24.90%		45.20%
Holista Coll Tech Limited [Member]
Ownership in fair value investment rate																							15.50%			15.50%
American Premium Water Corp [Member]
Onwership percentage																							0.80%			0.80%
American Medical REIT Inc [Member]
Onwership percentage																					15.80%		15.80%			15.80%
Nervotec Pte Ltd [Member]
Shares issued for acquisition | shares																	1,666
Ownership in investment at cost																	1.45%
Cost of stock																	$ 37,826
Hyten Global Thailand Co Ltd [Member]
Shares issued for acquisition | shares																3,800
Ownership in investment at cost																19%
Cost of stock																$ 42,562
K Beauty Research Lab Co Ltd [Member]
Onwership percentage																						18%		18%
Cost method investments, original cost																						$ 19,609		$ 19,609
Alset Capital Acquisition Crop [Member]
Onwership percentage																		23.40%
Alset Capital Acquisition Crop [Member] | Chief Executive Officer [Member]
Onwership percentage			23.40%
Sponsor [Member]
Onwership percentage																		10%
Ketomei Pte Ltd [Member]
Onwership percentage																													28%
Invested amount																							$ 207,402
Gain on loss on investment																							48,916
Amount lent																													$ 76,723
Additional investment																													$ 179,595
American Medical REIT Inc [Member]
Receivables net																						$ 8,901,285	0	$ 8,901,285
Transaction loss		$ 1,089,675
American Medical REIT Inc [Member] | Forecast [Member]
Loans receivable																									$ 8,350,000
American Medical REIT Inc [Member] | Loan One [Member]
Onwership percentage																						3.40%		3.40%
Debt instrument, interest percentage																						8%		8%
Loans receivable		$ 8,350,000																				$ 8,350,000		$ 8,350,000
Notes payable related parties																					$ 200,000
AMRE and AMRE Management [Member]
Onwership percentage																					15.80%
American Pacific Bancorp [Member]
Shares issued for acquisition | shares															250,000
American Pacific Bancorp [Member] | Hengfeng Finance Limited [Member]
Shares issued for acquisition | shares															3,500,001
Onwership percentage															100%
Purchase price															$ 1,500,000
Variable Interest Entity, Primary Beneficiary [Member]
Receivables net																						236,699	236,699	236,699
Securities Purchase Agreement [Member]
Accounts payable, current												$ 63,920,129
Common stock, par value | $ / shares												$ 0.001
Shares issued per share | $ / shares												$ 111.80
Securities Purchase Agreement [Member] | Alset International Limited [Member]
Number of warrant purchased | shares												1,500,000,000
Warrants and rights outstanding												$ 28,363,966
Securities Purchase Agreement [Member] | Liquid Value Development Pte Ltd [Member]
Stock repurchased during period, value												173,395
Securities Purchase Agreement [Member] | True Partner Capital Holding Limited [Member]
Stock repurchased during period, value												$ 6,729,629
Stock repurchased during period, shares | shares												62,122,908
Securities Purchase Agreement [Member] | American Pacific Bancorp Inc. [Member]
Stock repurchased during period, value												$ 28,653,138
Stock repurchased during period, shares | shares												4,775,523
Loan Agreement [Member] | National Australian Bank Limited [Member]
Non interest bearing deposit																						$ 36,316		36,316
Front Foot Benefit Assessments [Member]
Deferred revenue																							126,737	289,375
Front Foot Benefit Assessments [Member] | Minimum [Member]
Proceeds from sale of property, plant, and equipment																							3,000
Front Foot Benefit Assessments [Member] | Maximum [Member]
Proceeds from sale of property, plant, and equipment																							4,500
Deferred Revenue [Member]
Deferred revenue																							21,198	728,343
Land and Building [Member]
Depreciation on reclassified assets																							4,791,997	821,417
Depreciation expenses																							$ 197,609	$ 0

CONCENTRATIONS (Details Narrati

CONCENTRATIONS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Concentration Risk [Line Items]
Uninsured cash	$ 15,723,599	$ 57,905,303
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	81%	97%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	19%	3%

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenue	$ 4,480,442	$ 19,798,822
Cost of Sales	(3,731,990)	(11,301,814)
Gross Margin	748,452	8,497,008
Operating Expenses	(7,837,826)	(23,491,130)
Operating Income (Loss)	(7,089,374)	(14,994,122)
Other Income (Expense)	(39,123,131)	(103,489,455)
Net Income (Loss) Before Income Tax	(46,212,505)	(118,483,577)
Cash and restricted cash	18,521,903	60,802,179
Total assets	153,490,336	184,210,143
Real Estate Segment[Member]
Segment Reporting Information [Line Items]
Revenue	3,088,628	14,213,379
Cost of Sales	(3,016,200)	(11,073,756)
Gross Margin	72,428	3,139,623
Operating Expenses	(1,479,674)	(1,136,031)
Operating Income (Loss)	(1,407,246)	2,003,592
Other Income (Expense)	5,885	(8,955)
Net Income (Loss) Before Income Tax	(1,401,361)	1,994,637
Cash and restricted cash	2,592,577	7,493,921
Total assets	57,951,324	55,465,600
Digital Transformation Technology [Member]
Segment Reporting Information [Line Items]
Revenue	69,915
Cost of Sales	(23,423)
Gross Margin	46,492
Operating Expenses	(414,167)	(183,429)
Operating Income (Loss)	(367,675)	(183,429)
Other Income (Expense)	(1,359,977)	1,286,962
Net Income (Loss) Before Income Tax	(1,727,652)	1,103,533
Cash and restricted cash	514,260	245,780
Total assets	3,184,416	2,199,466
Biohealth Business [Member]
Segment Reporting Information [Line Items]
Revenue	753,651	5,543,066
Cost of Sales	(523,534)	(214,019)
Gross Margin	230,117	5,329,047
Operating Expenses	(850,044)	(3,624,200)
Operating Income (Loss)	(619,927)	1,704,847
Other Income (Expense)	(4,669,309)	(39,265,445)
Net Income (Loss) Before Income Tax	(5,289,236)	(37,560,598)
Cash and restricted cash	1,338,404	2,629,464
Total assets	4,861,615	11,056,779
Other [Member]
Segment Reporting Information [Line Items]
Revenue	568,248	42,377
Cost of Sales	(168,833)	(14,039)
Gross Margin	399,415	28,338
Operating Expenses	(5,093,941)	(18,547,470)
Operating Income (Loss)	(4,694,526)	(18,519,132)
Other Income (Expense)	(33,099,730)	(65,502,017)
Net Income (Loss) Before Income Tax	(37,794,256)	(84,021,149)
Cash and restricted cash	14,076,662	50,433,014
Total assets	$ 87,492,981	$ 115,488,298

SCHEDULE OF REAL ESTATE ASSETS

SCHEDULE OF REAL ESTATE ASSETS (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Real Estate [Abstract]
Construction in Progress	$ 15,506,572	$ 8,597,023
Land Held for Development	7,943,126	7,098,104
Rental Properties	31,169,031	24,820,253
Total Real Estate Assets	$ 54,618,729	$ 40,515,380

SUMMARY OF SINGLE FAMILY RESIDE

SUMMARY OF SINGLE FAMILY RESIDENTIAL PROPERTIES (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) Integer	Dec. 31, 2021 Integer
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Aggregate investment	$ 31,000,000
Single Family [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Number of Homes | Integer	132	109
Aggregate investment	$ 30,998,258
Average Investment Per Home	$ 234,835

REAL ESTATE ASSETS (Details Nar

REAL ESTATE ASSETS (Details Narrative)	12 Months Ended
	Dec. 31, 2022 USD ($) Integer	Dec. 31, 2021 USD ($) Integer
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Aggregate investment	$ 31,000,000
Depreciation	$ 882,814	$ 120,511
Single Family [Member]
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation [Line Items]
Number of Homes | Integer	132	109
Aggregate investment	$ 30,998,258

BUILDER DEPOSITS (Details Narra

BUILDER DEPOSITS (Details Narrative) - USD ($)		1 Months Ended
	Nov. 30, 2015	Nov. 30, 2015	Dec. 31, 2022	Dec. 31, 2021	Apr. 28, 2020	Jan. 03, 2019
Security deposit liability				$ 31,553
Lot Purchase Agreements [Member]
Security deposit liability			$ 0	$ 31,553
SeD Maryland Development LLC [Member] | Lot Purchase Agreements [Member]
Number of lots to purchase, description		Based on the agreements, NVR is entitled to purchase 479 lots for a price of approximately $64,000,000, which escalates 3% annually after June 1, 2018.
Purchase Price	$ 64,000,000
Security deposit liability	$ 5,600,000	$ 5,600,000			$ 220,000	$ 100,000
Security deposit liability, percentage	9.90%	9.90%

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Total notes payable	$ 181,846	$ 317,671
PPP Loan [Member]
Short-Term Debt [Line Items]
Total notes payable		68,502
Australia Loan [Member]
Short-Term Debt [Line Items]
Total notes payable		162,696
Motor Vehicle Loans [Member]
Short-Term Debt [Line Items]
Total notes payable	$ 181,846	$ 86,473

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)

12 Months Ended

Sep. 22, 2022

Mar. 15, 2022

May 28, 2021

May 17, 2021

Feb. 11, 2021

Jun. 18, 2020

Apr. 17, 2019

Jan. 07, 2017

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Oct. 13, 2019

Sep. 07, 2017

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 140,000

Collateral fee

$ 2,300,000

Loan processing fee

$ 381,823

Collateral for outstanding letters of credit

$ 300,000

Amortization of debt discount

450,000

$ 50,871,869

Debt instrument, interest rate, stated percentage

2.50%

Notes payable

181,846

317,671

Paycheck Protection Program Loan [Member]

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 68,502

Debt instrument, term

5 years

Debt instrument, interest rate, stated percentage

1%

Percentage of forgiven debt amount

6,000%

Notes payable

68,502

Australia Loan [Member]

Line of Credit Facility [Line Items]

Notes payable

162,696

Hire Purchase Agreement [Member]

Line of Credit Facility [Line Items]

Debt instrument, term

84 months

SeD Maryland Development LLC [Member] | Loan Agreement [Member]

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 8,000,000

Line of credit facility, maximum borrowing capacity

18,500,000

Long-term line of credit

$ 900,000

Line of credit facility, interest rate

1.50%

Collateral fee

$ 2,600,000

Line of credit facility, revolving credit conversion to term loan, description

outstanding balance of the revolving loan was $0

Alset EHome Inc [Member] | Loan Agreement [Member] | Manufacturers and Traders Trust Company [Member]

Line of Credit Facility [Line Items]

Line of credit facility, maximum borrowing capacity

$ 2,990,000

Loan processing fee

$ 61,679

Line of credit facility, expiration date

Jul. 01, 2022

Proceeds from lines of credit

$ 664,810

664,810

Debt instrument, unamortized discount

$ 42,906

Line of credit facility, increase, accrued interest

$ 25,225

Amortization of debt discount

$ 42,907

Alset EHome Inc [Member] | Loan Agreement [Member] | Manufacturers and Traders Trust Company [Member] | Minimum [Member]

Line of Credit Facility [Line Items]

Long-term line of credit

$ 20,000,000

SeD Perth Pty Ltd [Member] | Australia Loan [Member]

Line of Credit Facility [Line Items]

Debt instrument, face amount

$ 460,000

Line of credit facility, maximum borrowing capacity

$ 179,000

Debt instrument, maturity date

Dec. 31, 2018

Apr. 30, 2022

Deposits

$ 35,276

Personal guarantee

$ 500,000

SeD Perth Pty Ltd [Member] | Minimum [Member] | Australia Loan [Member]

Line of Credit Facility [Line Items]

Debt instrument, interest rate, stated percentage

4.48%

SeD Perth Pty Ltd [Member] | Maximum [Member] | Australia Loan [Member]

Line of Credit Facility [Line Items]

Debt instrument, interest rate, stated percentage

4.49%

Hong Leong Finance Limited [Member]

Line of Credit Facility [Line Items]

Debt instrument, term

84 months

Debt instrument, interest rate, stated percentage

1.88%

Debt amount

$ 184,596

Initial deposit

78,640

Monthly instalment, amount

$ 1,300

United Overseas Bank Limited [Member]

Line of Credit Facility [Line Items]

Debt instrument, interest rate, stated percentage

1.88%

Debt amount

$ 182,430

Initial deposit

66,020

Monthly instalment, amount

$ 1,472

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)																					1 Months Ended		6 Months Ended	8 Months Ended	12 Months Ended
	Oct. 17, 2022 USD ($) shares	Jul. 28, 2022 USD ($)	Jul. 12, 2022 USD ($) shares	May 17, 2022 USD ($) shares	Feb. 28, 2022 shares	Jan. 27, 2022 shares	Jan. 17, 2022 shares	Dec. 13, 2021 USD ($) shares	Dec. 08, 2021 shares	Jul. 30, 2021 shares	Jun. 14, 2021 USD ($) shares	May 13, 2021 USD ($) shares	Mar. 18, 2021 USD ($) shares	Mar. 12, 2021 USD ($) $ / shares shares	Nov. 24, 2020 USD ($) shares	Nov. 24, 2020 USD ($)	Jul. 17, 2020 USD ($) $ / shares shares	Mar. 02, 2020 USD ($) $ / shares	Jan. 01, 2018 USD ($)	Jan. 24, 2017 USD ($)	Jun. 30, 2022 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares	Jun. 30, 2022 USD ($)	Sep. 03, 2022	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2022	Aug. 31, 2022 USD ($)	Aug. 04, 2022 USD ($)	Aug. 04, 2022 SGD ($)	Jun. 28, 2022	Mar. 31, 2022 USD ($)	Oct. 29, 2021 USD ($)	Oct. 13, 2021 USD ($)	May 14, 2021 USD ($)	May 14, 2021 SGD ($)	Jan. 24, 2021	Dec. 31, 2020 USD ($)	Oct. 13, 2019 USD ($)
Number of shares issued | shares									3,374,624	3,374,624		3,374,624			108,000
Equity partners bonus payment amount	$ 1,743,734																								$ 8,429,620	$ 19,390,318
Investment																						$ 36,337,023			19,481,325	36,337,023
Investment at fair value																						35,327,987			19,163,290	35,327,987
Transaction loss																									(417,468)
Fair value of warrants																						$ 1,248,822			$ 456,653	$ 1,248,822
Common stock, par value | $ / shares																						$ 0.001			$ 0.001	$ 0.001
Shares Issued, Price Per Share | $ / shares														$ 10.03
Beneficial conversion feature value														$ 50,770,192
Shares purchase price | shares						500,000
Principal amount																																							$ 140,000
Debt instrument, interest percentage																																							2.50%
Loans and leases receivable related parties	$ 2,545
Interest expenses																									$ 1,853	$ 317,281
Liquid Value Development Pte Ltd [Member] | Maximum [Member]
Equity method investment, ownership percentage																									15.80%							15.80%
Liquid Value Development Pte Ltd [Member] | Minimum [Member]
Equity method investment, ownership percentage																																3.40%
American Medical REIT Inc [Member]
Transaction loss			$ 1,089,675
American Medical REIT Inc [Member] | Loan One [Member]
Notes payable related parties																																$ 200,000
Equity method investment, ownership percentage																						3.40%				3.40%
Debt instrument, interest percentage																						8%				8%
Loans and leases receivable related parties			8,350,000																			$ 8,350,000				$ 8,350,000
SeD Perth Pty Ltd [Member]
Equity method investment, ownership percentage																																					100%
HWH World Co [Member]
Equity method investment, ownership percentage																									19%
Alset Investment Pte LTD [Member]
Principal amount																						0			$ 0	0
Alset Capital Acquisition Crop [Member]
Equity method investment, ownership percentage																											23.40%
Chan Heng Fai [Member]
Notes payable related parties																						0			$ 0	0									$ 5,545,495	$ 7,395,472
Number of shares issued | shares					1,765,964		1,473,449																		50
Shares purchase price | shares								500,000
Principal amount								$ 6,250,000
Debt instrument, interest percentage								3%
Debt instrument maturity date								Dec. 31, 2024
MacKenzie Equity Partners [Member]
Equity partners bonus payment amount																					$ 50,000					$ 120,000
One Of Our Director [Member] | Alset Investment Pte LTD [Member]
Equity method investment, ownership percentage																																100%
Equity method investment aggregate cost																									$ 476,250							$ 476,250
Securities Purchase Agreement [Member]
Accounts payable, current														$ 63,920,129
Common stock, par value | $ / shares														$ 0.001
Shares Issued, Price Per Share | $ / shares														$ 111.80
Securities Purchase Agreement [Member] | Chan Heng Fai [Member]
Number of shares issued | shares					35,319,290		29,468,977
Principal amount								$ 6,250,000
Debt instrument, interest percentage								3%
Securities Purchase Agreement [Member] | Alset International Limited [Member]
Number of warrant purchased | shares														1,500,000,000
Fair value of warrants														$ 28,363,966
Securities Purchase Agreement [Member] | Liquid Value Development Pte Ltd [Member]
Stock repurchased during period, value														173,395
Securities Purchase Agreement [Member] | True Partner Capital Holding Limited [Member]
Stock repurchased during period, value														$ 6,729,629
Stock repurchased during period, value | shares														62,122,908
Securities Purchase Agreement [Member] | American Pacific Bancorp Inc. [Member]
Stock repurchased during period, value														$ 28,653,138
Stock repurchased during period, value | shares														4,775,523
Common Stock [Member]
Number of shares issued | shares																									15,819,452	67,502,481
New Electric CV Corporation [Member]
Equity partners bonus payment amount																	$ 122,039
Document Securities Systems Inc [Member]
Purchase of stock | shares													2,480,000
Gain on sale of shares investment													$ 2,480,000
Investment at fair value													200,128
Original cost													$ 2,279,872
Vivacitas [Member]
Number of shares purchased | shares													250,000
New Electric CV Corporation [Member]
Investment																						1,009,854			$ 327,565	$ 1,009,854
Purchase of shares and warrants, value																									1,067,808
New Electric CV Corporation [Member] | Stock and Warrant [Member]
Purchase of shares and warrants, value																									945,769
Liquid Value Development Pte Ltd [Member]
Notes payable related parties																						820,113			0	820,113
SeD Perth Pty Ltd [Member]
Notes payable related parties																						13,546			12,668	13,546
Alset CPN [Member]
Number of shares issued | shares											458,198	458,198
Debt conversion, converted instrument, amount											$ 63,920,128	$ 63,920,128
Interest payable											$ 306,438	$ 306,438
Shares purchase price | shares											2,123	2,123
MacKenzie Equity Partners [Member]
Professional fees																			$ 20,000		$ 25,000				350,000	360,000
Related party transaction description																								In addition, MacKenzie Equity Partners will be paid certain bonuses, including (i) a sum of $50,000 on June 30, 2022; (ii) a sum of $50,000 upon the successful financing of 100 homes owned by American Housing REIT Inc. with an entity not affiliated with SeD Development Management LLC (a subsidiary of the Company); and (iii) a sum of $50,000 upon the successful leasing of 30 homes in the Alset of Black Oak development.
Due to related party																						80,000			25,000	80,000
American Medical REIT Inc [Member]
Notes payable related parties																																$ 200,000
Exercise price | $ / shares																		$ 5
Fair value of warrants																										0
Transaction loss			$ 1,089,675
Fair value of warrants																						0				0
Interest payable																						130,000			0	130,000
Principal amount																		$ 200,000															$ 8,350,000
Debt instrument, interest percentage																		8%
Ipo price, description																		The amount of the warrants equals to the note principal divided by the exercise price. If AMRE goes to IPO in the future and IPO price is less than $10.00 per share, the exercise price shall be adjusted downward to fifty percent (50%) of the IPO price.
Document Securities Systems Inc [Member]
Gain on sale of shares investment													$ 2,480,000
Original cost													$ 2,279,872
Document Securities Systems Inc [Member] | Convertible Debt [Member]
Shares purchase price | shares			21,366,177
iGalen International [Member] | SeD Capital Pte Ltd [Member]
Interest payable																																						$ 61,555
Principal amount																				$ 350,000																		$ 350,000
Debt instrument maturity date description																				The term of the loan was two years, with an interest rate of 3% per annum for the first year and 5% per annum for the second year. The expiration term was renewed as due on demand after two years with 5% per annum interest rate.
Interest expenses																						412,754
HWH World Co [Member]
Due to related parties, amount																									236,699
Hapi Cafe Inc [Member]
Debt instrument, interest percentage		8%																													0%
Loans and leases receivable related parties																									197,596
Debt conversion original debt amount		$ 41,750
Debt interest rate		8%
Hapi Cafe Inc [Member] | Convertible Debt [Member]
Convertible loan amount																													$ 250,500	$ 360,000
Ketomei Drew [Member]
Loans and leases receivable related parties																												$ 29,922
Liquid Value Asset Management Limited [Member]
Investment at fair value																						2,987,039			3,042,811	2,987,039
Loan lend																																		$ 3,000,000
American Pacific Bancorp Inc. [Member] | Chan Tung Moe [Member]
Debt instrument, interest percentage															6%	6%
Due to officer															$ 560,000	$ 560,000
Debt instrument maturity date																Nov. 23, 2023
Debt instrument description																This loan was secured by an irrevocable letter of instruction on 4,000 shares of Alset Inc
Debt interest and principal																										840,000
American Pacific Bancorp Inc. [Member] | Lim Sheng Hon Danny [Member]
Due to officer															$ 280,000	$ 280,000
Debt instrument description																This loan was secured by an irrevocable letter of instruction on 2,000 shares of Alset Inc.
American Pacific Bancorp Inc. [Member] | Lim Sheng Hong [Member]
Debt interest and principal																										28,031
New Electric CV Corporation [Member]
Number of shares issued | shares																	122,039,000
Ownership percentage																	9.99%
Number of warrant purchased | shares																	1,220,390,000
Exercise price | $ / shares																	$ 0.0001
Equity partners bonus payment amount																	$ 122,039
Fair value of warrants																	$ 860,342
Director [Member]
Notes payable related parties																						$ 500,000			$ 0	$ 500,000
Number of shares issued | shares	7,276,163																				7,276,163
Equity method investments	$ 1,743,734																						$ 1,746,279
True Partners Capital Holding Limited [Member]
Purchase of stock | shares				62,122,908										62,122,908
Stock cost														$ 6,729,629
Equity, fair value disclosure														10,003,689
Additional paid in capital adjustment														$ 3,274,060
Transaction loss				$ 446,104
True Partners Capital Holding Limited [Member] | Common Stock [Member]
Purchase of stock | shares				17,570,948

SCHEDULE OF NET FUNDS RECEIVED

SCHEDULE OF NET FUNDS RECEIVED ON OFFERING AND WARRANTS EXERCISED (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, par value	$ 456,653	$ 1,248,822
Total	$ 6,213,000	$ 104,565,659
Mays Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	424,366
Number of offering and warrants exercised, par value	$ 424
Total	$ 39,765,439
Mays Offering [Member] | Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	235,032
Number of offering and warrants exercised, par value	$ 235
Total	$ 29,145,056
Mays Offering [Member] | Exercise of Pre Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	80,550
Number of offering and warrants exercised, par value	$ 81
Total	$ 16,110
Mays Offering [Member] | Exercise of Underwriters Series A Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	40,418
Number of offering and warrants exercised, par value	$ 40
Total	$ 3,755,774
Mays Offering [Member] | Exercise of Series A and Series B Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	68,366
Number of offering and warrants exercised, par value	$ 68
Total	$ 6,937,347
Mays Offering [Member] | Offering Expenses [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares
Number of offering and warrants exercised, par value
Total	$ (88,848)
Julys Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	867,924
Number of offering and warrants exercised, par value	$ 868
Total	$ 33,392,444
Julys Offering [Member] | Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	266,207
Number of offering and warrants exercised, par value	$ 266
Total	$ 28,957,297
Julys Offering [Member] | Exercise of Pre Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	488,510
Number of offering and warrants exercised, par value	$ 489
Total	$ 97,702
Julys Offering [Member] | Offering Expenses [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares
Number of offering and warrants exercised, par value
Total	$ (49,553)
Julys Offering [Member] | Exercise of Underwriters Over Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	113,207
Number of offering and warrants exercised, par value	$ 113
Total	$ 4,386,998
Decembers Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	2,082,333
Number of offering and warrants exercised, par value	$ 2,082
Total	$ 31,346,875
Decembers Offering [Member] | Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	946,166
Number of offering and warrants exercised, par value	$ 946
Total	$ 27,263,673
Decembers Offering [Member] | Exercise of Pre Funded Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	761,167
Number of offering and warrants exercised, par value	$ 761
Total	$ 8,823
Decembers Offering [Member] | Offering Expenses [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares
Number of offering and warrants exercised, par value
Total	$ (40,621)
Decembers Offering [Member] | Exercise of Underwriters Over Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of offering and warrants exercised, shares	375,000
Number of offering and warrants exercised, par value	$ 375
Total	$ 4,115,000

SCHEDULE OF WARRANT ACTIVITY (D

SCHEDULE OF WARRANT ACTIVITY (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Equity [Abstract]
Number of common shares warrants outstanding, beginning balance | shares	1,426,657
Exercise price, beginning balance	$ 35.80
Remaining contractual term outstanding, beginning balance	1 year 10 months 17 days
Aggregate intrinsic value, beginning | $
Number of common shares warrants vested and exercisable, beginning | shares	1,426,657
Exercise price, vested and exercisable beginning balance	$ 35.80
Remaining contractual term exercisable, beginning balance	1 year 10 months 17 days
Aggregate intrinsic value, vested and exercisable beginning | $
Number of common shares warrants granted | shares
Exercise price, granted
Number of common shares warrants exercised | shares	(792,169)
Exercise price, exercised	$ 0.02
Exercise price, forfeited, cancelled, expired
Number of common shares warrants outstanding, beginning balance | shares	634,488
Exercise price, ending balance	$ 80.40
Remaining contractual term outstanding, Ending balance	3 years 2 months 23 days
Aggregate intrinsic value, ending | $
Number of common shares warrants vested and exercisable, beginning | shares	634,488
Exercise price, vested and exercisable ending balance	$ 80.40
Remaining contractual term exercisable, ending balance	3 years 2 months 23 days
Aggregate intrinsic value, vested and exercisable ending | $

SCHEDULE OF CHANGES IN ACCUMULA

SCHEDULE OF CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF TAX (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning	$ 341,646	$ 2,143,338
Other Comprehensive Income	3,494,417	(1,801,692)
Balance at end	3,836,063	341,646
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning	(90,031)	(48,758)
Other Comprehensive Income	35,110	(41,273)
Balance at end	(54,921)	(90,031)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning	(367,895)	2,258,017
Other Comprehensive Income	489,167	(2,625,912)
Balance at end	121,272	(367,895)
AOCI Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning	799,572	(65,921)
Other Comprehensive Income	2,970,140	865,493
Balance at end	$ 3,769,712	$ 799,572

EQUITY (Details Narrative)

EQUITY (Details Narrative) - USD ($)																	1 Months Ended			9 Months Ended	12 Months Ended
	Apr. 11, 2022	Feb. 28, 2022	Jan. 27, 2022	Jan. 17, 2022	Dec. 14, 2021	Dec. 13, 2021	Dec. 08, 2021	Dec. 05, 2021	Jul. 30, 2021	Jul. 27, 2021	May 13, 2021	May 12, 2021	May 10, 2021	May 03, 2021	Jan. 19, 2021	Nov. 24, 2020	Sep. 30, 2021	Jul. 27, 2021	Jun. 30, 2021	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Jun. 17, 2021	Jun. 14, 2021	Mar. 12, 2021	Oct. 13, 2019
Class of Stock [Line Items]
Common stock, shares authorized																					250,000,000	250,000,000			20,000,000
Preferred stock, shares authorized																					25,000,000	25,000,000			5,000,000
Preferred Stock, Par or Stated Value Per Share																					$ 0.001	$ 0.001
Stock Issued During Period, Shares, Issued for Services															500
Stock Issued During Period, Value, Issued for Services															$ 60,900
Debt conversion of shares			500,000
Issuance of Common Stock, shares							3,374,624		3,374,624		3,374,624					108,000
Shares issued price per share																										$ 10.03
Class of warrants or right issued																	424,366			424,366
Proceeds from Issuance of Common Stock																					$ 6,213,000	$ 104,565,659
Proceeds from warrant exercise																						$ 3,249,339
Warrants issuance ecercise period										24 months
Common stock par value																					$ 0.001	$ 0.001
Percentage of Common stock					15%
Common Stock, Shares, Issued																					7,422,846	4,368,422
Issuance of Common Stock by Exercising Warrants							$ 105,000,000		$ 105,000,000		$ 105,000,000					$ 13,200,000					$ 3,895	$ 104,565,659
Common stock, shares outstanding				3,492,713,362																	7,422,846	4,368,422
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders																						$ 2,549,750	$ 411,250
Proceeds from Issuance of Warrants																						$ 60,300,464
Principal amount																											$ 140,000
Debt instrument, interest rate, stated percentage																											2.50%
Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Shares issued price per share																										111.80
Common stock par value																										$ 0.001
Alset [Member]
Class of Stock [Line Items]
Attributable interest																					85.40%	76.80%
Julys Offering [Member]
Class of Stock [Line Items]
Warrants to purchase shares																					867,924
Proceeds from Issuance of Common Stock																					$ 33,392,444
Offering cost																					$ 49,553
Decembers Offering [Member]
Class of Stock [Line Items]
Warrants to purchase shares																					2,082,333
Proceeds from Issuance of Common Stock																					$ 31,346,875
Offering cost																					$ 40,621
Common Stock, Shares, Issued																					7,422,846
Hapi Metaversa [Member]
Class of Stock [Line Items]
Issuance of Common Stock, shares																						280,000
Common stock, shares outstanding																						505,381,376
Hapi Metaversa [Member] | Hapi Metaverse [Member]
Class of Stock [Line Items]
Attributable interest																						99%
Gig World [Member]
Class of Stock [Line Items]
Issuance of Common Stock by Exercising Warrants																						$ 280,000
Alset International Limited [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights																						$ 0.04
Warrants to purchase shares																						1,721,303,416
Proceeds from Issuance of Warrants																						$ 58,000,000
Underwritten Public Offering [Member] | Series A Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights													$ 101.40
Underwritten Public Offering [Member] | Series B Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights													$ 65.90
Over-Allotment Option [Member] | Series A Warrant [Member]
Class of Stock [Line Items]
Number of warrants issued											40,418		40,418
Over-Allotment Option [Member] | Series A Warrant [Member] | Aegis Capital Corp [Member]
Class of Stock [Line Items]
Class of warrants or right issued																	68,201			68,201
Over-Allotment Option [Member] | Series B Warrant [Member]
Class of Stock [Line Items]
Number of warrants issued											40,418		40,418
Warrants to purchase shares													20,209
Over-Allotment Option [Member] | Series B Warrant [Member] | Aegis Capital Corp [Member]
Class of Stock [Line Items]
Class of warrants or right issued																	330			330
Common Stock [Member]
Class of Stock [Line Items]
Issuance of Common Stock, shares																					15,819,452	67,502,481
Issuance of Common Stock by Exercising Warrants																					$ 15,820	$ 67,502
Common Stock [Member] | Underwritten Public Offering [Member]
Class of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share										$ 0.001			$ 0.001					$ 0.001
Issuance of Common Stock, shares								903,833		266,207			235,032
Shares issued price per share								$ 12		$ 42.40			$ 101.40					$ 42.40
Common stock par value								$ 0.001
Common Stock [Member] | Over-Allotment Option [Member]
Class of Stock [Line Items]
Number of warrants issued													40,418
Class of warrants or right issued								375,000		113,207								113,207
Proceeds from warrant exercise					$ 4,115,000												$ 4,386,998
Underwriting discount, percentage								7%		7%								7%
Underwriting discount, percentage								1%		1.50%								1.50%
Stock issued for warrant exercise																	113,207
Warant exercise, description								The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering. Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.001 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full. At December 31, 2021 761,664 warrants were exercised, some in cashless exercise transactions									The Pre-funded Warrants were offered and sold to purchasers whose purchase of Common Stock in the Offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of the Company’s outstanding Common Stock immediately following the consummation of the Offering in lieu of Common Stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% of the Company’s outstanding Common Stock (or, at the election of the purchaser, 9.99%). Each Pre-funded Warrant is exercisable for one share of Common Stock at an exercise price of $0.20 per share. The Pre-funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-funded Warrants are exercised in full
Common Stock [Member] | Over-Allotment Option [Member] | Aegis Capital Corp [Member]
Class of Stock [Line Items]
Shares issued price per share																								$ 101.40
Class of warrants or right issued																			40,418
Pre Funded Units [Member] | Underwritten Public Offering [Member]
Class of Stock [Line Items]
Issuance of Common Stock, shares								1,553,833					80,550					488,510
Shares issued price per share								$ 11.98		$ 42.20			$ 101.20					$ 42.20
Warrants to purchase shares								1,553,833
Proceeds from warrant exercise								$ 27,231,875										$ 33,392,444
Prefunded Warrants [Member] | Underwritten Public Offering [Member]
Class of Stock [Line Items]
Shares issued price per share										$ 53								$ 53
Percentage of public offering price										125%
Prefunded Warrants [Member] | Over-Allotment Option [Member]
Class of Stock [Line Items]
Class of warrants or right issued					375,000					26,038								26,038
Prefunded Warrants [Member] | Underwritten Over Allotment [Member]
Class of Stock [Line Items]
Shares issued price per share					$ 12
Warrant [Member]
Class of Stock [Line Items]
Issuance of Common Stock by Exercising Warrants	$ 75,000,000
Chan Heng Fai [Member]
Class of Stock [Line Items]
Debt conversion of shares						500,000
Issuance of Common Stock, shares		1,765,964		1,473,449																	50
Principal amount						$ 6,250,000
Debt instrument, interest rate, stated percentage						3%
Conversion price						$ 12.50
Chan Heng Fai [Member] | Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Issuance of Common Stock, shares		35,319,290		29,468,977
Number of shares purchase		293,428,200		293,428,200
Percentage of ordinary shares				8.40%
Principal amount						$ 6,250,000
Debt instrument, interest rate, stated percentage						3%
Conversion price						$ 12.50
Investors [Member] | Pre Funded Units [Member] | Underwritten Public Offering [Member]
Class of Stock [Line Items]
Issuance of Common Stock, shares													80,550
International Investors [Member] | Hapi Metaversa [Member]
Class of Stock [Line Items]
Common stock, shares outstanding																						506,898,576
Officer [Member] | Alset International Limited [Member]
Class of Stock [Line Items]
Issuance of Common Stock, shares																					6,670,200
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture																						$ 73,292
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture																						1,500,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized																						6,380
Series A Preferred Stock [Member] | Chan Heng Fai [Member]
Class of Stock [Line Items]
Conversion of stock shares converted																			319,000
Debt conversion of shares																			6,380
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized																						2,132
Preferred Stock, Par or Stated Value Per Share																									$ 0.001
Series B Preferred Stock [Member] | Chan Heng Fai [Member]
Class of Stock [Line Items]
Conversion of stock shares converted												106,600
Debt conversion of shares												2,132
Debt conversion original debt amount												$ 13,000,000
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Par or Stated Value Per Share																									$ 0.001
Stock purchased														319,000
Stock Issued During Period, Shares, Other														6,380
Common Stock [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Common Stock																				$ 39,765,440

SCHEDULE OF FUTURE MINIMUM RENT

SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS (Details)	Dec. 31, 2022 USD ($)
Lease Income
2023	$ 1,148,308
2024	11,145
Total Future Receipts	$ 1,159,453

LEASE INCOME (Details Narrative

LEASE INCOME (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Lease Income
Lessor, operating lease, term of contract	1 year
Management fee expense	$ 90,630	$ 15,390
Leasing fees incurred	$ 174,850	$ 63,880

SCHEDULE OF FINANCIAL ASSETS ME

SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at cost	$ 88,367,803	$ 82,645,469
Total investment in securities at fair value	19,481,325	36,337,023
Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value	19,065,161	35,228,771
Fair Value, Inputs, Level 2 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Fair Value, Inputs, Level 3 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value	1,108,252	416,164
Investment Securities Fair Value [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at cost	76,264,051	72,000,301
Total investment in securities at fair value	13,749,957	25,320,694
Investment Securities Fair Value [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value	13,749,957	25,320,694
Investment Securities Fair Value [Member] | Fair Value, Inputs, Level 2 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Investment Securities Fair Value [Member] | Fair Value, Inputs, Level 3 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Investment Securities Trading [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at cost	11,268,362	9,809,778
Total investment in securities at fair value	5,315,204	9,908,077
Investment Securities Trading [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value	5,315,204	9,908,077
Investment Securities Trading [Member] | Fair Value, Inputs, Level 2 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Investment Securities Trading [Member] | Fair Value, Inputs, Level 3 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Notes Receivable [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at cost	138,599	138,599
Total investment in securities at fair value	88,599	98,398
Notes Receivable [Member] | Fair Value, Inputs, Level 1 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Notes Receivable [Member] | Fair Value, Inputs, Level 2 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Notes Receivable [Member] | Fair Value, Inputs, Level 3 [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value	88,599	98,398
Warrant [Member] | American Premium Water Corp [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at cost	696,791	696,791
Total investment in securities at fair value	327,565	1,009,854
Warrant [Member] | American Medical REIT Inc [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at cost
Total investment in securities at fair value
Warrant [Member] | Fair Value, Inputs, Level 1 [Member] | American Premium Water Corp [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Warrant [Member] | Fair Value, Inputs, Level 1 [Member] | American Medical REIT Inc [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Warrant [Member] | Fair Value, Inputs, Level 2 [Member] | American Premium Water Corp [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Warrant [Member] | Fair Value, Inputs, Level 2 [Member] | American Medical REIT Inc [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value
Warrant [Member] | Fair Value, Inputs, Level 3 [Member] | American Premium Water Corp [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value	$ 327,565	1,009,854
Warrant [Member] | Fair Value, Inputs, Level 3 [Member] | American Medical REIT Inc [Member]
Impairment Effects on Earnings Per Share [Line Items]
Total investment in securities at fair value

SCHEDULE OF FAIR VALUE OF EQUIT

SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Total equity securities	$ 19,163,290	$ 35,327,987
Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total equity securities	$ 19,065,161	$ 35,228,771
Document Securities Systems Inc [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Share price	$ 0.164	$ 0.672
Shares	62,812,264	19,888,262
Total equity securities	$ 10,301,211	$ 13,364,912
Fair value measurements, valuation processes, description	Investment in Securities at Fair Value	Investment in Securities at Fair Value
Amarantus Bio Science Holdings [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Share price	$ 0.002	$ 0.016
Shares	20,000,000	20,000,000
Total equity securities	$ 34,000	$ 328,000
Fair value measurements, valuation processes, description	Investment in Securities at Fair Value	Investment in Securities at Fair Value
Holista Coll Tech Limited [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Share price	$ 0.20	$ 0.034
Shares	42,999,621	43,626,621
Total equity securities	$ 850,432	$ 1,489,179
Fair value measurements, valuation processes, description	Investment in Securities at Fair Value	Investment in Securities at Fair Value
American Premium Mining [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Share price	$ 0.001	$ 0.002
Shares	354,039,000	354,039,000
Total equity securities	$ 212,423	$ 778,886
Fair value measurements, valuation processes, description	Investment in Securities at Fair Value	Investment in Securities at Fair Value
Value Exchange International Inc [ Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Share price	$ 0.170	$ 0.300
Shares	13,834,643	6,500,000
Total equity securities	$ 2,351,889	$ 1,950,000
Fair value measurements, valuation processes, description	Investment in Securities at Fair Value	Investment in Securities at Fair Value
Trading Stocks [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Total equity securities	$ 5,315,204	$ 9,908,077
Fair value measurements, valuation processes, description	Investment in Securities at Fair Value	Investment in Securities at Fair Value
Nervotec Pte Ltd [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares	1,666	1,666
Total equity securities	$ 35,958	$ 37,045
Fair value measurements, valuation processes, description	Investment in Securities at Cost	Investment in Securities at Cost
HWH World Co [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares	3,800
Total equity securities	$ 42,562
Fair value measurements, valuation processes, description	Investment in Securities at Cost
K Beauty [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares	3,600
Total equity securities	$ 19,609
Fair value measurements, valuation processes, description	Investment in Securities at Cost
True Partner Capital Holding Limited [Member] | Fair Value, Inputs, Level 1 [Member]
Defined Benefit Plan Disclosure [Line Items]
Share price		$ 0.119
Shares		62,122,908
Total equity securities		$ 7,409,717
Fair value measurements, valuation processes, description		Investment in Securities at Fair Value
Hyten Global [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares		3,800
Total equity securities		$ 42,562
Fair value measurements, valuation processes, description		Investment in Securities at Cost
UBeauty Limited [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares		3,600
Total equity securities		$ 19,609
Fair value measurements, valuation processes, description		Investment in Securities at Cost

SCHEDULE OF SIGNIFICANT INPUTS

SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares	Dec. 31, 2021 $ / shares
Sharing Services Inc [Member] | Measurement Input, Expected Dividend Rate [Member]
Measurement input	0
Sharing Services Inc [Member] | Measurement Input, Expected Dividend Rate [Member] | Fair Value, Inputs, Level 3 [Member]
Measurement input		0
Sharing Services Inc [Member] | Measurement Input, Price Volatility [Member] | Fair Value, Inputs, Level 3 [Member]
Measurement input		138.85
Sharing Services Inc [Member] | Measurement Input, Risk Free Interest Rate [Member] | Fair Value, Inputs, Level 3 [Member]
Measurement input		3.25
Sharing Services Inc [Member] | Measurement Input, Expected Term [Member] | Fair Value, Inputs, Level 3 [Member]
Contractual term in years		9 months 3 days
Sharing Services Inc [Member] | Measurement Input, Exercise Price [Member] | Fair Value, Inputs, Level 3 [Member]
Measurement input		0.15
New Electric CV Corporation [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Warrants and rights outstanding, term	7 years 6 months 21 days	8 years 6 months 29 days
New Electric CV Corporation [Member] | Measurement Input, Price Volatility [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Dividend Yield	186.1	186.5
New Electric CV Corporation [Member] | Measurement Input, Risk Free Interest Rate [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Dividend Yield	3.95	1.48
New Electric CV Corporation [Member] | Measurement Input, Exercise Price [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Dividend Yield	0.001	0.001
New Electric CV Corporation [Member] | Measurement Input, Share Price [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Dividend Yield	0.0006	0.0022
New Electric CV Corporation [Member] | Measurement Input Dividend Yield [Member] | Fair Value, Inputs, Level 3 [Member] | Warrant [Member]
Dividend Yield	0	0

SCHEDULE OF CHANGE IN FAIR VALU

SCHEDULE OF CHANGE IN FAIR VALUE (Details) - Sharing Services Convertible Note [Member] - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net Investment Income [Line Items]
Beginning balance	$ 1,108,252	$ 38,604,701
Total losses	40,201	(57,179)
Conversion of DSS Preferred Stock	(37,439,270)
Ending balance	$ 1,148,453	$ 1,108,252

SCHEDULE OF FAIRVALUE OF FINANC

SCHEDULE OF FAIRVALUE OF FINANCIAL INVESTMENTS (Details) - USD ($)		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021
NECV [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Assets		$ 1,038,946	[1]	$ 348,688
Liabilities		2,507,797	[1]	4,049,594
Net Income (Loss)		128,968	[1]	(873,550)
Holista [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Assets		3,717,593		5,031,866
Liabilities		2,660,281		2,870,177
Net Income (Loss)		(1,053,668)		(1,018,871)
DSS [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Assets		264,880,000	[1]	284,826,000
Liabilities		82,231,000	[1]	84,522,000
Net Income (Loss)		(52,214,667)	[1]	$ (31,921,000)
VEII [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Assets	[1]	5,047,729
Liabilities	[1]	2,676,237
Net Income (Loss)	[1]	$ 185,321
[1]Data derived from Financial Statement as of September 30, 2022 which was the latest available date source we could reach. 12-month Net Income (Loss) was estimated by adding one-third of 9-month Net Loss.

INVESTMENTS MEASURED AT FAIR _3

INVESTMENTS MEASURED AT FAIR VALUE (Details Narrative)				12 Months Ended
	Oct. 17, 2022 USD ($)	Feb. 26, 2021 USD ($) $ / shares	Jul. 17, 2020 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Oct. 29, 2021 USD ($)	Mar. 02, 2020 USD ($) $ / shares	Oct. 13, 2019
Realized loss on investments				$ 7,308,580	$ 4,698,078
Unrealized loss on securities investment				31,350,358	49,190,748
Change in fair value of convertible note				40,201	57,179
Debt instrument, interest rate, stated percentage								2.50%
Purchase of Investment Securities	$ 1,743,734			$ 8,429,620	19,390,318
Number of warants exercised | shares				792,169
Warrants and rights outstanding				$ 456,653	$ 1,248,822
Warrant outstanding | shares				634,488	1,426,657
New Electric CV Corporation [Member]
Number of warrant purchased | shares			122,039,000		232,000,000
Equity method investment, ownership percentage			9.99%
Equity method investment number of shares acquired | shares			1,220,390,000
Class of warrant or right, exercise price of warrants or rights | $ / shares			$ 0.0001
Purchase of Investment Securities			$ 122,039
Number of warants exercised | shares					232,000,000
Warrants and rights outstanding					$ 232,000
Warrant outstanding | shares					988,390,000
Sharing Services Inc [Member] | Measurement Input, Expected Dividend Rate [Member]
Debt securities, trading, measurement input				0
Vector Com co. Ltd [Member]
Convertible debt		$ 88,599
Debt instrument, interest rate, stated percentage		2%
Debt instrument, term		2 years
Debt instrument, convertible, conversion price | $ / shares		$ 21.26
American Medical REIT Inc [Member]
Debt instrument, interest rate, stated percentage							8%
Notes receivable, related parties						$ 200,000	$ 200,000
Fair value of warrants					$ 0
Class of warrant or right, exercise price of warrants or rights | $ / shares							$ 5
Warrants and rights outstanding					$ 0
DSS Convertible Preferred Stock [Member]
Preferred stock, convertible, shares issuable | shares					42,575
Conversion of stock, shares issued | shares					6,570,170
Warrant [Member] | New Electric CV Corporation [Member]
Fair value of warrants				$ 327,565	$ 1,009,854

SCHEDULE OF COMPONENTS OF INCOM

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Current:
Federal		$ 45,736
State		46,179
Total Current		91,916
Deferred:
Federal	(3,905,452)	(2,725,007)
State	1,163,407	(1,266,545)
Total Deferred	(2,742,045)	(3,991,553)
Valuation Allowance	2,742,045	3,991,553
Total Income Tax Expense		91,916
Pre-tax Loss	$ (46,212,505)	$ (118,483,577)
Effective Income Tax Rate	0%	(0.10%)

SCHEDULE OF RECONCILIATION OF I

SCHEDULE OF RECONCILIATION OF INCOME TAX (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Federal Statutory Tax Rate	21%	21%
State Income Tax, Net of Federal Income Taxes	0%	0%
Intercompany Management & Oversight Fees	0%	(0.10%)
Capitalized Construction Costs	0%	0.20%
Minority interest in Partnerships	0%	0.10%
Deferred Finance Costs	(0.40%)	(0.20%)
Amort of BCF Debt Discount	0%	(9.00%)
Miscellaneous Permanent Items	0.20%	0%
Non includible foreign entities loss/(income)	(13.80%)	(9.60%)
Valuation Allowance	(7.10%)	(2.50%)
Effective Income Tax Rate	0%	(0.10%)

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Interest Income	$ (6,304,175)	$ (5,660,333)
Interest Expense	5,802,873	5,100,076
Depreciation and Amortization	(140,886)	(10,434)
Impairment	2,253,228	2,253,228
Accrued Expense	1,102,779	60,662
Unrealized Loss on Investment	4,324,883	2,512,554
Partnership Loss	13,175	13,175
Other Amortization	1,160,710
Others	377,180	(224,637)
Net Operating Loss	1,297,770	2,047,388
Total deferred tax asset	9,887,537	6,091,679
Valuation Allowance	(9,887,537)	(6,091,679)
Net Deferred Tax Asset

SCHEDULE OF OTHER COUNTRY INCOM

SCHEDULE OF OTHER COUNTRY INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Cumulative loss & other deferred tax assets before tax	$ (25,140,421)	$ (11,692,089)
Tax at the domestic tax rates applicable to profits in the countries where the Company operates	(4,273,872)	(1,987,655)
Deferred tax assets not recognized	4,273,872	1,987,655
Income tax expenses recognized in profit or loss		442,098
SG Companies [Member]
Operating Loss Carryforwards [Line Items]
Cumulative loss & other deferred tax assets before tax	$ (25,140,421)	$ (11,692,089)
Effective tax rates	17%	17%
Tax at the domestic tax rates applicable to profits in the countries where the Company operates	$ (4,273,872)	$ (1,987,655)
Deferred tax assets not recognized	4,273,872	1,987,655
Income tax expenses recognized in profit or loss
HK Companies [Member]
Operating Loss Carryforwards [Line Items]
Cumulative loss & other deferred tax assets before tax
Effective tax rates	16.50%	16.50%
Tax at the domestic tax rates applicable to profits in the countries where the Company operates
Deferred tax assets not recognized
Income tax expenses recognized in profit or loss
KR Companies [Member]
Operating Loss Carryforwards [Line Items]
Cumulative loss & other deferred tax assets before tax
Effective tax rates	25%	19.24%
Tax at the domestic tax rates applicable to profits in the countries where the Company operates
Deferred tax assets not recognized
Income tax expenses recognized in profit or loss		442,098
AU Companies [Member]
Operating Loss Carryforwards [Line Items]
Cumulative loss & other deferred tax assets before tax
Effective tax rates	30%	30%
Tax at the domestic tax rates applicable to profits in the countries where the Company operates
Deferred tax assets not recognized
Income tax expenses recognized in profit or loss

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Federal operating loss carryforwards	$ 7,573,000
State operating loss carryforwards	2,020,000
Deferred tax assets, valuation allowance	9,887,537	$ 6,091,679
Current federal tax expense		45,736
State income tax receivable		46,179
Foreign Tax Authority [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Operating loss carryforwards	4,270,000	1,990,000
Maryland State [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Current federal, state and local, tax expense (benefit)	143,574	151,211
Current federal tax expense	111,351	77,390
State income tax receivable	32,223	$ 73,821
Maximum [Member]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Deferred tax assets, valuation allowance	$ 3,795,858

SCHEDULE OF OPERATING AND RENEW

SCHEDULE OF OPERATING AND RENEWED LEASE TERMS RENTAL (Details)	12 Months Ended
	Dec. 31, 2022
Product Liability Contingency [Line Items]
Lessee, operating lease, description	As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are at a range from 0.5% to 4.5% per annum in 2022 and from 0.5% to 5.4% per annum in 2021
SG AI [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	June 2022 to May 2023
SG F and B [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	October 2021 to September 2024
Singapore - Four Seasons Park [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	July 2022 to July 2024
Singapore - Hapi Cafe [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	July 2022 to June 2024
Singapore - PLQ [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	December 2022 to July 2024
HONG KONG
Product Liability Contingency [Line Items]
Lessee, operating lease, description	October 2022 to October 2024
Hong Kong - Warehouse [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	November 2022 to October 2024
Hong Kong - Shop [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	October 2022 to September 2024
South Korea - Hapi Cafe [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	August 2022 to August 2025
South Korea - HWH World [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	August 2022 to July 2025
TX [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	May 2022 to January 2023
Bethesda, Maryland, USA [Member]
Product Liability Contingency [Line Items]
Lessee, operating lease, description	January 2021 to March 2024

SCHEDULE OF LEASE PAYMENTS (Det

SCHEDULE OF LEASE PAYMENTS (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
2023	$ 944,807
2024	656,668
2025	195,811
Total Minimum Lease Payments	1,797,287
Less: Effect of Discounting	(169,248)
Present Value of Future Minimum Lease Payments	1,628,039	$ 667,343
Less: Current Obligations under Leases	(45,556)	(283,989)
Long-term Lease Obligations	$ 1,582,483	$ 383,354

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Narrative)				12 Months Ended
	Dec. 31, 2018	Nov. 23, 2015 USD ($) a	May 28, 2014 USD ($) a	Dec. 31, 2022 USD ($) a	Dec. 31, 2021 USD ($) a ft²	Aug. 16, 2021 a	Oct. 13, 2019 USD ($)
Loss Contingencies [Line Items]
Area of land				197	15,811	19.5
Rental rate				$ 30,998,258
Rent expense				$ 685,724	$ 587,685
Lessee operating lease description				As our leases do not provide a readily determinable implicit rates, we estimate our incremental borrowing rates to discount the lease payments based on information available at lease commencement. Our incremental borrowings rates are at a range from 0.5% to 4.5% per annum in 2022 and from 0.5% to 5.4% per annum in 2021
Operating lease, right-of-use asset				$ 1,614,159	659,620
Operating lease, liability				1,628,039	667,343
Debt and lease obligation				$ 189,475	$ 188,125
Principal amount							$ 140,000
Interest rate							2.50%
Lots Sales Agreement [Member]
Loss Contingencies [Line Items]
Real estate improvements description	On December 31, 2018, SeD Maryland entered into the Third Amendment to the Lot Purchase Agreement for Ballenger Run with NVR. Pursuant to the Third Amendment, SeD Maryland converted the 5.9 acre CCRC parcel to 36 lots (the 28 feet wide villa lot) and sell to NVR. SeD Maryland pursued the required zoning approval to change the number of such lots from 85 to 121, which was approved in July 2019. Subsequently, SeD Maryland Development signed the Fourth Amendment to the Lot Purchase Agreement, pursuant to which NVR agreed to purchase all of the new 121 lots
Purchase of land lots | a				3	88
Purchase of land lots, net | a				479	476
Lots Sales Agreement [Member] | SeD Maryland Development LLC [Member] | Ballenger Run [Member]
Loss Contingencies [Line Items]
Area of land | a		197
Real estate sales		$ 15,700,000
Lots Sales Agreement [Member] | NVR Inc. [Member] | Ballenger Run [Member]
Loss Contingencies [Line Items]
Area of land | a			197
Real estate sales			$ 15,000,000
Minimum [Member]
Loss Contingencies [Line Items]
Rental rate				$ 2,335
Maximum [Member]
Loss Contingencies [Line Items]
Rental rate				$ 23,020

SCHEDULE OF OPTION ACTIVITY (De

SCHEDULE OF OPTION ACTIVITY (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Options for common shares, Outstanding at beginning	1,061,333	1,061,333
Exercise price, vested and exercisable at beginning	$ 0.09	$ 0.09
Remaining Contractual Term, outstanding	1 year	2 years	3 years
Aggregate intrinsic value, outstanding at beginning
Options for common shares, vested and exercisable at beginning	1,061,333	1,061,333
Exercise price, vested and exercisable at beginning	$ 0.09	$ 0.09
Remaining contractual term,vested and exercisable	1 year	2 years	3 years
Aggregate intrinsic value, vested and exercisable at beginning
Options for common shares, granted
Exercise price, granted
Options for common shares, exercised
Exercise price, exercised
Options for common shares, forfeited, cancelled, expired
Exercise price, forfeited, cancelled, expired
Options for common shares, Outstanding at end	1,061,333	1,061,333	1,061,333
Exercise price, outstanding at end	$ 0.09	$ 0.09	$ 0.09
Aggregate intrinsic value, outstanding at end
Options for common shares, vested and exercisable at end	1,061,333	1,061,333	1,061,333
Exercise price, vested and exercisable at end	$ 0.09	$ 0.09	$ 0.09
Aggregate intrinsic value, vested and exercisable at end

DIRECTORS AND EMPLOYEES_ BENE_3

DIRECTORS AND EMPLOYEES’ BENEFITS (Details Narrative)	12 Months Ended
	Dec. 31, 2022 shares
Share-Based Payment Arrangement [Abstract]
Stock reserved under incentive compensation plan	25,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)								12 Months Ended
	Mar. 17, 2023 USD ($)	Mar. 16, 2023 USD ($)	Feb. 06, 2023 USD ($) Integer $ / shares shares	Dec. 08, 2021 USD ($) shares	Jul. 30, 2021 USD ($) shares	May 13, 2021 USD ($) shares	Nov. 24, 2020 USD ($) shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Mar. 12, 2021 $ / shares
Subsequent Event [Line Items]
Issuance of Common Stock, shares | shares				3,374,624	3,374,624	3,374,624	108,000
Shares issued per share | $ / shares										$ 10.03
Issuance of Common Stock by Exercising Warrants				$ 105,000,000	$ 105,000,000	$ 105,000,000	$ 13,200,000	$ 3,895	$ 104,565,659
Common Stock [Member]
Subsequent Event [Line Items]
Issuance of Common Stock, shares | shares								15,819,452	67,502,481
Issuance of Common Stock by Exercising Warrants								$ 15,820	$ 67,502
Underwriting Agreement [Member] | Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Share price | $ / shares			$ 0.001
Issuance of Common Stock, shares | shares			1,727,273
Shares issued per share | $ / shares			$ 2.20
Number of days | Integer			45
Proceeds from offering			$ 3,300,000
Underwriting Agreement [Member] | Subsequent Event [Member] | Common Stock [Member] | Over-Allotment Option [Member]
Subsequent Event [Line Items]
Issuance of Common Stock, shares | shares			212,863
Rausch Coleman Homes Houston LLC [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Issuance of Common Stock by Exercising Warrants		$ 6,586,250
Davidson Homes LLC [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Issuance of Common Stock by Exercising Warrants	$ 10,022,500